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A quantitative study of collagen and elastin content in human lung tissue has
been made in relation to a morphometric measure of airspace size. The subjects
included non-smokers, smokers with and without macroscopic emphysema and
three subjects with alpha 1-protease inhibitor (al-Pi) deficiency. In the selection of
tissue samples, pleural and major bronchovascular structures were excluded,
thereby limiting the study to changes in the acinar unit. Airspace size was
determined morphometrically as Alveolar Wall surface area per Unit Volume of lung
(AWUV). Total collagen was determined as hydroxyproline and elastin was
determined as the specific cross-links desmosine and isodesmosine.
The results were as follows:
1. There were no significant differences in AWUV, collagen content or elastin
content between the upper and lower lobes within a single lung from both a non-
smoker and a smoker without macroscopic emphysema.
2. Analysis of 102 samples from 9 smokers' lungs with no signs of macroscopic
emphysema showed significant negative correlations between AWUV and
collagen content and between AWUV and elastin content such that as the surface
area of alveolar wall per unit volume decreased there was an increase in both the
collagen and elastin content of the remaining alveolar tissue. These results may
reflect the heterogeneity in the collagen content, elastin content and airspace size
of the various structures within the acinar unit, or, at least in the case of collagen,
may reflect the presence of fibrotic tissue within the alveolar walls as a result of
exposure to cigarette smoke.
3. In tissue samples from 14 non-smokers there was no significant correlation
between age and collagen content or between AWUV and collagen content.
4. Samples taken from smokers' lungs where either macroscopic centriacinar
emphysema or panacinar emphysema or a mixture of centriacinar and panacinar
emphysema were present were found to have a significantly higher collagen
content than samples from non-smokers. Samples from smokers' lungs without
macroscopic emphysema also had a higher collagen content than samples from
non-smokers though this was not statistically significant. This increased
collagen may represent fibrotic tissue in thickened alveolar walls as a result of
inflammatory injury caused by cigarette smoke followed by fibrotic healing.
i v
5. Tissue samples from the lungs of three al-Pi deficient subjects had
a significantly higher collagen content than samples from a non-smoker,
though there were no significant differences in elastin content.
The increase in collagen content is consistent with the presence of fibrotic lung
tissue.
In view of these findings the definition of emphysema, which states that no
obvious fibrosis is present, may have to be revised. The protease-antiprotease
hypothesis of emphysema, which attributes the loss of alveolar wall in emphysema
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The following is a list of abbreviations which are used in the main text of the thesis.
AMINO ACIDS
Single letter code Three letter code Amino acid
A Ala alanine
C Cys cysteine
D Asp aspartic acid






















a 1 -Pi alpha 1 - protease inhibitor
ANOVA analysis of variance
AWUV alveolar wall surface area per unit volume
of inflated lung
B/B0% amount of HRP-coupled second antibody
which is bound, expressed as a percentage
of that bound in the absence of soluble
antigen
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FACIT fibril-associated collagens with
interrupted triple helices
FIP Fast Interval Processor
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1.1 The Structure and Function of the Respiratory Tract.
The main function of the respiratory tract is to bring atmospheric oxygen into
close association with venous blood. The oxygen then diffuses into the blood and is
carried on haemoglobin to all the tissues of the body. Similarly waste carbon dioxide
is removed from the body when it diffuses from the blood into the respiratory tract.
Other functions include elimination of inhaled particles and organisms, filtration of
particulate matter from the circulation and metabolism of certain drugs and enzymes.
The lungs also serve as a route of administration of anaesthetic and other drugs and
have a role in water balance and the maintenance of blood pH (Seaton et al., 1989).
Efficient gas exchange is achieved by virtue of the large surface area of the
internal epithelium of the lungs. However, this also results in increased opportunities
for damage to the lungs by organisms, particles and gases and for absorption into the
body of harmful substances.
The upper respiratory tract, which includes the nose, the pharynx, the paranasal
sinuses, the eustachian tube and the larynx, has several functions besides air
conduction, including swallowing, air conditioning, smell and speech.
The lower respiratory tract begins where the trachea extends from the larynx.
The trachea runs down to the level of the fifth thoracic vertebra and averages about
10-12 cm in the adult human. At its lower end the trachea divides into the right and
left main bronchi. The right main bronchus divides into the right upper lobe
bronchus, which in turn divides into anterior, apical and posterior segmental bronchi,
and the bronchus intermedius. This latter gives off middle lobe and apical lower lobe
bronchi, then divides into the four basal segmental bronchi, anterior, medial (cardiac),
posterior and lateral. The middle lobe bronchus divides into medial and lateral
segmental bronchi. The left main bronchus gives off upper and lower lobe bronchi;
the upper lobe bronchus divides into apico-posterior and anterior segmental bronchi
and a lingular bronchus that in turn divides into superior and inferior bronchi.
The left lower lobe bronchus gives off an apical bronchus and then divides into
anterior, lateral and posterior segmental bronchi. There is no left medial basal
segmental bronchus. Anomalous bronchi are, however, relatively frequent
(Seaton etal., 1989; Flenley, 1990).
The trachea, main bronchi and lower lobe bronchi are outside the lung. All other
bronchi are situated within the lung.
The lower airways are known as bronchi down to the smallest divisions
containing cartilage, however sparse. They then become bronchioles, the final branch
of this type being the terminal bronchiole. Subsequent divisions contain increasing
numbers of alveoli in their walls and are called respiratory bronchioles; these give off
the alveolar ducts which then give off the alveolar sacs. The lung unit from each
terminal bronchiole is called the acinus (Figure 1.1).
Figure 1.1 Digital binary image from a histological section of human lung
parenchyma showing the successive change in structure from
proximal to distal end of the acinar unit. The dashed box
represents 1mm2 of tissue. Magnification x 40.
Kindly supplied by Dr. M.R. Lang, Department of Pathology,
University of Edinburgh. T = terminal bronchiole;
R = respiratory bronchiole; D = alveolar duct; A = alveolar sac.
From the smallest bronchi there are about 3-4 further sub-divisions of
bronchioles before the terminal one is reached. There are about 25,000 terminal
bronchi, each of which divides into two respiratory bronchioles (Horsfield, 1981).
There are usually two subsequent divisions of respiratory bronchioles, the more
peripheral branches containing more alveoli, and the final division is into alveolar ducts
which are completely surrounded by alveoli. Up to nine generations of alveolar ducts
occur before the alveolar sacs arise as the terminal unit of the airways.
There are about 28 orders of division of the tracheobronchial tree. The total number of
alveoli has been estimated to be between 2 and 6 x 10^ (Angus and Thurlbeck, 1972;
Hansen and Ampaya, 1975).
One side of each respiratory bronchiole is devoid of alveoli and in their place runs
a pulmonary artery. These vessels give off arteriolar branches which in turn supply
the capillaries to alveoli. Each alveolus is surrounded by a network of capillaries with
very thin walls composed of endothelial cells. The alveolar wall thus consists of a
layer of alveolar epithelial cells (Type I and Type II pneumocytes), their basement
membrane, a thin interstitial space which contains collagen and elastin, unmyelinated
nerves and occasional macrophages, the capillary basement membrane and capillary
endothelial cells (Corrin, 1981). In many places the basement membranes fuse,
minimising the distance for gas diffusion from alveolar space to capillary to about
0.2 pm. The capillaries then join to form venules which in turn become pulmonary
veins.
The pleura, which covers the lung, consists of a single layer of mesothelial cells,
without basement membrane. A layer of connective tissue separates it from the
adipose tissue of the chest wall and from alveoli.
1.2 Emphysema.
The National Heart, Lung and Blood Institute, at their workshop on the definition
of emphysema (Snider et al., 1985), reaffirmed the 1962 American Thoracic Society
definition of emphysema, but with the qualification that obvious fibrosis should be
absent. Emphysema was defined as "a condition of the lung characterised by
abnormal permanent enlargement of air spaces distal to the terminal bronchioles
accompanied by destruction of their walls and without obvious fibrosis".
Destruction was defined as "nonuniformity in the pattern of respiratory airspace
enlargement so that the orderly appearance of the acinus and its components is
disturbed and may be lost". An acinus is defined as "the respiratory airspaces arising
from a single terminal bronchiole". Destruction may be recognised by the naked eye,
by subgross examination (low power magnification) of an inflation-fixed lung slice,
or by light microscopic evaluation of thick (200 - 400 p.m) or thin (4-6 |im) stained
and mounted sections.
Three major anatomic subtypes of emphysema have been described based on the
portions of the acinus primarily involved, as observed in mild disease.
As emphysema becomes more severe, classification into the anatomic subtypes
becomes difficult. The three anatomic subtypes are:
a. Centriacinar emphysema (Leopold and Gough, 1957; Kuhn and Askin, 1985).
Centriacinar emphysema is characterised by selective and dominant involvement of the
respiratory bronchioles with subsequent extension of the process to the alveoli.
Two different forms are known. The first of these is classically associated with
cigarette smoking and air-flow obstruction and is known as centrilobular emphysema.
The lesion usually begins and is most severe in the upper lung.
The second form is associated with exposure to coal and other mineral dust and also
results in dilation of respiratory bronchioles with intense accumulations at those sites
of dust-laden macrophages. The lesion is relatively uniformly distributed in the lungs,
and has been termed focal emphysema. In those exposed to coal dust, the term coal
pneumoconiosis is used.
b. Panacinar emphysema (Wyatt et ai, 1962; Eriksson, 1965; Thurlbeck, 1976;
Kuhn and Askin, 1985). Panacinar emphysema, also known as panlobular
emphysema, tends to involve ah of the acinus uniformly. The process tends to be
worse at the base of the lung and to accompany the centrilobular emphysema of
cigarette smokers. As emphysema becomes severe, it is increasingly difficult to
distinguish between centrilobular and panacinar emphysema. Some pathologists feel
that centrilobular emphysema progresses into panacinar emphysema. Panacinar
emphysema is commonly observed with homozygous alpha 1-antitrypsin deficiency.
c . Distal acinar emphysema. In distal acinar emphysema, the alveolar ducts and
sacs are predominantly involved.
It has been shown that there is an age related increase in airspace size in
non-smokers, such that between one-third (Thurlbeck, 1967b) and one-quarter
(Gillooly and Lamb, 1993a) of the total alveolar walls are lost between the ages of
20 - 80 years (Figure 1.2). This increase in airspace size is not regarded as
emphysema but rather as a normal increase associated with advancing age in adult
lungs.
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Figure 1.2 Digital binary images from histological sections of human lung
parenchyma demonstrating the enlargement of airspace size with age
and as a result of panacinar emphysema. Magnification x 40.
Kindly supplied by Dr. M.R. Lang, Department of Pathology,
University of Edinburgh.
The association between homozygous alpha 1-antitrypsin deficiency and
pulmonary emphysema (Laurell and Eriksson, 1963) was dicovered at about the same
time as the work of Gross et al. (1964) on the experimental model of papain-induced
emphysema. The logical connection between these two independent studies was the
theory that emphysema might be due to an imbalance between naturally occurring
proteases and antiproteases. Much of the rationale for the experimental work done
since then arose from this concept.
Gross et al. (1964) were the first to produce an experimental model of
emphysema which bore any resemblance to human centrilobular emphysema.
They did this in rats by the intratracheal injection of the proteolytic enzyme papain.
They were attempting to ameliorate the fibrotic response of rat lungs to quartz dust
exposure, but instead noted the development of a patchy air-space lesion that
developed within hours after instillation of papain. Destruction of respiratory
bronchioles and alveolar ducts was believed to have occurred before alveolar wall
disruption.
Johanson et al. (1973) exposed rats to an aerosol of 10% papain for four hours.
They found that papain selectively attacked the amorphous component of elastic fibres,
leaving the micro-fibrils intact. Collagen was not altered histologically.
Connective tissues appeared normal in animals examined later than four weeks after
exposure. Taken together with the findings of Pierce et al. (1961), that the lung
content of collagen and elastin in human emphysema was not significantly different
from normal, the observations of Johanson et al. (1973) led these authors to propose
a pathogenic mechanism for the development of emphysema that involved acute
dissolution of elastin by proteolytic enzymes, followed by structural remodelling of the
lung with regeneration on the persisting microfibrillar skeleton. Following on from
this, Kaplan et al. (1973) produced emphysema in Syrian hamsters by an intratracheal
injection of porcine pancreatic elastase. The induction of emphysema was inhibited
by mixing the elastase with normal serum but not by mixing with serum deficient in
alpha 1-antitrypsin. The fact that another elastase occurs in granules of both neutrophil
polymorphonuclear leucocytes (neutrophils) and macrophages means that it is available
to act within the lung. Marco et al. (1971) demonstrated that aerosolised homogenates
of neutrophils and macrophages produced emphysema in dogs. Janoff et al. (1977)
showed, by an immunoperoxidase technique, the direct attachment of human
neutrophil elastase to elastic fibres within alveolar walls. In enzyme treated tissue,
some alveolar walls showed severe depletion of intercellular structures with the
exception of collagen, which was generally preserved.
Habitual cigarette smoking is probably the single most important aetiologic co-
factor in the pathogenesis of human emphysema. As early as 1964,
Anderson et al. showed a strong relationship between centrilobular emphysema and
smoking in 71 autopsies. No significant relationship was found between smoking
and panacinar emphysema. The importance of smoking and age in the development of
centrilobular emphysema has been confirmed by Thurlbeck et al. (1974), who looked
at random necropsies from three populations in Canada, Wales and Sweden and found
that the severity of emphysema was related to cigarette smoking. Age and sex also
played a role, with women having less emphysema than men when normalised for age
and smoking history.
Janoff and Carp (1977), in their search for a mechanism by which cigarette
smoking might favour excess of free proteases in the lung, showed that whole,
unfractionated cigarette smoke suppressed the antiprotease activity of normal human
serum, pure human alpha 1-antitrypsin and human bronchopulmonary lavage fluid.
Kilburn and McKenzie (1975) showed that cigarette smoke recruited neutrophils from
the trachea to the terminal bronchioles of hamster lungs. Neutrophil and macrophage
numbers are also increased in the lungs of cigarette smokers compared to non-smokers
(Pratt et al., 1969; Niewoehner et al., 1974; Hunninghake and Crystal, 1983).
It has also been shown that cultured alveolar macrophages release factors that are
chemotactic for neutrophils (Hunninghake et al., 1980; Merrill et al., 1980;
Cohen et al., 1982). Hunninghake and Crystal (1983) demonstrated that human
alveolar macrophages secrete neutrophil chemotactic factors when exposed to cigarette
smoke in vitro, and that unstimulated macrophages from smokers release more of these
factors than do cells from non-smokers. Nicotine, at high concentrations, has also
been shown to be a chemoattractant for neutrophils, whereas at more physiological
concentrations it enhances the chemotactic responsiveness of neutrophils to C5a, a
chemotactically active peptide generated during activation of the complement cascade
(Totti et al., 1984). Once inflammation has been initiated by cigarette smoke, products
of proteolysis might serve to maintain the inflammatory reaction.
Proteolytic digestion products of both elastin and collagen have been shown to have
chemotactic activity for neutrophils in vitro (Chang and Houck, 1970;
Senior et al., 1980).
By the late 1970s and early 1980s, therefore, data had accumulated suggesting
an inflammatory process, resulting from cigarette smoke, in the pathogenesis of
emphysema. Cigarette smoke had been shown to attract neutrophils and alveolar
macrophages into the lung and thereby increasing the protease burden in the lung, in
particular elastase. Cigarette smoke had also been shown to reduce the
anti-protease activity of alpha 1-antitrypsin, the natural defense against elastase.
The question, however, remained as to the mechanism by which cigarette smoke
inactivates alpha 1-antitrypsin. Alpha 1-antitrypsin inactivates serine proteinases of
vastly different specificities by forming 1 : 1 molar complexes which are stable even in
the presence of sodium dodecyl sulphate (Pannell et al., 1974). Johnson and Travis
(1978) showed that the reactive centre of human alpha 1-antitrypsin contains
a methionine residue. They later tested the importance of this residue by oxidising the
inhibitor with increasing concentrations of N-chlorosuccinimide
(SucNCl; Johnson and Travis, 1979). A maximum of two of the eight methionine
residues in the alpha 1-antitrypsin molecule were modified, even at very high levels of
oxidising agent (40 mol of SucNCl/mol of inhibitor). Over 95% inhibitory activity
towards porcine trypsin, porcine pancreatic elastase, and human neutrophil elastase
was lost when the two methionine residues were oxidised. However, if the oxidised
inhibitor was incubated with the three proteinases for extended periods of time much of
the inhibitory activity towards porcine trypsin and human neutrophil elastase was
regained but there was no inhibition of porcine elastase. N-terminal sequence analysis
of a peptide fragment obtained from a papain digest of oxidised alpha 1-antitrypsin and
purified by gel filtration and shown to contain the reactive site (Johnson and Travis,
1978) confirmed that the reactive centre methionine had been oxidised. Gel
electrophoresis revealed that trypsin and neutrophil elastase complexes with oxidised
alpha 1-antitrypsin were unstable after treatment with SDS. Johnson and Travis (1979)
concluded that it was quite likely that cigarette smoke contains, or is capable of
forming, oxidising agents which inactivate alpha 1-antitrypsin through conversion of
the reactive centre methionine to the sulphoxide or sulphone form, thereby reducing the
proteinase inhibitor activity that is normally present in the lung. A second source of
oxidants may be due to accidental biological oxidation. Myeloperoxidase (MPO), an
enzyme present in large amounts in human neutrophils acts together with hydrogen
peroxide (H2O2) and a halide to generate potent oxidants capable of reacting with
a variety of cellular and humoral targets (Clark, 1983). Although MPO serves its
primary role as a microbicidal agent within phagocytic vacuoles, it is released, along
with H2O2, into extracellular fluid during phagocytosis. Phagocytic cells, including
neutrophils, are present in increased numbers in the lungs of cigarette smokers.
Several workers have now shown that the elastase-inhibitory capacity of
alpha 1-antitrypsin is lost when exposed either to a cell-free MPO - H2O2 - halide
system or to human neutrophils, both of which result in a loss of the ability of the
inhibitor to bind and therefore inactivate human neutrophil elastase
(Carp and Janoff, 1980; Clark et al., 1981; Matheson et al., 1981;
Zaslow et al., 1983).
The neutrophil is now thought to be the most likely source of elastase in the
pathogenesis of human emphysema. Alveolar macrophages are thought to be a source
of neutrophil chemotactic factor and a possible endogenous source of elastase
(White et al., 1977; Campbell et al., 1979; Banda et al., 1980;
McGowan et al., 1983). In summary the protease-antiprotease hypothesis of the
pathogenesis of human emphysema in cigarette smokers is as follows: cigarette smoke
attracts alveolar macrophages to cluster around respiratory bronchioles (Niewoehner et
al., 1974) with a release of neutrophil chemotactic factor, and possibly elastase.
Neutrophils are recruited to the area from the blood and release elastase. Alpha 1-
antitrypsin (also known as alpha 1-protease inhibitor, al - Pi), the natural defense
against proteases, is rendered inactive by oxidation from oxidants present in cigarette
smoke or from the myeloperoxidase system of neutrophils or indeed both. Elastase is
then left, unimpaired, to breakdown the elastin fibre network ultimately leading to a
permanent loss of alveolar architecture.
1.3 Collagen.
1.3.1 Introduction.
The collagens are a family of proteins integral to the structure and function of the
extracellular matrix (Table 1.1). Some collagens represent the most abundant proteins
in a variety of vertebrate tissues, including lung. At least fourteen different types have
been discovered forming a wide range of structures in a range of tissue types (for
reviews see van der Rest and Garrone, 1991; Hulmes, 1992).
Collagens of various types are the major group of proteins in the lung and are present
in all the major structures, including airways, blood vessels, parenchyma and the
basement membranes of epithelial and endothelial cells.
Common to all collagens is the presence of one or several domains that have a
characteristic triple helical conformation. The amino acid sequences of the triple
helical domains are characterised by a repeating triplet amino acid sequence, X-Y-Gly,
where about 30% of the X and Y positions are occupied by proline and hydroxyproline
residues, respectively.
The collagen triple helix is composed of three polypeptide chains (a chains)
where each chain is itself a left-handed helix (Ramachandran and Kartha, 1954; 1955).
Each chain assembles with two other chains in a right-handed super-helix in which
every glycine residue is buried along the axis of the helix (Traub and Piez, 1971; Piez
and Miller, 1974). Since glycine is the only amino acid with no side chain, there is an
absolute requirement that it occupies every third position. Any other amino acid
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Table 1.1 Vertebrate collagens.
Most common Tissue
Class Type a chains molecular form distribution
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collagen I in tendon
and ligament.
XIV al(XTV) [al(XrV)]3 Skin and tendon.
Short chain
collagens
Vffl ai(vno, a2(Vm) ? Descemet's
membrane.








Long Chain vn al(VII) [oi(vn)b Associated with the
basement membrane
of certain epithelial
cell layers eg. at the
dermal-epidermal
junction in skin.
Collagen XIII Xffl al(Xm) [al(xm)b ? Skin and intestine
Collagen molecules are composed of three a chains. Different chains within a single molecule
are designated using Arabic numerals, while different collagen types are designated using
Roman numerals.
would perturb the triple helical conformation (Ramachandran and Reddi, 1976).
Amino acids in the X and Y positions have their side chains directed outward where
they can participate in lateral interactions, particularly with other triple helices.
The collagen types have been grouped according to their appearance in the
electron microscope. Collagens I, II III, V and XI appear as striated fibrils and are
therefore referred to as the fibrillar collagens. The banding pattern is a result of the
aligment of staggered 300 nm collagen molecules with gaps and overlaps
(Hodge and Petruska, 1963). Fibrils are formed as a result of lateral interaction
between homologous regions within the triple helical domains (Hulmes et al., 1973).
The molecules are staggered by approximately 67 nm (the D-stagger).
Fibrils of more than one collagen type have been shown to occur in vivo
(Henkel and Glanville, 1982; Keene et al., 1987; Birk et al., 1988;
Mendler et al., 1989).
1.3.2 Biosynthesis of Fibril-Forming Collagens.
The fibrillar collagens are first synthesised as precursor prepro a chains
containing N-terminal hydrophobic pre-peptide (or signal) sequences. The pre-peptide
probably binds to the membrane of the rough endoplasmic reticulum (E.R.) and leads
to the translocation of the prepro a chains into the cisternae of the rough E.R.
(Blobel et al., 1979; Davis and Tai, 1980). The signal sequence is then removed
during or shortly after translocation. In the rough E.R. cisternae the pro a chains
undergo extensive processing by post-translational modifications. Certain proline and
lysine residues are hydroxylated by prolyl 4-hydroxylase, to a lesser extent by prolyl
3-hydroxylase, and by lysyl hydroxylase, respectively (Kivirikko and Myllyla, 1985;
Kivirikko et al., 1989, 1990). The presence of hydroxyproline residues provides
critical stability to the triple helix of the collagen molecule which would otherwise be
unstable at body temperature (Prockop et al., 1979). Most of the hydroxylation
occurs while the nascent polypeptide chains are growing on the ribosomes.
Hydroxylation continues, however, after release of complete polypeptide chains from
the ribosomes into the cisternae of the rough E.R., until triple helix formation of the
pro a chains prevents any further hydroxylation. Prolyl 4-hydroxylase requires an
X-Pro-Gly sequence and lysyl hydroxylase an X-Lys-Gly sequence
(Kivirikko and Myllyla, 1985; Kivirikko et al., 1989, 1990). As a result
4-hydroxyproline and hydroxylysine occupy almost exclusively the Y position of the
X-Y-Gly sequence. Prolyl 3-hydroxylase requires a Pro- 4-hydroxyproline -Gly
sequence (Risteli et al., 1977). The exception to this rule occurs in the
non-triple-helical extensions at both the amino (N) and carboxy (C) terminals. In both
these regions, a single lysine residue, not followed by a glycine, is frequently
hydroxylated. Certain hydroxylysine residues are further modified by glycosylation,
both co-translationally and post-translationally (Kivirikko and Myllyla, 1979)
O-Glycosylation of hydroxlysine is catalysed by two specific enzymes:
(1) Galactosylhydroxylysyltransferase, which transfers galactose from UDP-galactose
to peptidyl hydroxylysine, forming O-a-D-galactosylhydroxylysine, and
(2) glucosylgalactosylhydroxylysyltransferase, which transfers glucose from
UDP-glucose to galactosylhydroxylysine, forming 0-(3-D-(2-a-D-glucosyl)-
galactosylhydroxylysine. The extent of glycosylation is variable for the different
genetic types of collagen and in the same collagen type from different tissues in the
same organism.
The C-propeptides of procollagen contain asparagine-linked carbohydrate units
that are not present in the collagen domain of the molecule (Olsen et al., 1977;
Clark, 1979; Torre-Bianco et al., 1992). A mannose-rich oligosaccharide side chain
is transferred to an asparagine residue in the -Asn-X-Ser/Thr-sequence
(Olsen et al., 1977; Clark, 1979; Torre-Bianco et al., 1992).
An important step prior to triple helix formation is association and registration of
the three chains through the globular C-terminal domains. Accompanying these
events is the formation of intra- and interchain disulphide bonds, catalysed by the
enzyme protein disulphide isomerase. Triple helix formation then proceeds,
in a zipper-like fashion, from the C-terminus to the N-terminal domain
(Engel and Prockop, 1991). It is thought that triple helix formation occurs within the
cisternae of the rough E.R. However, the possibility exists that the triple helix may
be formed only as the pro a chains reach the Golgi apparatus (Prockop et al., 1979).
All the fibrillar procollagens have the same overall structure (Mayne and
Burgeson, 1987). In addition to the main triple helical domain of about 337 Gly-X-Y
repeats, propeptides are present at both ends of the molecule. At the carboxyl end,
the disulphide-bonded globular portion (the C-propeptide) is separated from the triple
helix by a short linear domain which contains the C-proteinase cleavage site. At the
amino end, the N-propeptide is usually composed of three structural regions: a highly
variable globular region, a central short triple helical domain and a short linear domain
that connects the peptide to the main triple helix and which contains the N-proteinase
cleavage site. The globular region is absent in the pro a 2 (I) chain and is up to
383 residues in the pro a 1 (XI) chain (Yoshioka and Ramirez, 1990).
A number of possible functions have been suggested for the propeptides
(Prockop et al., 1979). As already discussed, the C-propeptides probably direct chain
association. Both propeptides may also prevent premature fibril formation,
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control fibrillogenesis, increase the rate and efficiency of folding of the pro a chains
into a triple helix and, after they have been cleaved, provide a negative feedback
mechanism to inhibit procollagen synthesis. Evidence suggests that both the
C-propeptide and the N-propeptide may function as a negative feedback inhibitor of
collagen biosynthesis (Wu et al., 1986, 1991; Bornstein and Sage, 1989). They may
also facilitate intracellular transport and packaging of procollagen into secretory
granules.
The procollagen molecules are secreted into the extracellular space from secretory
vesicles following packaging in the Golgi apparatus (Olsen, 1991).
During secretion, or immediately following it, the N- and C-propeptides are
enzymically removed by the procollagen N- and C-proteinases (Hojima et al., 1989).
The removal of the C-propeptide is necessary for fibril formation, whereas molecules
with intact N-propeptides can still form fibrils, but they are smaller in diameter than the
fibrils formed from fully processed collagen molecules (Fleischmajer et al., 1983;
Hulmes, 1983; Chapman, 1989). The enzymes are neutral proteinases and require
calcium for maximal activity. The N-propeptides of both type I and type II
procollagen are cleaved by the same enzyme (type I N-proteinase;
Hojima et al., 1989). The enzyme requires the triple helical conformation for maximal
activity. Synthetic peptides with identical sequences to the cleavage site in pro a 1 (I)
chains are not cleaved by the enzyme (Morikawa et al., 1980). A different calcium
dependent N-proteinase cleaves the N-propeptide of type III procollagen
(Nusgens et al., 1980; Halila and Peltonin, 1984, 1986). A C-proteinase, which
cleaves the C-propeptide of types I, II and III procollagens, has been purified from
several tissue sources (Hojima et al., 1985; Kessler et al., 1986). It also has a neutral
pH optimum and requires calcium for maximal activity. A glycoprotein, which has
been purified from mouse fibroblast culture medium and which is devoid of
procollagen processing activity itself, has been shown to enhance the activity of
C-proteinase (Kessler and Adar, 1989; Kessler et al., 1990).
The collagen molecules produced by cleavage of procollagen spontaneously
assemble into fibrils that are microscopically indistinguishable from mature fibrils
found in tissues. The immature fibrils, however, lack tensile strength until they are
cross-linked by a series of covalent bonds (Prockop et al., 1979). Cross-linking of
newly synthesised collagen fibrils is catalysed by the copper dependent enzyme lysyl
oxidase (Kagan and Trackman, 1991). Lysyl oxidase catalyses the oxidative
deamination of the £ amino groups of certain lysine and hydroxylysine residues to the
corresponding aldehydes allysine and hydroxyallysine, respectively. These aldehydes
spontaneously condense with non-oxidised or oxidised lysines (or hydroxylysines)
to form various Schiff base and aldol condensation cross-links, respectively.
Collagens I, II and III contain four sites involved in cross-linking. Two sites are at
the end of the molecule in the non-triple helical regions (telopeptides) and two are
towards each end of the triple helix. An allysine or hydroxyallysine in the telopeptide
of one collagen molecule reacts spontaneously with a lysine or hydroxylysine in the
triple helix of an adjacent molecule in a head to tail configuration, thus stabilising the
D stagger. Initially, a number of bi-functional cross-links are formed. As collagen
matures a variety of tri-functional cross-links are formed (Eyre et al., 1984;
Last et al., 1990).
1.3.3 Non-fibril Forming Collagens.
1.3.3.1 Collagen IV.
Collagen IV, one of a number of non-fibrillar collagens, is a major component of
basement membranes. Basement membranes are sheet-like structures composed of
laminin, heparan sulphate proteoglycans, nidogen (entactin) and BM-40 (osteonectin,
SPARC) entrapped in a network of collagen IV (Timpl, 1989).
They are produced by epithelial, endothelial, and many mesenchymal cells and provide
a number of functions including support for cells and cell layers, selective molecular
sieves such as the glomerulus of the kidney, and between tissue compartments.
They also act to impede inflammatory and tumour cells and are involved in cell
attachment, growth and differentiation (Yurchenco and Schittny, 1990).
The collagen IV molecule which has been characterised extensively is
a heterotrimer consisting of two a 1 (IV) chains and one a 2 (IV) chain.
Evidence exists for the presence of three additional chains (a 3 (IV), a 4 (IV) and
a 5 (IV)), although it is not known whether they can form heterotrimers with either the
a 1 (IV) or a2 (IV) chains (Saus et al., 1988; Hostikka et al., 1990). Their molecular
assemblies are also not known. The collagen IV molecule measures approximately
400 nm in length and possesses a globular, non-collagenous (NC), domain at its
C-terminus (NCI) and a short 30 nm triple helical segment at the N-terminus (the 7S
domain) which has a role in oligomer formation. Unlike the fibrillar collagens, the
molecule is not proteolytically modified before self-assembly. The main triple-helix
also differs from the fibrillar collagens in that it is interrupted by short non-triple
helical sequences. In human collagen IV there are 21 interruptions in the a 1 (IV)
and 23 in the a 2 (IV) chain and these match each other in location in most cases to
give a total of 25, fairly evenly distributed, interruptions along the helix
(Timpl, 1989). Electron microscopy has shown that these interruptions impart
increased flexibility to the molecule (Hofmann et al., 1984). A characteristic feature
of the triple-helical domain is the presence of seven or eight Cys residues, mainly
located in the non-helical sequences and in the 7S domain, which are involved in intra-
and inter-molecular cross-links (Timpl, 1989). The a 1 (IV) and a 2 (IV) segments of
the globular NCI domain each have six Cys residues. Each set of Cys residues forms
three disulphide bonds to give two symmetrical sub-domains within the NCI segment
(Siebold et al., 1988).
Collagen IV self-assembles into a stable three-dimensional network using three
types of interaction. Dimers can be generated by interactions between the
NCI domains while tetramers are formed by the lateral association of 7S segments
which are aligned alternatively in parallel and antiparallel fashion. The dimers are
stabilised through disulphide exchange between corresponding Cys residues of two
monomeric domains (Siebold et al., 1988). The tetramers are stabilised through
disulphide bonds and non-reducible lysine and/or hydroxylysine derived cross-links.
A further function of the NCI domain may include the selection and alignment of
newly synthesised al (IV) and a2 (IV) chains, since evidence suggests that folding
of the triple helix starts from its C-terminus (Dolz et al., 1988). The third type of
interaction occurs through the lateral association of two dimers (Yurchenco and
Schittny, 1990), to form an irregular polygonal network.
1.3.3.2 FACIT Collagens.
Collagens IX, XII and XIV constitute a group of fibril-associated collagens with
interrupted triple helices (FACITS, Gordon and Olsen, 1990). They do not form
fibrils themselves, but are specifically associated with certain fibrillar collagens.
The best studied of this group is collagen IX which is associated with collagen II
(Mayne and Burgeson, 1987). Collagen IX is a heterotrimer composed of three distinct
chains, a 1 (IX), a 2 (IX) and a 3 (IX). Four non-helical or non-collagenous (NC)
domains interrupt three helical/collagenous (COL) domains.
COL 1 and COL 2 are involved in the interaction with collagen II fibrils via covalent
cross-links (van der Rest and Mayne, 1988). The NC3 domain acts as a hinge, such
that the COL 3 and NC4 domains extent outwards from the fibril surface. The NC3
domain of the a 2 (IX) chain contains a five amino acid insertion which provides an
attachment site for a glycosaminoglycan side chain. The size of the side chain is
variable. It is absent or small in cartilage and very large in avian vitreous humor
(Brewton et al., 1991). The N-terminal NC4 domain has an estimated isoelectric
point of about 10, and is therefore thought to interact with the acid proteoglycans
found in the cartilage matrix (Vasios et al., 1988). However, the absence of an NC4
domain in avian vitreous humor suggests that an alternative function of collagen IX
may be the attachment of the large glycosaminoglycan side chain to collagen II fibrils.
In cartilage, the N-terminal NC4 domain of the a 1(IX) chain is 243 residues
long. However, in the primary stroma of the chick cornea this domain is only a few
amino acid residues long (Svoboda et al., 1988). This is due to the use of two different
transcription start sites in the a 1 (IX) gene (Nishimura et al., 1989).
An alternative promoter and first exon are located about 20 kilobase pairs downstream
from exon 1 in an intronic sequence of the a 1 (IX) gene (between exons 6 and 7).
This alternative promoter and first exon have also been found in the mouse and human
al(IX) gene (Muragaki et al., 1990).
Collagen XII is a homotrimer, [a 1 (XII)]3, containing two COL domains and
one large N-terminal NC3 domain (Dublet et al., 1989). Collagen XII interacts with
collagen I fibrils in tendons and ligaments possibly via the COL 1 domain.
Collagen XIV is the latest FACIT to be discovered. It is a homotrimeric
molecule found in skin and tendon (Gordon et al., 1991). Characterisation of the
molecule at the cDNA and protein levels indicates that it is similar to but clearly distinct
from collagen XII.
1.3.3.3 Short-chain Collagens.
Molecules of collagens VIII and X are half the length of the fibrillar collagens and
are therefore referred to as the short-chain collagens. As with all non-fibrillar
collagens, their triple helices are interrupted by several short non-helical domains.
Collagen X is synthesised by hypertrophic chondrocytes during the process of
endochondral bone formation (Schmid and Linsenmayer, 1987). The molecule is a
homotrimer, [a 1 (X)]3, with three domains: (a) a short non-helical region at the
N-terminus, (b) the main, interrupted, triple helical region, and (c) a globular
C-terminus. Within the hypertrophic cartilage, collagen X is found as pericellular
mats of filamentous material which surround the hypertrophic chondrocytes, and some
is found along the surface of collagen II fibrils (Schmid and Linsenmayer, 1990;
Poole and Pidoux, 1989). The structure of collagen VIII predicted from cDNA
analysis is similar to that of collagen X. The non-helical N-terminal domain of
collagen VIII is, however, considerably larger than that of collagen X, and a portion of
the C-terminal globular domain shows some differences (Yamaguchi et al., 1989).
Collagen VIII was first isolated from endothelial cell cultures by Sage and Bornstein
(1987) and is a component of the basement membrane (Descemet's membrane)
separating corneal endothelial cells from the corneal stroma where it appears as a
hexagonal network (Sawada et al., 1990). Two chains have been characterised from
Descemet's membrane, a 1 (VIII) and a 2 (VIII). The stoichiometric arrangement of
the two chains remains, however, to be established.
1.3.3.4 Collagen VI.
Collagen VI, which is found in most connective tissues, is a heterotrimer made
up of three different chains: a 1 (VI), a 2(VI) and a 3 (VI) (Timpl and Engel, 1987).
An unusual feature is the relatively short (105 nm) central triple helix which accounts
for less than half of the total mass of the protein. The triple helix is further
characterised by two non-helical interruptions and 11 Arg-Gly-Asp repeats throughout
the triple-helix. Such sequences have been shown to have a role in the interaction of
matrix proteins, in particular fibronectin, with integrin cell receptors
(Sekiguchi, 1991). The non-helical N- and C-terminal domains are characterised by
the presence of repeats showing significant similarities to the A domains of von
Willebrand factor (van der Rest and Garrone, 1991).
The mode of molecular aggregation of collagen VI has been studied using rotary
shadowing and electron microscopy of native and partially denatured or digested
molecules (Timpl and Engel, 1987). Dimers are first formed by a staggered anti-
parallel aligment of monomers with a 75 nm overlap in their triple-helical domains.
Tetramers are then formed by the lateral association of dimers with their ends in
register.
1.3.3.5 Collagen VII.
Collagen VII is found associated with the basement membrane of certain
epithelial cell layers (e.g. at the dermal-epidermal junction in skin) where it forms
anchoring fibrils linking the basement membrane to anchoring plaques found within
the underlying matrix (Burgeson, 1987). It is thought to be a homotrimer consisting
of a large, approximately 420 nm long, interrupted triple-helix and two non-helical
domains, one at each end of the triple-helix. The N-terminal domain consists of three
50 nm long arms each terminated by a small globular domain. The C-terminal domain
consists of a small globular region which is thought to be proteolytically removed
during molecular assembly. Molecules first assemble into anti-parallel dimers with an
overlap of 60 nm at the C-terminal end. The region of overlap is stabilised by
disulphide bonds. The dimers then aggregate in register to form the anchoring fibril.
The anchoring fibrils form a bridge between the basement membrane and the anchoring
plaques probably via binding of the large globular N-terminal domain to collagen IV
found both in basement membrane and in the anchoring plaques
(van der Rest and Garrone, 1991). The resulting network entraps other matrix
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components such as collagen I and collagen III fibrils, thus forming a firm connection
between the epithelium and stromal matrix.
1.4 Collagen and the Lung.
1.4.1 Amounts and Types of Collagen.
It has been estimated that collagen comprises between 10-20% of the dry weight
of the adult human lung and between 60-65% of lung connective tissue
(Rennard and Crystal, 1982). Collagens I and III account for approximately 90% of
lung parenchymal collagen in a ratio of 2 : 1 (Seyer et al., 1976;
Rennard and Crystal, 1982; Kirk et al., 1984a). Immunofluorescence studies with
type-specific antibodies have shown that collagens I and III are found throughout the
interstitium of the alveolar structures (Madri and Furthmayr, 1980;
Raghu et al., 1985). Collagens I and III are also present in the connective tissue
sheaths that surround the tracheobronchial tree and are found in all regions of the
pulmonary arteries and veins as well as in the visceral pleura
(Rennard and Crystal, 1982).
Collagen II in lung is confined to the cartilage of the trachea and large bronchi
(Bradley et al., 1974).
Collagen IV is the major component of basement membranes and therefore has
been localised to the epithelial and capillary basement membranes of the alveolar
structures where it constitutes approximately 5% of parenchymal collagen
(Rennard et al., 1980a; Madri and Furthmayr, 1980). It is also found in the
endothelial basement membranes of the pulmonary arteries and veins and the epithelial
basement membranes of the tracheobronchial tree.
Collagen V is also present in basement membranes. In the alveolar structures it
is not clear whether it is limited to the epithelial and endothelial basement membranes
or whether it is present in the interstitial matrix as well (Madri and Furthmayr, 1979;
1980). Collagen V is thought to constitute approximately 5% of parenchymal lung
collagen (Rennard et al., 1980a).
It seems likely that some of the minor collagens which are associated with certain
fibrillar collagens in other areas of the body will be found in the lung. Thus, collagen
VI may be found co-distributing with collagens I and III in the pulmonary vasculature
and interstitium and collagens IX, X and XI may be associated with collagen II in
cartilage (Laurent, 1986).
The collagen content (amount/dry weight) of the tracheobronchial tree and
pulmonary vasculature is greater than that in the parenchyma. However, as the total
mass of the parenchyma is much larger, the bulk of the collagen is found in the
alveolar structures (Rennard and Crystal, 1982).
The data available on the collagen content of lung in relation to age is conflicting.
Pierce and Hocott (1960), and Wright et al., (1960) found no significant correlation
between right middle lobe collagen or total lung collagen, respectively, and age.
Briscoe et al., (1959) showed an increase in parenchymal collagen, as a percentage of
dry weight, with increasing age, while Johnson and Andrews (1970) showed a
decrease in parenchymal collagen, as a percentage of total ("crude") parenchymal
connective tissue, with increasing age. These disagreements seem to be due to
sampling techniques and to the way the data is expressed.
Andreotti et al (1983) found a decrease in collagen with age when the data were
expressed, more appropriately, per unit volume of lung parenchyma after inflation at a
standard pressure of 25 cm H2O followed by fixation with formalin. Andreotti et al.
(1983) found no correlation between collagen content and age when collagen was
expressed per gram dry weight of tissue, a method which does not take into account
possible changes from normal in the amount of alveolar wall per unit volume.
1.4.2 Turnover.
During normal growth and development, as well as repair of tissues, it is
important that the process of collagen synthesis be counterbalanced by collagen
degradation. The major pathway of degradation involves a group of enzymes known
as the collagenases (Harris et al., 1984; Jeffrey, 1986). These are neutral
metallo-proteases requiring both Ca2+ and Zn^+ for activity. The best characterised
collagenases are capable of degrading collagens I, II and III. They attack the collagen
molecule at one specific site in the triple helix to produce a N-terminal three-quarter
fragment and a C-terminal one-quarter fragment. At body temperature the fragments
denature to random coils and are further degraded by other proteases. The fragments
may also be taken up by cells by phagocytosis and be further degraded within
lysosomes (Etherington, 1980). The cathespins B and N, found within lysosomes,
have been shown to have collagenolytic activity.
Most studies of collagen turnover have utilised radiotracer techniques where the
incorporation of radiolabeled proline into collagen is followed. Synthesis is
determined from the specific radioactivity of proline and hydroxyproline in collagen
extracted at various time points. Similarly, degradation can be determined from the
specific radioactivity of hydroxyproline in the tissue-free pool.
Using these techniques it has been shown that lung collagen in rats and rabbits is
being synthesised at a rate of about 9-10% per day (i.e., an amount of collagen
equivalent to 9-10% of the total pool), and that a significant proportion (up to a third)
of newly synthesised collagen (procollagen) is degraded rapidly after its production,
probably intracellularly (Laurent, 1982; McAnulty and Laurent, 1987).
Because radiotracer studies are limited to a few hours duration, the measured rates of
collagen turnover reflect only the early phases of the molecular assembly of collagen
and not the turnover of mature cross-linked collagen. Cross-linking and maturation of
collagen has been shown to take days and even weeks for completion
(Pinto and Bentley, 1974).
It seems likely that turnover of mature cross-linked collagen is most relevant in
pathophysiological processes in the lung. However, Laurent and McAnulty (1983)
demonstrated both an increased synthesis and decreased degradation of collagen in the
early stages of fibrosis in rabbits caused by the intratracheal instillation of bleomycin.
1.5 Elastin.
Elastin is a major component of the connective tissue of blood vessels and the
lung. It is also present in elastic cartilage, skin, ligaments and the uterine cervix.
Elastin exhibits an intrinsic elasticity that gives the tissues where it is present an
extensibility and subsequent recoil dependent only on the application of some physical
force.
The elastic fibre is composed of two chemically and morphologically distinct
components. An amorphous component, elastin, is the major fraction, comprising
90% of the mature fibre. Unlike collagen, elastin lacks any repeating pattern when
seen under the electron microscope. The second, microfibrillar, component is
a glycoprotein which appears as small fibrils 10-12 nm in diameter located at the
periphery of the amorphous elastin. Evidence suggests that the microfibrils are
secreted into the extracellular matrix before elastin synthesis and function as
a nucleation site for elastin deposition (Ross et al., 1977). As development proceeds,
the fibrillar component becomes saturated with the elastin and as a result is seen only at
the periphery of mature elastin fibres. Kadar and Robert (1975) demonstrated
morphologically that removal of the elastin component resulted in the appearance of the
underlying fibrillar component. Elastin synthesis has been documented in fibroblasts,
smooth muscle cells, chondrocytes, endothelial cells and, more recently, in lung
mesothelial cells (Mecham et al., 1981; Burke and Ross, 1979; Quintarelli et al., 1979;
Cantor et al., 1980; Mecham et al., 1983; Mandl et al., 1986). The process is initiated
by transcription from the elastin gene and data indicates that elastin synthesis is
regulated by the transcription and availability of elastin messenger RNA
(Burnett et al., 1980). Translation of the messenger RNA produces the soluble
precursor molecule, tropoelastin, first purified and partially characterised by
Sandberg et al. (1969) from copper-deficient porcine aorta. Tropoelastin is secreted
into the extracellular matrix as a protein with a molecular weight of 72,000 and with a
similar amino acid composition to insoluble elastin except that it contains additional
lysine residues. Recent evidence suggests that alternative splicing of a single elastin
gene may give rise to distinct messenger RNA molecules (Indik et al., 1987;
Raju and Anwar, 1987; Yeh et al., 1989). Translation of such elastin messenger RNA
molecules would result in significant variation in amino acid sequence. In fact three
tropoelastin isoforms have been identified in chick lung (Rich and Foster, 1987), and
a variety of bovine tissues (Wrenn et al., 1987; Parks et al., 1988). The proportion of
the bovine tropoelastin isoforms appear to vary according to the stage of development
(Parks et al., 1988).
Elastin is cross-linked by the unique amino acids, desmosine and isodesmosine
(Partridge et al., 1963; Thomas et al., 1963). Lysyl oxidase is the enzyme that
initiates the biosynthesis of the cross-links by catalysing the oxidative deamination of
the e amino groups of all but five or six of the total 37 lysine residues to
oc-aminoadipic semi-aldehydes (Pinnell and Martin, 1968). These reactive residues
(allysines) spontaneously condense to form various Schiff base and aldol condensation
crosslinks. Within a few days most of the cross-links have isomerised into the stable
quaternary pyridinium ring structures of desmosine and isodesmosine (Figure 1.3).
Desmosine and isodesmosine are tetrafunctional but normally join only two chains.
Sandberg and Davidson (1984) hypothesised that the amino acid sequence - Lys - Ala -
Ala -Lys - of one molecule meets the amino acid sequence - Lys -Ala - Ala - Ala - Lys
- of another molecule. Three Lys residues in these sequences are converted to allysine
residues and the fourth provides the ring nitrogen of the pyridinium cross-link. It is
not clear how the final cross-links form. However, coacervation may play a role by
closely apposing the appropriate residues (Urry et al., 1974).
Two other cross-linking amino acids have also been found, lysinonorleucine,
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Figure 1.3 The structures of the elastin-specific cross-links desmosine,
isodesmosine and merodesmosine.
Adapted from Mecham and Heuser (1991).
One of the main features of elastin-containing tissues is their ability to be deformed to
large extensions by relatively small forces and then return to their original dimensions.
Elastin can be extended by 100-150% before it breaks, compared to fibrillar collagen
which breaks at extensions of about 5 - 8%. The precise physicochemical properties
that account for elastin's rubber-like characteristics have not been fully characterised.
Thermodynamic studies of purified elastin led Hoeve and Flory (1974) to propose that
elastin behaves as a classical "rubber" consisting of cross-linked chains randomly
oriented. According to the model, an unstretched rubber network is in a state of
maximum entropy (i.e. maximum disorder), and an external force that acts to extend
the network will increase the order of the network (i.e. decrease its entropy) by
imposing a degree of preferred orientation in the direction of extension on each of the
random chains in the network. When the external force is removed, elastic recoil
occurs because the ordered chains return to their initial, disordered state according to
the second law of thermodynamics which states that systems proceed spontaneously to
a state of maximum entropy. Nuclear magnetic resonance (NMR) studies on elastin
indicate that the backbone chain of the elastin monomer is highly mobile
(Torchia and Piez, 1973; Fleming et al., 1980).
Although the dominant molecular pattern of elastin is that of a kinetically free,
random-coil network there are some features of elastin structure that indicate regions of
local order. Circular dichroism has indicated the presence of helical secondary
structure associated with the alanine-rich sequences in the crosslink regions
(Foster et al., 1976). Several hydrophobic repeat sequences are also found in elastin,
including the pentapeptide Pro - Gly- Val- Gly - Val and a hexapeptide Pro - Gly - Val
- Gly - Val - Ala. It has been shown that both sequences contain a (3 turn and,
consequently, when repeated several times on a helical axis form a (3 spiral
(Urry, 1983). These areas of secondary structure could serve to restrict movement
around chemical bonds and, therefore, the kinetic mobility assumed for an ideal rubber
may not hold for all areas of elastin.
Elastin is an extremely hydrophobic protein with approximately 70% of its amino
acid side chains being nonpolar. This property has led several workers to propose
alternative models of elastin structure which account for its elasticity
(Weis-Fogh and Andersen, 1970; Gray et al., 1973; Urry et al., 1974).
These models stress the importance of water-protein interactions in the mechanism of
elastic recoil. The authors state that hydrophobic interactions are disrupted when
nonpolar regions of the molecule are exposed to water when elastin is stretched.
Elastic recoil occurs due to the reaggregation of the nonpolar groups with the expulsion
of the absorbed water. Like the "rubber" model the elastic energy is stored as
a decrease in entropy though in this model the entropy is largely associated with the
water. Further thermodynamic studies made by Gosline (1978) support the idea that
water-protein interactions contribute to the elastic mechanism but the results are in no
way at variance with the "rubber" model. The actual mechanism is probably a
dynamic blend of these two extremes.
1.6 Elastin and the Lung.
The elasticity of the lung is determined most importantly by elastin.
Elastic fibres are ubiquitous in the lung, and as with other organs these fibres are
closely associated with collagen and proteoglycans. Morphologic studies have
demonstrated elastic fibres in all the major lung structures, including airways, blood
vessels, parenchyma, and pleura (Starcher, 1986). In the larger pulmonary arteries
and airways elastic fibres are present both as loops and as longitudinal bundles.
In the vessels fibres are more prominent in the media but they are also evident in the
adventitia and intima. The fibres are also seen in the submucosal areas of the airways.
In the respiratory bronchioles, elastic fibres become more distinct distally.
Light microscopic observations have shown that elastic and collagen fibres
assume an integral fibre network which forms the architectural skeleton of the alveolar
structure. Elastic and collagen fibres encircle respiratory bronchioles and alveolar
ducts in a helical fashion. They then completely encircle the alveolar mouths before
appearing as a fine mesh in the alveolar walls (Pierce and Ebert, 1965;
Young et al., 1980). Using electron micrographs, Mercer and Crapo (1990) produced
reconstructions of elastic and collagen fibres in order to determine their spatial
arrangement within the acinar unit. These authors found that in normal human lungs
the highest concentrations of collagen and elastic fibres were found in the alveolar
tissue, where they surrounded the alveolar ducts. In this region the collagen-to-elastic
fibre ratio was 1.0. Further out from the alveolar ducts, in the alveolar walls, the
collagen-to-elastic fibre ratio was 1.5-2.0. They also found that the elastic fibres
encircling the alveolar mouths occurred in two configurations relative to the adjacent
collagen fibres. In one configuration, the elastic fibres were in intimate contact with
the adjacent collagen fibres and were seen to be interwoven with numerous collagen
fibrils of the collagen fibre, indicating some sort of mechanical interconnection.
In the second configuration, elastic fibres were in a tight band-like configuration and
were spacially separated from the adjacent collagen fibres. Collagen fibrils of the
alveolar duct wall were found to have a wave-like arrangement and meandered about
one another with no apparent order or uniform pattern.
The close association of collagen and elastic fibres does not seem to support the
theory that axial elongation of elastic fibres accounts for the elasticity of the lung.
While elastin has a large range of extensibility and exhibits ideal elastic behaviour,
collagen has a high tensile strength and a short range of extensibility. Elastic fibres,
therefore, may be unable to undergo axial elongation owing to the inelasticity of
collagen. The spiral arrangement of closely associated elastic and collagen fibres
around the alveolar ducts led Pierce and Ebert (1965) to propose an alternative model.
They proposed that the lung expands by unfolding its structure with the extension of
the ductal helices. This uncoiling of the helices produces torsion or twisting in the
tissue fibres leading to elastic recoil as the fibres react against this deformation.
The Setnikar and Mead model (for review see Snider and Karlinksy, 1977), on the
other hand, proposes that elastic and collagen fibres operate in parallel and
independently of each other. The model, based on the observations made by
Orsos (1907) and von Hayek (1960) that the collagen fibres of human lungs appear as
wavy bundles, assumes the collagen fibres to be spirally coiled or serpentine at resting
lung volume. At low lung volumes the elastic fibres are extensible. As lung volume
increases the coiled collagen fibres straighten, resulting in a falling compliance of the
combined networks and greatly increased stiffness of the lungs at maximal lung
volume. The collagen network is, therefore, believed to limit total pulmonary
distention. In vitro and in vivo studies, using collagenase or elastase for selective
disruption of connective tissue components, support the theory of parallel functioning
of elastic and collagen fibres (Snider and Karlinsky, 1977). Most recently, Mercer and
Crapo (1990) found that collagen fibrils of alveolar wall collagen fibres have
a wavelike arrangement, in keeping with the model, and may be extended by as much
as 16% before they become straight and limit further extension.
Elastin has been estimated to constitute approximately 18% of dry weight of the
lung connective tissue (Pierce et al., 1961). Dissection of the lung into pleura,
bronchioles, large blood vessels, and parenchyma has shown that the highest amount
of elastin is found in parenchyma (16-40% dry weight of connective tissue;
Pierce and Ebert, 1965).
Many authors have reported an increase in lung elastin with age.
Pierce and Hocott (1960) found an increase in the elastin content of the right middle
lobe with increasing age. Wright et al. (1960) also found an increase in total lung
elastin with age. Briscoe and Loring (1958) and Johnson and Andrews (1970)
showed an increase in parenchymal elastin with increasing age when expressed as a
percentage of dry weight of tissue or as a percentage of total ("crude") connective
tissue, respectively. Pierce and Ebert (1965) and John and Thomas (1972), however,
could demonstrate an age related increase in the elastin content only in the pleura,
with no change in the parenchyma. As with the studies on the collagen content of the
lung with increasing age, the disagreements seem to be due to sampling technique and
to the way the data is expressed. Andreotti et al. (1983) reported an increase in
parenchymal elastin with age when expressed in milligrams per gram of dried
parenchyma, but could find no correlation with age when elastin content was
expressed per unit volume of parenchyma after inflation at standard pressure of 25 cm
H2O followed by fixation with formalin.
Physiological turnover of insoluble elastin appears to be very slow.
Under normal conditions the mature lung parenchymal elastin is metabolically stable
over the human life span (Shapiro et al., 1991).
1.7 The Collagen and Elastin Content of the Lung in Emphysema.
The earliest studies of the collagen and elastin content of normal and
emphysematous lungs were made by Wright et al. (1960) and Pierce et al. (1961).
Whole lung measurements did not show any alteration in the content of collagen or
elastin in severe pulmonary emphysema as compared to a series of control lungs.
A study of individual tissue blocks also showed no relationship between collagen and
elastin content and the severity of emphysema (Pierce et al., 1961). Pecora et al.
(1967) refined the sampling technique and obtained 5 gram pieces of lung tissue from
multiple sites within a lung to get a more representative picture. They found that the
mean collagen content per 100 grams wet weight of tissue in the emphysematous
group was greater than, and the elastin values were about the same as, that of the
control group. Importantly, the data of Pecora et al. (1967) were more representative
of parenchymal tissue, since most of the samples were obtained from peripheral areas
that are relatively low in bronchial or brochiolar tissue. Total lung collagen content of
the emphysematous lungs was greater than, and the elastin content was less than, that
of the control group. Chrzanowski et al. (1980) measured the elastin specific cross-
linking amino acids desmosine and isodesmosine in 1 gram aliquots of lung
parenchyma, after removal of pleura, large airways and blood vessels, in normal lungs
and in lungs with panacinar emphysema associated with abnormal alpha 1 -Pi
phenotypes. Elastin proportions were expressed as a percentage of parenchymal
crude connective tissue. The results showed significantly reduced proportions of lung
elastin in pulmonary emphysema except in patients treated with glucocorticoids which
may decrease collagen synthesis and, therefore, increase the relative proportions of
elastin.
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Biochemical measurements have also been made on animal models of
emphysema (for reviews see Karlinsky and Snider, 1978; and Snider et al., 1986).
In general, total lung elastin has been shown to be significantly reduced immediately
after intratracheally instilled elastase but then returns to normal after several weeks.
In vivo radiolabelling techniques have confirmed biosynthesis of lung elastin after its
degradation. Total lung collagen changes little after elastase treatment.
However, in vivo radiolabelling with l^C-proline has revealed an increase in collagen
biosynthesis following elastase treatment (Yu and Keller, 1978; Kobrle et al., 1982;
Karlinsky et al., 1983). These studies indicate that damage and repair of collagen are
a part of elastase-induced emphysema. However, the proportion of total lung collagen
damaged must be very small, since highly sensitive radiolabelling techniques must be
used to show it.
Belton et al. (1977) showed ultrastructural abnormalities of the collagen fibrils
within the alveolar walls in areas of emphysema. The collagen fibres lost the parallel
orientation observed in normal regions and were randomised in alveolar walls adjacent
to foci having alveolar enlargement. Collagen fibrils in regions of severe emphysema
appeared enlarged and swollen. No change in the quantity of elastic fibres could be
seen when nonemphysematous areas were compared with areas of mild or severe
emphysema. However, there did appear to be an alteration in the distribution of
elastic fibres. Aggregations of dense elastic fibres were frequently clumped within the
free edges of alveolar walls. Fukuda et al. (1989) demonstrated abnormal elastic
fibres by electron microscopy and by light and electron microscopic
immunohistochemistry for elastin in a patient with panacinar emphysema due to
alpha 1-antitrypsin deficiency and in three patients with centriacinar emphysema related
to anthracosis. Four types of abnormal elastic fibres were found: (1) finely disrupted
fibres; (2) fibres with vacuolar changes and deposits of electron-dense granular
material; (3) accumulations of small, rounded amorphous components of elastic fibres
near bundles of micro-fibrils; and (4) large, confluent masses consisting mainly of
aggregates of irregularly and compactly arranged, small-sized amorphous components.
The amorphous components stained evenly with anti-elastin antibody. Finely
disrupted fibres were frequently found in the patient with panacinar emphysema and
were presumed to have been damaged by elastase. The other three types of elastic
fibres were frequently found in the patients with centriacinar emphysema.
They suggested that: (1) the vacuoles and electron-dense deposits in elastic fibres
probably represented damage to elastic fibres; (2) the small round amorphous
components in elastic fibres might be formed from abnormal elastogenesis; and (3) the
large, confluent elastic masses were formed by the aggregation of elastic fibres in areas
of coalescence of alveolar walls undergoing structural remodelling.
Nagai and Thurlbeck (1991) performed dissecting light and scanning electron
microscopy on 14 lungs with mild centrilobular emphysema, two of which also had
mild panacinar emphysema. The lungs were surgically resected, mainly for cancer.
The walls of centrilobular emphysematous spaces were either thick or thin.
The former were less frequent but contained considerable fibrous tissue. The thin
walls contained focal areas of fibrosis. No fibrosis was seen in the walls of panacinar
emphysematous spaces. These observations seem to challenge the definition of
emphysema and raises the question, what is meant by excess fibrosis?
They concluded that some sort of quantitative study should be made of the amount of
collagen in emphysematous spaces.
1.8 Aims.
Evidence from animal models of emphysema and more recently from microscopic
observations of emphysema in humans, suggests that both elastin and collagen are
affected during the pathogenesis of emphysema. It would appear that as well as
degradation there is resynthesis, or repair, or even redistribution of elastin and
collagen.
Previous studies on the collagen and/or elastin content of lung in relation to
emphysema can be critisised either because whole lungs were used or the reference
terms were inappropriate. The use of whole lungs (Wright et al., 1960; Pierce et al.,
1961) fails to recognise the heterogeneity of the lung structure with respect to collagen
and elastin content (Pierce and Ebert, 1965). Since emphysematous lesions are
limited to the acinar unit of the lung, measurements on the whole lung or on one of its
lobes may fail to show changes in lung parenchyma. Both studies cited above could
not show a difference in the collagen and elastin content of whole emphysematous
lungs compared to non-emphysematous lungs.
The second criticism relates to the reference terms used for the expression of the
data. Previous studies have failed to take into account changes in the amount of
alveolar wall in emphysema. Thus Pecora et al. (1967) expressed collagen and elastin
per 100 grams wet weight of parenchyma. Johnson and Andrews (1970),
Chrzanowski et al. (1980), and Tarjan et al. (1989) expressed their data as a
percentage of total ("crude") connective tissue in samples of lung parenchyma.
Andreotti et al. (1983) stated "in the quantitative analysis of connective tissue, data
should be expressed referring to the spatial unit of measurement which is specific for
the structure under examination". Therefore, when studying connective tissue in
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lung, data should be expressed with reference to a unit volume of inflated lung
parenchyma.
When expressed as micrograms per cubic centimeter of inflated lung
parenchyma, Andreotti et al. (1983) found that collagen content decreased with age
while elastin content did not show any significant correlation with age. It has been
estimated morphometrically that between one-third (Thurlbeck, 1967b) and
one-quarter (Gillooly and Lamb, 1993a) of the total alveolar walls is lost between the
ages of 20-80 years. Clearly interpretation of collagen and elastin content of alveolar
walls in relation to emphysema must take into consideration the aforementioned
findings.
The aims of the present study were to make measurements of collagen and elastin
on the alveolated portions of lungs, after removal of pleura, large airways and blood
vessels and to correlate these measurements with those of airspace size, with particular
reference to microscopic emphysema.
The specific aims were two-fold:
(1) to quantitate total collagen and elastin in the alveolar walls of emphysematous
and non-emphysematous lungs;
(2) to quantitate the different genetic types of collagen in the alveolar walls of
emphysematous and non-emphysematous lungs.
31
CHAPTER 2. MATERIALS AND METHODS
2.1 Tissue Sampling and Morphometry.
2.1.1 Fresh Lung Samples.
Whole lungs or lobes were obtained from patients who had undergone surgery
for the removal of peripheral tumours at the City Hospital, Edinburgh. All patients
had a history of smoking, were aged between 55-85 years and showed no evidence of
macroscopic emphysema.
An additional two lungs were obtained at autopsy from a 75 year old smoker and
an 85 year old non-smoker, neither of whom showed any signs of macroscopic
emphysema.
2.1.1.1 Agarose Inflation and Sampling of Resected Lung Samples.
In order to express the biochemical data in relation to lung structure,
a technique was developed which allowed collagen and elastin content to be measured
on known volumes of fresh, inflated lung. The technique of agarose inflation was
developed because the standard procedure of inflation by intrabronchial perfusion with
buffered formalin (Wentworth, 1950) was thought to be unsuitable due to the reaction
of formaldehyde with the amino groups of lysine (Kadler and Chapman, 1988) and
therefore possible interference with the determination of the elastin specific cross-
linking amino acids desmosine and isodesmosine, although it was recognised that the
amino groups of the lysine residues are not free in the peptide-bound cross-links.
Following removal, lung tissue was immediately placed on ice and sent to the
Department of Pathology, University of Edinburgh, where it was further processed
and analysed morphometrically by Dr. M.R. Lang. A random zone of lung,
approximately 100mm x 50mm x 50mm and well away from the tumour, was
transpleurally inflated by injecting 150-200 ml of a 2% agarose solution heated to
30°C. The zone was considered inflated when the surface of the pleura became firm
and smooth in appearance. The tissue was kept on ice for a further 10 minutes until
the agarose had solidified within the airspaces, effectively maintaining alveolar
architecture. The inflated zone was then dissected free from the surrounding lung,
trimmed of pleura and stored at 4°C for a further 20 minutes. After placing the zone
on a purpose built template, slices approximately 20mm x 20mm x 2mm were taken
with a surgical skin graft knife blade. The position of each slice within the zone was
recorded and alternate slices were stored in 10% buffered formalin for histology and
subsequent morphometry, and 70% ethanol for collagen and elastin determinations.
The slices for biochemical measurements were further subdivided and their co¬
ordinates from within the larger slice recorded and their exact dimensions determined
with calipers. All samples were then examined microscopically and those containing
large amounts of broncho-vascular material were discarded. From the nine resected
lungs obtained, a total of 102 samples were prepared for biochemical analysis.
Figure 2.1 shows a schematic representation of the sample preparation procedure.
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Figure 2.1. Schematic representation of agarose inflation and sampling of resected
lung samples for morphometry and biochemical analysis.
2.1.1.2 Sampling of Post Mortem Lungs.
In order to study regional variation in airspace size, and collagen and elastin within
a lung, the two whole autopsy lungs were examined. Three zones (upper, middle and
lower) within both upper and lower lobes from the right lung were prepared as above.
The data obtained from regions within each lobe and between upper and lower lobes
were analysed using one-way analysis of variance (ANOVA) on the Apple Macintosh
version of the program Minitab.
2.1.2 Formalin Inflated Lung Samples.
Samples were also obtained from a store of formalin inflated lungs kept in the
Department of Pathology, University of Edinburgh. Whole lungs were obtained at
autopsy (one lung from each subject), and lobes were obtained from patients
undergoing surgery for the removal of peripheral tumours. These lungs and lobes
represented 14 lifelong non-smokers (age range 22 - 82 years) and 29 smokers
(age range 43 - 82 years). The midsaggital slice of each lobe was examined by an
experienced pathologist (Dr. D. Lamb, Department of Pathology,
University of Edinburgh) in order to determine the type of macroscopic emphysema
when present. Macroscopic emphysema was considered present if airspace size was
greater than 1 mm in diameter (Gould et al., 1988). The smoking group thus
comprised 11 cases with centriacinar emphysema, nine cases with panacinar
emphysema, five cases with a mixture of centriacinar and panacinar emphysema, and
four cases with no macroscopic emphysema.
2.1.3 Alpha 1-Protease (al-Pi) Deficient Lungs.
Lungs from six subjects were obtained at autopsy. Of these lungs, three were
from subjects with al-Pi deficiency, kindly supplied by the Heart and Lung Unit,
Freeman Hospital, Newcastle-upon-Tyne. The genotype and smoking histories of
these subjects were, however, not available. The remaining lungs were from two
heavy smokers and one non-smoker.
2.1.4 Morphometry.
2.1.4.1 Preparation of Agarose Inflated Tissue.
Formalin fixed slices of agarose inflated lung were dehydrated through a graded
ethanol series and embedded in paraffin. From each slice histological sections were
cut at 4 jam on a rotary microtome, and floated onto microscope slides.
The sections were de-waxed in xylene and stained by the haematoxylin and eosin
method of Culling (1963). Alveolar wall surface area per unit volume of lung
(AWUV) was determined for each 1 mm^ field in an 121mm2 region within each
section by Dr. M.R. Lang (Department of Pathology, University of Edinburgh) using
a Fast Interval Processor (FIP; Tucker and Shippey, 1983; Aherne and Dunnill, 1982).
The dimensions of paraffin embedded and agarose inflated fresh tissue differed
slightly due to shrinkage during processing to paraffin. It was therefore necessary to
calculate a shrinkage factor for each section and adjust the morphometric data
accordingly. To do this, tissue slice areas were measured before and after processing.
The ratio of these measurements was used to calculate the area shrinkage, and the
square root of this ratio gave the linear shrinkage. As the dimensions of AWUV are
mm"' (ie. mm^/mm^), all AWUV results were corrected by the linear factor
(Gillooly etal., 1991).
2.1.4.2 Preparation of Formalin Inflated Tissue.
Lungs or lobes were floated in 10% buffered formalin and inflated by
intrabronchial perfusion with 10% buffered formalin at a pressure of 25cm H2O from
an elevated reservoir until the pleural surface became firm and smooth. Mean case
AWUV was estimated on a FIP by Dr. M. Gillooly (Department of Pathology,
University of Edinburgh) from six random 20mm x 20mm x 5mm blocks taken from
the midsaggital slice of each lobe (Gillooly and Lamb, 1993a). The blocks were
embedded in glycol methacrylate resin and from each block 3 pm sections were cut.
The sections were then stained by the haematoxylin and eosin method of
Culling (1963). AWUV was determined for each 1 mm^ field in an 121mm2 region
within each section.
A further 20mm x 20mm x 5mm block was taken from the midsaggital slice of
each lung for further AWUV measurements and for collagen determinations. In the
emphysematous lungs, blocks were taken from areas free of macroscopically visible
emphysematous lesions as it was not possible to determine AWUV values in areas of
macroscopic emphysema. Furthermore, it was felt that sampling areas remote from
gross lesions would be more indicative of the early stages of the disease process.
A technique was developed by Dr. M.R. Lang (Department of Pathology,
University of Edinburgh) which allowed the determination of both AWUV and
collagen to be made on adjacent histological sections. Blocks of tissue were removed
from the formalin fixative and placed on an absorbent tissue. Gentle pressure was then
applied in order to expel the formalin from the blocks. The blocks were then immersed
in an Optimal Cutting Temperature compound (Tissue-Tek;
Bayer Diagnostics, England) for 15 min until the airspaces were fully penetrated.
Tissue-Tek maintains airspace inflation and block rigidity during histological
processing. The tissue was then frozen in liquid nitrogen and four 20mm x 20mm x
25pm serial sections (total volume 40mm3) were cut on a cryostat for collagen
determination. An adjacent 3 }im section was cut for AWUV determination.
Figure 2.2 shows a schematic representation of the sample preparation technique.
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Figure 2.2. Schematic representation of the sampling procedure of formalin
inflated lungs for morphometry and biochemical analysis.
2.1.4.3 Preparation of al-Pi Deficient Lungs.
One lobe from each lung was inflated with 10% buffered formalin as described in
section 2.1.4.2. Between five and eight random 20mm x 20mm x 5mm blocks were
then prepared using the technique developed by Dr. M.R. Lang (Department of
Pathology, University of Edinburgh) which allows the determination of both AWUV
and collagen to be made on adjacent histological sections (section 2.1.4.2). Thus four
20mm x 20mm x 25pm serial sections (total volume 40mm3) were pooled for collagen
determination and an adjacent 3|im section was prepared for AWUV determination.
The second lobe of each lung was inflated with 70% (v/v) ethanol at a standard
pressure of 25cm H2O in order to allow the determination of elastin to be made.
Between 5 and 9 random 20mm x 20mm x 5mm blocks were then prepared using the
technique developed by Dr. M.R. Lang (Department of Pathology, University of
Edinburgh) and described in section 2.1.4.2. A total of fifteen 20mm x 20mm x 25pm
serial sections (total volume 150mm3) were pooled for collagen and elastin
determination and an adjacent 3pm section was prepared for AWUV determination.
The lungs from the two heavy smokers and from the non-smoker were prepared
in exactly the same way.
2.1.4.4 AWUV Measurement by the Fast Interval Processor (FIP).
Emphysema has traditionally been assessed macroscopically by examining whole
lung slices (Dunnill, 1962, 1970; Ryder et al., 1969; Thurlbeck, 1967(a);
Thurlbeck et al., 1968, 1970). However, by the time emphysematous spaces are
visible to the naked eye as much as 75% of the alveolar surface area may have been
lost (Lamb, 1990). Since the interest of this study was early emphysema, a technique
was used which allowed changes in the amount of alveolar wall to be assessed
microscopically. All morphometric measurements were carried out by Dr. M.R. Lang
and Dr. M. Gillooly (Department of Pathology, University of Edinburgh).
The FIP (Tucker and Shippey, 1983), is a rapid scanning device which has been
adapted for use with lung tissue. It uses the technique of mean linear intercept
(Lm; Dunnill, 1962, 1964; Duguid et al., 1964; Thurlbeck, 1967a,b,c; Bignon et al.,
1969; Depierre et al., 1972; Hasleton, 1972; Hansen and Ampaya, 1975), which has
become the standard technique for measuring alveolar surface area on tissue sections.
The technique involves counting the total number of intercepts made by a test line in a
histological section of alveolar tissue. This figure is then used to calculate the average
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distance between intercepts and from this alveolar wall surface area per unit volume
(AWUV, expressed as mm^/mm^) can be derived (Aherne and Dunnill, 1982).
The FIP consists of a computer linked Nikon inverted microscope equipped with
a motorised stage and a Fairchild CCD linear image sensor. The sensor consists of a
stationary array of photosensitive units which recognise the optical density pattern of
the specimen. Each histological section was scanned electronically in the y-axis by the
sensor at 10 (im intervals. Sections were scanned mechanically in the x-axis by
moving the stage in 1 pm steps. In total, an area of 121 mm^ was scanned on each
histological section. The image obtained from the scan consists of a grid of picture
elements or "pixels". A user-defined threshold limit determines which pixels are
recognised as tissue pixels and which are background pixels. A size filter then
ensures that groups of thresholded pixels less than 6pm in diameter are ignored, thus
eliminating cells, debris, and background "noise".
For ease of calculation, intercept totals for each 1 mm^ area (from within the 121
mm^ field) were stored by the computer. Each electronic scan creates a "test-line" 1
mm in length for each 1 mm^ area, and, as areas are scanned at 10 pm intervals, the
total test-line length is 100 mm for each area (100 electronic scans 1 mm in length).
The stored intercept totals from each 1 mm^ area were then transferred to a mainframe
computer (Unix System) and mean AWUV values were calculated.
Values of Lm and AWUV were derived as follows:
Lm = Total test-line length/total number of intercepts.
V = volume (mm^)
Surface area (mm^) = 2 V/Lm
AWUV (mm^/mm^) = 2/Lm
2.2 Biochemical Procedures.
2.2.1 Tissue Preparation.
Lung samples were defatted by homogenisation in cold acetone followed by
stirring overnight at 4°C. The homogenate was re-extracted once in acetone and dried
under vacuum.
2.2.2 Determination of Total Collagen.
Total collagen was measured using 4-hydroxyproline (Hyp) as a relatively
specific amino acid marker. Hyp accounts for approximately 13% dry weight of
collagen (Bornstein and Traub, 1979). Minor amounts are also present in some other
proteins, e.g. elastin (Sandberg et al., 1981), Clq (a subcomponent of the first
component of complement; Reid et al., 1972), acetylcholinesterase (Rosenberry and
Richardson, 1977), and pulmonary surfactant-associated glycoproteins (White et al.,
1985; Benson et al., 1985; Ross et al., 1986; Floros et al., 1986). However,
compared to collagen, the amounts are quantitatively insignificant. Three methods were
used for Hyp determination, as described below.
2.2.2.1 Colorimetric Reaction for 4-HydroxyproIine.
Since Hyp is peptide bound, samples must be hydrolysed to release the Hyp for
analysis. Samples were hydrolysed in, typically, 1.05 ml 6N hydrochloric acid (HC1)
for 16 hr at 116°C in sealed tubes (12 mm x 100 mm). At the end of the reaction the
HC1 was removed by evaporation in a Speed Vac Concentrator (Savant Instruments
Inc., Farmingdale, N.Y., USA) and the samples were reconstituted in 2 ml water.
The colorimetric reaction for Hyp is based on the oxidation of Hyp to pyrrole-2-
carboxylic acid using chloramine T (Figure 2.3). Pyrrole-2-carboxylic acid is then
reacted with p-dimethylaminobenzaldehyde (Ehrlich's reagent) to form a complex that
is detected and quantified as a chromophore having an absorbance at 557nm. The
colorimetric reaction does not detect 3-hydroxyproline due to its instability during
oxidation (Szymanovicz et al., 1978).
The method used was that of Woessner (1961), which is satisfactory for the
determination of Hyp when applied to pure collagen or where the bulk of the
non-collagenous proteins have been removed. The method cannot be used for
samples containing less than 2% Hyp as the presence of other amino acids partially
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The reagents were made up as follows:
Hyp standard. A stock solution of 10 pg/ml 4-Hydroxy-L-prolinewas prepared
in distilled water and aliquots were frozen and kept at -30°C until required.
Standards were prepared on the day of use by diluting the stock with water to
obtain concentrations of 0.625 - 5 p.g/2 ml. A reagent blank was also prepared
containing 2 ml water.
Buffer. 50 g of citric acid monohydrate, 120 g sodium acetate trihydrate, and
34 g sodium hydroxide were dissolved in approximately 1 litre of distilled
water. The pH was adjusted to 6.0 with glacial acetic acid and the final volume
made up to 1 litre with distilled water. The buffer was stored at 4°C under
toluene.
Chloramine T (Sodium p-toluenesulphonchloramide). A 0.05 M solution was
prepared on the day of use by dissolving 0.705 g chloramine T in 10 ml water.
15 ml methyl cellosolve (2-methoxy ethanol) and 25 ml buffer were then added.
Perchloric acid. A 3.15 M solution was prepared by diluting 34 ml of 60% (v/v)
perchloric acid to 100 ml with water.
p-Dimethylaminobenzaldehyde (Ehrlich's reagent). A 20% (w/v) solution was
prepared on the day of use by dissolving lOg of p-dimethylaminobenzaldehyde
in a final volume of 50 ml. Heating in a 60°C water bath aided solubilisation.
The procedure was as follows: Hyp oxidation was started by adding 1 ml
chloramine T to each tube. The tubes were then mixed on a Vortex mixer and allowed
to stand for 20 min at room temperature. The chloramine T was then destroyed by
adding 1 ml perchloric acid, mixing and allowing to stand for 5 min. Finally, 1 ml
p-dimethylaminobenzaldehyde solution was added and mixed until no Schlieren pattern
was seen. The tubes were placed in a 60°C water bath for 20 min, then cooled in cold
tap water for 5 min. The absorbance was determined at a wavelength of 557 nm.
The amounts of Hyp in each sample were determined directly from a standard curve
constructed with known concentrations of pure Hyp. After removal from the 60°C
water bath and cooling, the colour is stable for at least 1 hr. The colour, however,
decreases after 25 min of heating.
2.2.2.2 Determination of 4-Hydroxyproline on an Amino Acid
Analyser.
As an alternative method for measuring Hyp in crude lung samples, an amino
acid analyser was used. The method is based on the derivatisation of free amino
groups, either primary or secondary, when exposed to phenylisothiocyanate (PITC) in
the presence of a base, diisopropylethylamine (DIEA). PITC reacts quantitatively
yielding a phenylthiocarbamyl-amino acid (PTC - AA). The PTC -AA derivatives
have a strong UV absorbance at 254 nm.
The procedure was as follows: A known amount of nor-leucine (125nmoles) was
added to the samples as internal standard prior to hydrolysis. The samples were dried
in a Speed Vac Concentrator and placed in a vial (5 tubes/vial) containing 0.5 ml 6N
HC1. The acid and vials were then purged with argon and the vials were sealed with a
PTFE lined screw cap. Vapour phase hydrolysis was carried out at 110°C for 24 hr.
The samples were reconstituted in 200pl 0.025% (w/v) K3ethylenediaminetetra-acetic
acid (K3EDTA), filtered through a 0.22|i,m filter (Gelman Sciences Ltd.,
Northampton, England) and, after an appropriate dilution
(1 : 100 with water), applied directly to a model 420 A amino acid analyser
(Applied Biosystems Inc., Foster City, CA., USA) by Dr. A. D. Cronshaw
(WelMet Protein Characterisation Facility, Department of Biochemistry,
University of Edinburgh).
The amino acids were labelled automatically by the analyser and the resulting
derivatives were separated on a 2.1 mm ID (internal diameter) x 22 cm cartridge-style
reverse-phase column packed with C18 bonded phase silica. The peaks were resolved
(Figure 2.4) by gradient elution as follows: 0-4 min, 0-2% buffer B; 4-10 min, 2-13%
buffer B; 10-20 min, 13-35% buffer B; 20-25 min, 35-64% buffer B; 25-30 min,
64-100% buffer B. Buffer A was 50 mM sodium acetate, 3% (v/v) acetonitrile, final
PH 5 .22. Buffer B was 32 mM sodium acetate, 70% (v/v) acetonitrile, final pH 6.1.
The eluate was monitored at 254 nm. The amounts of each amino acid in the samples
were determined from their peak areas in relation to the peak areas produced by a
standard containing known amounts (50 pmoles) of each amino acid plus 50 pmoles
nor-leucine. The total amount of each amino acid in the original sample was then
obtained after correcting for recovery of the internal standard of nor-leucine.
2.2.2.3 Determination of 4-HydroxyproIine by High Pressure
Liquid Chromatography (HPLC) with Fluorimetric
Detection.
As a final procedure for the determination of Hyp in crude lung samples, HPLC in
conjunction with the specific derivatisation and detection of imino acids was employed.
The method is based on the principle described by Einarsson (1985), in which primary
amines are blocked by reaction with orthophthaldialdehyde (OPA) in the presence of
(3-mercaptoethanol, followed by labelling of the imino acids proline and Hyp via their
secondary amine group with 9-fluorenylmethylchloroformate (FMOC-C1).
The procedure was as follows: A known amount (160 pig) of
3,4-dehydroproline (3, 4-DHP) was added to each sample as internal standard.
Samples were then hydrolysed in 1,05ml 6N HC1 under nitrogen, in sealed tubes,
for 24 hr at 110°C. The HC1 was removed by evaporation and the samples were
reconstituted in 200 pi 0.025% (w/v) K3EDTA. The derivatisation procedure and
chromatography conditions were essentially those of Teerlink et al. (1989).
An appropriate amount of sample (5pl) was diluted in a total volume of 0.9 ml water.
Then 0.15 ml of a 0.8 M sodium borate buffer (pH 9.5) was added, followed by 0.1
ml of acetonitrile containing 0.37M OPA and 0.37M P-mercaptoethanol.
After 30s, 0.1 ml of a 0.75 M solution of iodoacetamide in acetonitrile was added to
neutralise the excess of P-mercaptoethanol. After a further 30s, 0.3 ml of 5mM
FMOC-C1 in acetone was added and immediately thereafter the reaction mixture was
extracted twice with 2.0 ml of diethyl ether. The ether extracts were discarded.
The lower phase was diluted with 1 ml of water and a 20 pi portion was
chromatographed. Standard solutions containing known amounts of Hyp and a fixed
amount of 3,4-DHP were treated in the same way as samples.
HPLC analysis was performed on a 4.6 mm ID x 25 cm Dynamax-300A column
(Rainin Instrument Co. Inc., Woburn, MA., USA) packed with 5 pm C18 bonded
spherical silica using a Gilson model 306 solvent delivery system and a Gilson model
231 autosampler (Gilson Medical Electronics S.A., Villiers-le-Bel, France).
The peaks were resolved isocratically, at a flow rate of 1.0 ml/min, using 30% (v/v)
acetonitrile in 50 mM acetic acid (adjusted, after mixing, to pH 4.3 with 1M NaOH).
Fluorescence of the eluate was monitored with a Perkin-Elmer model LC-240
fluorimeter (Perkin-Elmer Ltd., Beaconsfield, England) using an excitation wavelength
of 260 nm and an emission wavelength of 330 nm. Results were calculated from
calibration curves, constructed with known concentrations of pure Hyp versus the ratio
of the peak area of Hyp to the peak area of 3, 4-DHP.
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Figure 2.4 Separation of a standard mixture of amino acids on an Applied
Biosystems model 420A amino acid analyser.
2.2.2.4 Calculation of Total Collagen Amounts
from 4-Hydroxyproline.
Collagen standards for quantitation of the relative amounts of collagens I and III
in lung (section 2.2.5.2) and for Enzyme Linked Immunosorbent Assay (ELISA;
section 2.2.5.4), were quantified prior to use from their Hyp content as measured by
the colorimetric assay. Hyp accounts for 14.2% of the dry weight of collagen I
(Miller and Gay, 1982, 1987) and therefore a multiplication factor of 7.0 was used to
convert the amount of Hyp to total collagen. Similarly, a multiplication factor of 5.8
was used for collagen III (17.25% Hyp) and a factor of 6.6 for collagen IV
(15.12% Hyp; Miller and Gay, 1982, 1987).
2.2.3 Determination of Elastin.
Elastin was measured using the elastin-specific cross-links desmosine and
isodesmosine which are separated, on the basis of differences in their hydrophobicity,
on a C18 reverse-phase HPLC column followed by U.V. detection at 270nm.
In order to remove interfering substances the hydrolysate samples were treated by
the cellulose "mini-column" method of Skinner (1982). The method is based on the
selective adsorption of desmosine and isodesmosine onto cellulose in an organic acid-
alcohol mixture followed by their elution with water. Mini columns were made from 3
ml plastic transfer pipettes (L.I.P. Equipment and Services Ltd., Shipley, England) by
cutting off the top hemisphere of the bulb (which then becomes
a 4 ml solvent reservoir) and plugging the tip with a single glass bead of 3.5 - 4.5 mm
diameter. The barrel of the pipette was then clipped in a frame. A slurry was
prepared by mixing lOg CF1 cellulose (Whatman Biosystems Ltd., Maidstone,
England) with 200 ml of the mobile phase, n-butanol / acetic acid / water
(4:1:1 v/v). The mixture was shaken to approximate homogeneity and then
sonicated for 2-4 min to remove air bubbles. The columns were then packed to a
height of 45 - 50 mm by pipetting 4 - 5 ml of the slurry into the bulb reservoir and
allowing the cellulose to settle. A further 5 ml of mobile phase was added to wash
fine particles from the bulb resevior. Samples, typically 120 - 150 |il of hydrolysate,
were made up to a total volume of 0.5 ml with water and mixed, in order of addition,
with acetic acid (0.5 ml), cellulose slurry (0.5 ml) and n-butanol (2 ml). The samples
were transferred onto the prepared column and the tubes washed with 1.5 ml mobile
phase which was also transferred to the columns. The columns were then washed
with 15 ml mobile phase which removes interfering substances. Desmosine and
isodesmosine were eluted from the column with water (5 ml). The samples were then
dried in a Speed Vac Concentrator, reconstituted in 100 pi water, filtered through a
0.22 |im filter and 10 pi was loaded onto the HPLC column.
The HPLC method used was essentially that of Yamaguchi et al. (1987) using the
same column and solvent delivery system as for Hyp measurement
(section 2.2.2.3). The peaks were resolved isocratically, at a flow rate of 0.8 ml/min,
using 18% (v/v) acetonitrile / 82% (v/v) 0.1M sodium phosphate containing 20 mM
sodium dodecyl sulphate (SDS), final pH 4.5. The eluate was monitored at 270nm
with a model 759 U.V. absorbance detector (Applied Biosystems Inc., Foster City,
CA., USA). Results were calculated from calibration curves, constructed with known
concentrations of pure desmosine or isodesmosine (Elastin Products Co., Inc.,
Owensville, MO., USA) versus peak area.
2.2.4 Expression of Collagen and Elastin Data in Relation to
Morphometry.
Biochemical measurements of Hyp and desmosine or isodesmosine were
expressed per mm^ of inflated tissue. These values were also divided by their
corresponding adjacent slice AWUV values to give amounts per unit area of alveolar
wall (i.e. per mm^).
2.2.5 Analysis of Different Collagen Types.
2.2.5.1 Cleavage of Collagen by Cyanogen Bromide (CNBr).
Cynanogen bromide (CNBr) digestion in formic acid has been shown to
solubilise the bulk of the total collagen from lung tissue (Laurent et al., 1981a).
Pepsin, on the other hand, solubilises less than 35% of total collagen in lung tissue
(Seyer et al., 1976; Reiser and Last, 1980), and this procedure may also selectively
solubilise particular collagen types. CNBr was therefore used as the method of choice
in extracting collagen from lung samples.
The action of CNBr upon proteins is unique in its selective attack on methionine
(Gross, 1967). When methionine reacts with CNBr it is converted to homoserine
lactone, which under acidic conditions is in equilibrium with homoserine (Figure 2.5).
The formation of homoserine results in the liberation of the amino group of the residue
that followed methionine. Accordingly, a residue of methionine which originally
occupied an endo-position is converted to homoserine (lactone), which becomes the C-
terminal residue of a peptide fragment. The reaction takes place under acidic
conditions in order to denature the protein and to expose the side chains of methionine
to attack by CNBr, which may be added in excess.
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Figure 2.5 Cleavage of methionyl-X bonds with CNBr according to Gross (1967).
Excess reagent and by-products, such as methylthiocyanate, are volatile and readily
removed by lyophilisation.
2.2.5.2 Determination of Collagens I and III in Lung.
The method of Laurent et al. (1981a) was applied to the quantitation of the
relative amounts of collagens I and III in human lung. Approximately 50 mm^ of
agarose inflated lung parenchymal tissue was homogenised in a 1 ml all glass
homogeniser (Fisons Instruments, East Grinstead, England) with 1 ml of 50 mM
sodium phosphate, 0.15 M NaCl, pH 7.4 (PBS) at 4°C, and then transferred to a 10
ml Teflon centrifuge tube (Nalgene, supplied by Merck Ltd., Glasgow, Scotland).
The homogeniser was then washed with a further 4 ml of PBS which was also
transferred to the centrifuge tube. The homogenate was centrifuged at 4000 g for
5 min and the residue was rehomogenised in 2% sodium dodecyl sulphate (SDS) at
room temperature. The homogenate was again centrifuged and the SDS extraction
repeated a further four times. The remaining residue was then extracted three times
with PBS to remove the unbound SDS. The residue was then rehomogenised in
acetone, centrifuged at 4000 g for 5 min and the supernatant discarded. This step was
repeated and the pellet was dried under vacuum.
The dried pellet was homogenised in a 1 ml all glass homogeniser in 0.6 ml of
70% formic acid and the homogenate was transferred to a 10 ml Teflon centrifuge
tube. The homogeniser was washed with a further 0.6 ml of 70% formic acid which
was also transferred to the centrifuge tube. A further 0.3 ml of a 50 mg/ml solution of
CNBr in 70% formic acid was then added. Nitrogen gas was bubbled through the
homogenate and the tubes were sealed. The tubes were mixed end-over-end for 6 hr in
a 25°C incubator (Lab-Therm, Adolf Kiihner AG., Basel, Switzerland). At the end of
the reaction, the digest was centrifuged at 5000 g for 20 min to pellet insoluble
material. The supernatant was collected, diluted 15-fold with water and lyophilised.
Collagen I from rat tail and collagen III from rat skin, both purified and kindly
donated by Dr. D.R. Shackleton and Dr. J.R.E. McBeath respectively (Department of
Biochemistry, University of Edinburgh), were used as standards. Known amounts,
previously quantified using the colorimetric assay ofWoessner (1961) to measure Hyp
(section 2.2.2.1), were digested using a three-fold excess (w/w) of CNBr in 70%
formic acid. Nitrogen gas was bubbled through the mixture and the tubes were
sealed. The tubes were then mixed end-over-end for 6 hr in a 25°C incubator.
The digest was diluted 15-fold with water and lyophilised.
CNBr peptides in both tissue extracts and collagen standards were analysed by
discontinuous SDS-PAGE using a separating gel of 12% acrylamide (section 2.2.5.3).
Equal amounts of the collagen standards were mixed and dilutions run singly.
Samples were run in duplicate.
2.2.5.3 Discontinuous SDS - Polyacrylamide Gel Electrophoresis
(SDS - PAGE).
The relative amounts of the major lung collagens (I and III) were determined
using discontinuous SDS-PAGE to separate the peptides generated by CNBr
digestion. Discontinuous SDS-PAGE is a widely used technique which separates
proteins according to their molecular weight. SDS is a negatively charged detergent
that binds to proteins such that approximately 0.5 mol of SDS is bound per amino acid
residue. This large amount of negatively charged detergent molecules is sufficient to
overwhelm the intrinsic charge on the polypeptide chain so that the net charge per unit
mass becomes approximately constant. In the presence of SDS and the reducing agent
(3-mercaptoethanol (which reduces disulphide bonds) proteins are denatured and adopt
an extended coil configuration. Electrophoretic migration is then determined by the
effective molecular length or approximate molecular weight of the polypeptide chain.
Molecular weights can be estimated from a plot of distance migrated versus log
molecular weight, using proteins of known molecular weight as standards.
Collagenous proteins behave anomalously in SDS-PAGE in comparison to
typical globular proteins (Furthmayr and Timpl, 1971). The collagen I a chains
migrate with apparent molecular weights of 133,000 for al and 122,000 for a2
compared with the true values of 96,000 for each chain. The different mobilities of
the al and a2 chains in SDS-PAGE could be due to localised conformation effects
resulting from restricted rotation of polypeptide chains about imino acid residues
(Furthmayr and Timpl, 1971).
Discontinuous SDS-PAGE was performed in vertical slab gels using the buffer
system of Laemmli (1970). Gels containing 4.5% (stacking gel), 6.0% or 12%
(separating gel) acrylamide were prepared from a stock solution of 30% (w/v) of
acrylamide and 0.8% (w/v) of N, N'-bis-methylene acrylamide. The final
concentrations in the separating gel were as follows: 0.375M Tris-HCl (pH 8.8) and
0.2% (w/v) SDS. The gels were polymerised chemically by the addition of
tetramethylethylenediamine (TEMED; 25|il/50ml separating gel) and 2% ammonium
persulphate (1.25ml/50ml separating gel). Gels 13 cm x 14 cm were prepared in 16
cm x 18 cm glass plates with 1.5 mm spacers. The stacking gels of height 2 cm
contained 0.125M Tris- HC1 (pH 6.8) and 0.2% SDS (w/v) and were polymerised
chemically by the addition of TEMED (25|il/25ml stacking gel) and 2% ammonium
persulphate (0.625ml/25ml stacking gel). The electrode buffer (pH 8.3) contained
0.025 M Tris, 0.192 M glycine and 0.1% SDS (w/v). The samples contained the
final concentrations : 0.1M Tris-HCl (pH 6.8), 2% (w/v) SDS , 10% (v/v) glycerol,
3% (v/v) (3-mercaptoethanol and 0.001% (w/v) bromophenol blue as the dye. The
proteins were completely denatured by immersing the samples, in microcentrifuge
tubes, for 3.0 min in boiling water. The samples were then loaded into the wells
using a 100 p.1 microsyringe (Hamilton Bonaduz AG., Bonaduz, Switzerland).
Electrophoresis was carried out at 40mA constant current per gel until the bromophenol
blue marker reached the bottom of the gel (about 3 1/2 hr).
Gels were fixed and stained simultaneously overnight in 250 ml 8% (v/v) acetic
acid/50% (v/v) methanol containing 0.1% (w/v) Coomassie Brilliant Blue R-250.
Gels were then destained over 5-6 hr by continuous shaking in several changes of
8% (v/v) acetic acid.
Densitometric scanning of the gels was performed at 530 nm using a
Chromoscan 3 scanning densitometer (Joyce-Loebl, Gateshead, England), linked to an
IBM-compatible microcomputer, and having a slit width of 0.3 mm x 5 mm.
Peaks were integrated using the Chromoscan 3 External Data Analysis Package.
2.2.5.4 Enzyme-Linked Immunosorbent Assay (ELISA) for
Collagen IV.
As collagen IV is a relatively minor component of the lung, the sensitivity
afforded by an immunological technique was considered to be the most suitable
method for its quantitation. An attempt was therefore made to apply an ELISA to the
quantitation of the peptides of collagen IV resulting from CNBr digestion.
The technique used was based on those of Rennard et al. (1980b) and Bellon (1985).
In principle, purified antigen is first allowed to adsorb to flat-bottomed microtitre
wells. Next, an antibody/soluble antigen mixture is incubated with the insolubilised
antigen. In a non-equilibrium assay, antibody and soluble antigen are pre-incubated
together, usually overnight, before their addition to the microtitre wells containing the
insolubilised antigen. In an equilibrium assay, antibody and soluble antigen are added
to the microtitre wells containing the insolubilised antigen without pre-incubation.
The wells are washed and a second antibody (raised against the first antibody and
covalently linked to an enzyme) is added, allowed to bind and then the unbound excess
second antibody is removed. Finally, a substrate for the bound enzyme is added to
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the wells and the subsequent reaction produces a chromophore.
Incubation of first antibody with soluble antigen inhibits binding to the insolubilised
antigen. The amount of inhibition depends on the amount of soluble antigen present.
Therefore, incubation of antibody with known amounts of soluble antigen allows the
construction of a standard curve from which amounts of antigen in samples can be
determined.
The procedure used for the ELISA was as follows: CNBr peptides of purified
human collagen IV (Sigma Chemical Co., Poole, England) were dissolved in 20 mM
sodium carbonate buffer, pH 9.6, and 100 pi was added to each well of a microtitre
plate (NUNC., Gibco Ltd., Paisley, Scotland). Adsorption was allowed to take place
overnight in a humidified atmosphere at 4°C. The coated plate was then washed three
times with 20 mM PBS, pH 7.4, containing 1% (w/v) bovine serum albumin (BSA)
and 0.05% (v/v) Tween 20. This buffer was also used to dilute anti-collagen IV
antibody and the soluble collagen IV peptides. In the equilibrium assay, 50 pi of
soluble peptides were added to the antigen-coated wells followed by the addition of 50
pi of antibody. The mixture was then incubated at room temperature for 2 hr. In the
non-equilibrium assay, antibody and soluble peptides were incubated together
overnight at 4°C. A 100 pi aliquot of the pre-incubation mixture was then added to
the antigen-coated wells followed by incubation at room temperature for 2 hr.
The plates were then washed as before. The second antibody (covalently linked to
horseradish peroxidase, HRP) was diluted in the above buffer and 100ml was added
to each well followed by incubation at room temperature for 2 hr. The plate was
washed and 200 pi of substrate for HRP was then added to each well and the reaction
allowed to proceed for 1 hr in the dark at room temperature. The substrate used for
HRP was O-phenylenediamine dissolved in methanol (10 mg/ml) and diluted 1 : 100
into 0.03% (v/v) hydrogen peroxide (H2O2) in distilled water. The substrate was
prepared fresh on the day of use. The reaction was stopped by the addition of 50 pi
of 4N sulphuric acid. The absorbance at 490nm was measured directly through the
microtitre wells using a microtitre plate reader (Dynatech Laboratories Ltd.,
Billinghurst, England).
A number of antibodies were compared, all of which had been raised against
native human collagen IV. Two polyclonal antibodies were raised in rabbits, one was
a gift from Dr. V. Duance (AFRC, Bristol), the other was obtained commercially
(Euro-diagnostics BV., Apeldoorn, Holland). One affinity purified antibody was
raised in goats (Southern Biotechnology Associates, Inc., Birmingham, AL., USA).
Two mouse monoclonal antibodies were also tested, both obtained commercially
(Serotec, Oxford, England and Euro-diagnostics BV., Apeldoorn, Holland).
HRP-coupled anti-species antibodies were obtained from the Scottish Antibody
Production Unit (SAPU), Law Hospital, Carluke. Anti-rabbit antibody and anti-goat
antibody had been raised in donkey, and anti-mouse antibody had been raised in
sheep.
Anti-collagen IV antibodies (Euro-diagnostics BV.) were also purified by
immunoaffinity chromatography against CNBr peptides of human collagens I and
III (Sigma Chemical Co., Poole, England). The method used was a modification of
the method described by Wick et al. (1979). Lyophilised CNBr peptides of collagens
I and III (500|ig of each type), were dissolved in 1 ml 0.1M sodium phosphate buffer,
pH 8.0, containing 0.4M NaCl. A further 2 ml of a pre-washed suspension of CNBr
activated Sepharose 4B (Pharmacia Biosystems Ltd., Milton Keynes, England), in the
above buffer, was added. The reaction was then allowed to proceed for 2 days at
4°C. The Sepharose was kept in suspension by continuously rotating the tube
end-over-end. At the end of the incubation period, the reaction mixture was
transferred to a Poly-Prep column (Bio-Rad Laboratories Ltd., Hemel Hempstead,
England), and the reaction stopped by filtration of the gel and a subsequent incubation
with 0.1M Tris-base for 2 hr at room temperature. The adsorbents were then washed
successively, at 4°C, with 10 ml each of 0.1M sodium phosphate, pH 8.0, PBS, pH
7.2, 1 M acetic acid, 0.05M HC1 containing 0.15 M NaCl and finally again with PBS.
100 |il of antiserum (Euro-diagnostics BV.), was added to the top of the column,
allowed to run into the gel and then washed in with approximately 900 (ll PBS.
After 1 hr the unbound material was collected with a PBS wash. The antibodies were
then concentrated to approximately their original volume in an Amicon
Micro-concentrator (Amicon Ltd., Stonehouse, England).
2.2,6 Statistical Analysis.
Statistical analyses were performed using the Apple Macintosh versions of the
programs Cricket Graph and Minitab. The product-moment correlation coefficient (r)
was considered significant when p < 0.01. The Analysis of Variance ratio (F) and the
Mann-Whitney rank sum test were considered significant when p < 0.05.
CHAPTER 3. DEVELOPMENT OF TECHNIQUES
3.1 Elastin.
Two previous studies of the elastin content in various tissues used reverse-phase
High Performance Liquid Chromatography (HPLC) to measure desmosine and
isodesmosine (Yamaguchi et al., 1987; Schwartz et al., 1990). In both studies,
elution was achieved isocratically using a phosphate buffer/acetonitrile mixture
containing 20 mM SDS, final pH 4.5. However, because the reverse-phase columns
used in these studies differed in both manufacturer and dimensions, the acetonitrile
concentration needed to achieve separation of desmosine and isodesmosine in a
reasonable time differed markedly. Yamaguchi et al. (1987) used 36% acetonitrile,
and Schwartz et al. (1990) used 10 % acetonitrile. Therefore, in order to determine
the concentration of acetonitrile needed to achieve separation of desmosine and
isodesmosine in a reasonable time, a linear gradient from 0% acetonitrile to 30%
acetonitrile was used initially. Buffer A consisted of 0.1M sodium phosphate
containing 20mM SDS, final pH 4.5. Buffer B consisted of 30% acetonitrile / 70%
0.1M sodium phosphate containing 20 mM SDS, final pH 4.5. Gradient elution from
0% buffer B to 100% buffer B was achieved at a flow rate of 0.8 ml/min over 30 mins
(Figure 3.1). From Figure 3.1, the concentration of acetonitrile needed to achieve
optimum separation of desmosine and isodesomine was estimated to be 18%, i.e. the
concentration of acetonitrile mid-way between the two peaks. This was confirmed by
repeating the separation isocratically using 18% acetonitrile (Figure 3.2).
The chromatogram produced with a crude tissue hydrolysate was complex
(Figure 3.3). Identification of desmosine and isodesmosine peaks was difficult and
quantitation was not possible due to their poor resolution from contaminating peaks.
Like Yamaguchi et al. (1987), the cellulose "mini-column" method of Skinner (1982)
was used therefore to purify desmosine and isodesomine from the crude hydrolysate
prior to chromatography. Figure 3.4 shows a typical chromatogram produced from a
"purified" hydrolysate, i.e. after pre-treatment on the cellulose mini-column. Skinner
(1982) demonstrated recoveries of between 99% and 102% following purification of




Figure 3.1 Separation of isodesmosine (ISO) and desmosine (DES) on a reverse-
phase C18 HPLC column by gradient elution from 0% buffer B
to 100% buffer B. Buffer A consisted of 0.1M sodium phosphate
containing 20mM SDS, final pH 4.5. Buffer B consisted of 30%
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Figure 3.2 Separation of isodesmosine (ISO) and desmosine (DES) on a reverse-
phase C18 HPLC column by isocratic elution with 18%
acetonitrile / 82% 0. IM sodium phosphate containing 20mM SDS,
final pH 4.5.
57
,—.— ——, — —-—| - 1 1 ' | ' ' ' I ' ' ' ~1
0 5 10 15 20 25
Time (min)
Figure 3.3 Chromatogram of a crude lung hydrolysate sample injected onto a
reverse-phase C18 HPLC column and eluted isocratically with
18% acetonitrile / 82% 0.1M sodium phosphate containing











Figure 3.4 Chromatogram of a lung hydrolysate sample after purification on a
cellulose mini-column (section 2.2.3) and injection onto a reverse-
phase C18 HPLC column followed by isocratic elution with 18%
acetonitrile / 82% 0.1M sodium phosphate containing 20mM SDS,
final pH 4.5. ISO = isodesmosine, DES = desmosine.
3.2 Collagen.
The method for Hyp determination by reverse-phase HPLC with fluorimetric
detection (section 2.2.2.3) was essentially that of Teerlink et al. (1989).
However, a modification to the published method was found to be necessary. It was
shown that isocratic elution using 34% acetonitrile failed to resolve the proline peak
from the FMOC-OH peak completely (Figure 3.5), whereas 30% acetonitrile resulted
in a better resolution of these peaks. Figure 3.6 shows the separation of the FMOC
derivatives of Hyp from 3, 4-DHP, with retention times of 8.22 min and 20.64 min
respectively. At 27.27 min, FMOC-OH, the hydrolysis product of FMOC-C1, is well
resolved from proline, which has a retention time of 33.48 min.
3.3 Quantitation of the Relative Amounts of Collagens I and III.
Preliminary data on the relative amounts of collagens I and in in lung tissue were
obtained using the method of Laurent etal. (1981a). These procedures have been
reported to remove the bulk of potentially contaminating non-collagen proteins
(Laurent et al., 1981a). A typical separation of CNBr peptides by discontinuous
SDS-PAGE is shown in Figure 3.7.
Quantitation of the relative amounts of collagens I and III in lung tissue was
accomplished by determining the relationship between known amounts of CNBr
fragmented collagen standards applied to the gels and the relative sizes of peaks
corresponding to CNBr peptides distinctive for each collagen type. Such a relationship
is shown for two bands identified, with reference to the literature
(Laurent et al., 1981a; Kelley et al., 1984; Kirk et al., 1984a; Bateman et al., 1986), as
al(I)-CB-8 and al(III)-CB-5 (Figure 3.8). The plots were linear with correlation
coefficients of 0.984 or greater. The effect of a fixed amount of one collagen type on
the standard curve of the other collagen type was not evaluated. However, from
Figures 3.7 and 3.12, it seems unlikely that the standard curve of one collagen type in
the presence of a fixed amount of the other collagen type would be significantly
displaced. The relative amounts of collagens I and HI in the lung extracts were then
determined from the peak sizes of these two bands in relation to the standard curve.
Using the peptides al(I)-CB-8 and al(III)-CB-5, the relative amounts of collagen
types I and III were quantified in eight lungs. Results were obtained from four
separate gels, each with its own set of standards.
The mean value for the amount of collagen III as a proportion of the total amount
of collagens I + III was found to be 0.77 ± 0.1 (SEM; n = 8). This value is at
variance with previous results from human lung. For example, Seyer et al. (1976) and
Kirk et al. (1984a) also analysed CNBr extracts of lung and found the proportion of
collagen III to be 0.33 and 0.29, respectively. A possible explanation for the present
findings is incomplete digestion of the collagen III standard by CNBr. It can be seen
from the gel (Figure 3.7) that there are a number of higher molecular weight
components present in the collagen standards which are not present in the lung
extracts. These components may include higher molecular weight peptides in which
al(III)-CB-5 is still incorporated. As the standards and samples were reduced prior
to electrophoresis the al(III)-CB-5 band may be contaminated with al(III)-CB-9
which under non-reducing conditions runs with higher molecular weight components
as it is known to be involved in intra-molecular disulphide bridges (G.F. Faurent,
personal communication).
In the course of this study it was found that collagen could not be extracted by
CNBr from lung tissue which had been stored in 70% ethanol for long periods of time
(approximately two years). With fresh agarose inflated lungs (section 4.3) it was
found that the mean total Hyp content of 50 mm^ samples was 227 nmol
(SD 158 nmol; n = 102). CNBr soluble fractions from equivalent samples (n = 25)
stored in 70% ethanol for approximately two years were found to contain less than
4.77 nmol Hyp by the method of Woessner (1961; section 2.2.2.1). This represents
less than 2.1% of extractable Hyp. The samples used in this preliminary study had
been stored in 70% ethanol for approximately 12 weeks. One explanation for reduced
extraction efficiency is failure of cleavage of collagen molecules due to atmospheric
oxidation of methionine residues during storage. It is known that methionine
sulphoxide and methionine sulphone are not converted to homoserine by CNBr
(Gross, 1967). Methionine sulphoxide and methionine sulphone can be quantitated
after alkaline hydrolysis followed by amino acid analysis (Ray and Koshland, 1962).
This represents, therefore, a means whereby the effects of storage on the conversion
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Figure 3.5. Separation of Hyp, 3, 4-DHP, FMOC - OH and proline (Pro) on a
reverse-phase C18 HPLC column by isocratic elution with 34%
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Figure 3.6 Separation of Hyp, 3,4 - DHP, FMOC-OH and proline (Pro) on a
reverse-phase C18 HPLC column by isocratic elution with 30%
acetonitrile in 50mM acetic acid, final pH 4.3.
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Figure 3.7 Discontinuous SDS-PAGE of CNBr digests of collagen I and
collagen III standards and extracts of agarose inflated lung
tissue. Tracks 1-4, mixed collagen I and collagen III standards from
rat tail and rat skin respectively; Track 1, 50 pg collagen I + 50 |j,g
collagen III; Track 2, 40 jLLg collagen I + 40 fig collagen III; Track 3,
20 pg collagen I + 20 pg collagen III; Track 4, 10 pg collagen I
+ 10 pg collagen III. Tracks 5-8, extracts of agarose inflated lung
tissue. Tissue samples were treated prior to CNBr digestion using
the SDS extraction procedure of Laurent et al. (1981a). Standards and
tissue samples were reduced prior to electrophoresis.
(a) 60000
Total CNBr peptides from collagen I (jag)
Total CNBr peptides from collagen III (jig)
Figure 3.8 Relationship between peak areas for individual CNBr peptides and total
amounts of CNBr digested collagen standards analysed by
SDS-PAGE. (a) al (I) - CB - 8; (b) al (III) - CB - 5.
3.4 Enzyme-Linked Immunosorbent Assay (ELISA) for
Collagen IV.
3.4.1 Antibody/Antigen Optimisation.
In the ELISA for collagen IV the amount of peptides used for coating the well
and the concentration of primary antibody were determined simultaneously in order to
optimise assay conditions. For this purpose wells were coated with serial dilutions of
CNBr peptides from collagen IV and subsequently incubated for 2 hr with serial
dilutions of antiserum. The amounts of peptide and antiserum were chosen to
generate 0.8 - 1.0 absorbance unit. A typical optimisation assay for collagen IV,
using the antiserum supplied by V. Duance (AFRC, Bristol), is shown in Figure 3.9.
For this particular assay, a peptide amount of 7.3 |Xg per well and an antiserum dilution
of 1:500 were chosen which gave an absorbance of 1.0.
The effect of equilibrium on the assay was examined in order to improve the
sensitivity. In the equilibrium assay, soluble antigen and antiserum were added
simultaneously to the antigen-coated wells which allowed soluble and insoluble antigen
to compete directly for binding to the primary antiserum. In the non-equilibrium
assay, soluble antigen and antiserum were incubated together at 4°C overnight before
being added to the antigen-coated wells. The 50% inhibitory level was calculated
from standard curves plotted using the software package Assayzap (Dr. P. Taylor,
MRC, Centre for Reproductive Biology, Edinburgh). Under non-equilibrium
conditions, the sensitivity of an assay using the antiserum supplied by V. Duance was
greater, as illustrated in Figure 3.10. This increase in sensitivity is reflected in a shift
of the standard curve to the left. The 50% inhibitory level for the non-equilibrium
assay was 0.19 fig/100 (ll and for the equilibrium assay approximately 0.70 (lg/100
|il. There appeared to be no depression of binding between 0.4 fig/100|il and 0.8
(lg/100 jllI with the equilibrium assay which would again reflect a lack of sensitivity.
All subsequent assays were performed under non-equilibrium conditions.
3.4.2 Cross-reactivities.
The cross-reaction of CNBr peptides of collagen I and collagen III with a number
of anti-collagen IV antisera was assessed from standard curves produced by reacting
anti-collagen IV antisera with serial dilutions of CNBr peptides from purified collagens
I, III and IV in a non-equilibrium ELISA. The standard curves produced by a typical
cross-reactivity experiment are shown in Figure 3.11. Cross-reaction was quantified
at the 50% inhibitory level (Abraham, 1969) and the results are summarised in
Table 3.1. All antisera tested cross-reacted to varying degrees with the CNBr peptides
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Figure 3.9 Optimisation of antibody (Ab) dilution and amount of CNBr peptides
coating each microtitre plate well in an ELISA for collagen IV.
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Figure 3.10 Comparison of an equilibrium versus a non-equilibrium ELISA
for CNBr peptides of collagen IV. Each point on the graph
represents the mean of three determinations ± SEM.
B/B0% = amount of HRP-coupled second antibody which is
bound, expressed as a percentage of that bound in the absence
of soluble antigen.
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Figure 3.11 Cross-reaction of CNBr peptides from collagen I and collagen
III with anti-collagen IV antiserum in an ELISA for collagen
IV. Each point on the graph represents the mean of three
determinations ± SEM. B/BO% = amount of HRP-coupled second
antibody which is bound, expressed as a percentage of that bound in
the absence of soluble antigen.
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3.4.3 The Use of Monoclonal Antibodies.
In order to overcome the problem of lack of specificity of the polyclonal antisera,
two commercially available monoclonal antisera were tested in a sandwich type assay
using a polyclonal antiserum as the "capture" antiserum and a combination of the two
monoclonal antibodies as the "conjugate" antibody. Normally the HRP is
"conjugated" directly to the primary antibody. However, for the purposes of this
assay, HRP conjugated anti-mouse antiserum was used. It was found, however, that
optimisation of capture and conjugate antisera dilution was impossible due to a lack of
antibody-antigen reaction (data not shown), even at a low antisera dilution (1 : 50).
In order to test the reactivity of both polyclonal antisera and monoclonal
antibodies, microtitre plate wells were coated with collagen IV CNBr peptides
(7.3 |lg/well) as described in section 2.2.5.4. To half the wells was added
a polyclonal antiserum (1 : 100 dilution) and to the remaining wells was added a
1 : 100 dilution of a 1 : 1 combination of the two monoclonal antibodies.
Reactivity was measured with the use of HRP-coupled antispecies antisera and HRP
substrate (section 2.2.5.4). It was found that while the polyclonal antiserum showed
good reactivity as expected, the monoclonal antibodies showed no reaction with the
peptides. The results are summarised in Table 3.2. The reactivity of HRP-coupled
anti-mouse antiserum was tested by coating wells with a 1 : 100 dilution of a 1 : 1
combination of the two monoclonal antibodies followed by the addition of HRP-
coupled anti-mouse antiserum. After incubation the wells were washed and substrate
added. The results are summarised in Table 3.3 and show that HRP-coupled anti-
mouse antiserum reacts well with the adsorbed monoclonal antibodies. The lack of
any colour production by monoclonal antibodies was therefore due to their inability to
bind to CNBr peptides of collagen IV.
3.4.4 Purity of Collagens I, III and IV for use in ELISA.
In order to assess the purity of human collagens I, III and IV from the Sigma
Chemical Co., with respect to each other, CNBr digests of each collagen type were
analysed by discontinuous SDS-PAGE (section 2.2.5.3). The patterns produced by
each type are shown in Figure 3.12. Characteristic bands for collagens I and III were
identified with reference to the literature (Laurent et al., 1981a; Kelley et al., 1984;
Kirk et al., 1984a; Bateman et al., 1986) and demonstrated that these collagen types
were distinct from each other. The patterns given by CNBr digested collagens III and
IV were very similar demonstrating possible cross-contamination. The CNBr pattern
produced by either type, however, did not conform to the patterns produced by
purified rabbit collagens III and IV (Laurent et al., 1981a), although both the Sigma
collagen types did possess a band which ran to the al(III)-CB-5 position. Laurent et
al. (1981a) demonstrated that collagen IV does not possess a peptide that runs to this
position. The possibility that non-collagen proteins were contributing to the
complexity of the patterns seen in the present study cannot be excluded. Interpretation
of the gel might have been made easier had the samples not been reduced prior to
electrophoresis. As previously mentioned in section 3.3, al(III)-CB-9 may
contaminate the al(III)-CB-5 band when samples are reduced prior to electrophoresis
(G.J. Laurent, personal communication). Running samples unreduced would,
therefore, have allowed al(III)-CB-5 to be measured more accurately, as ocl(III)-CB-
9 would have run as a disulphide bonded dimer and so, much more slowly. It was
therefore impossible to draw any conclusions from the cross-reactivity experiments
with respect to measuring collagen IV in lung.
In the lung parenchyma, collagens I and III are present in approximately
12 x and 6 x greater quantities, respectively, compared to collagen IV (Seyer et al.,
1976; Rennard et al., 1980a; Madri and Furthmayr, 1980; Rennard and Crystal, 1982;
Kirk et al., 1984a). The quantities of collagens I and III in the lung compared to
collagen IV may not necessarily be high enough to cross-react significantly with the
anti-collagen IV antisera tested and therefore may not present a problem in an ELISA
for collagen IV in human lung. Further experiments are required using pure collagens
III and IV to establish accurate values for the cross-reactivity of anti-collagen IV
antisera to collagens I and III.
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Table 3.1. Cross-reaction of CNBr peptides of collagen I and collagen III with
a number of anti-collagen IV antisera.
Antiserum Cross-reactivity (%)
Collagen I Collagen III
V.Duance 10.5 36.6
Euro-diagnostics BV. 5.1 14.5
Immunoaffinity purified 7.1 9.5
Euro-diagnostics BV.
Southern Biotechnology 6.1 91.0
Cross-reaction was quantified at the 50% inhibitory level (Abraham, 1969).
72
Table 3.2. Reactivity of rabbit and mouse anti-collagen IV antisera with
collagen IV CNBr peptide-coated micro-titre plate wells (7.3 jig/well).
Antiserum Mean Absorbance at 490 nm ±
Standard Error of the Mean (SEM)
Rabbit anti-collagen IV 1.46 ± 0.03
Mouse anti-collagen IV ND
Anti-sera were diluted 1:100. ND = not detected, n = 6.
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Table 3.3. Reactivity of HRP coupled anti-rabbit and anti-mouse antisera with
rabbit and mouse anti-collagen IV antisera-coated microtitre plate
wells (1:100 antiserum dilution/well).
Antiserum Mean Absorbance at 490 nm ±
Standard Error of the Mean (SEM)
Rabbit anti-collagen IV 1.59 ± 0.03
Mouse anti-collagen IV 1.04 ± 0.07







Figure 3.12 Discontinuous SDS-PAGE of CNBr digests of human collagens
I, III and IV supplied by the Sigma Chemical Co.
Track 1, collagen I; Track 2, collagen III; Track 3, collagen IV.




4.1 Assessment of Biochemical Techniques.
It was important to determine the reproducibility of the various biochemical
techniques and the linearity of the calibration curves over the concentration ranges used
in each assay.
4.1.1 Hydroxyproline Determination.
Hyp has been shown to be stable during hydrolysis in 6N HC1 even in the
presence of carbohydrates (Jackson and Cleary, 1967).
The within-batch imprecision of Hyp determination on the amino acid analyser
(the PTC derivatisation technique) was assessed by determining the Hyp content of
several aliquots from a single sample hydrolysate within a single batch.
The between-batch imprecision of Hyp determination on the amino acid analyser was
assessed by the repeated measurement of aliquots from a single sample hydrolysate in
different batches. Different sample hydrolysates were used for assessing within-batch
and between-batch imprecision. The results are summarised in Table 4.1.
The within-batch and between-batch imprecision of Hyp determination by HPLC
with fluorimetric detection (the FMOC-C1 derivatisation technique) was assessed using
paired data obtained from several sample hydrolysates analysed in duplicate both
within a batch and between two batches (Percy-Robb et al., 1980). The results are
summarised in Table 4.1. The coefficients of variation are lower using the FMOC-C1
derivatisation technique compared with the PTC derivatisation technique and therefore
the former was the method of choice.
The FMOC-C1 derivatisation technique was introduced somewhat later in the
project and approximately 60% of Hyp measurements on agarose inflated lungs
(64 samples) were made using the PTC derivatisation technique. In order to determine
whether Hyp measurements from the two methods could be combined, results were
obtained by each method on 10 different samples. Comparison by the Mann-Whitney
rank sum test showed that the results obtained by either method did not differ
significantly (p=0.97), and therefore it was concluded that Hyp results from both
methods could be combined.
The calibration curves in which known amounts of pure Hyp standards were
plotted versus the ratio of the peak area of Hyp to the peak area of a fixed amount of
3,4-DHP, were linear with correlation coefficients of 0.999 or greater over the
concentration range 3.75 pmol-60.0 pmol Hyp/20 pi injected.
Table4.1.Within-batchandbetween-bvariationiqua tita ionofHypnminoclyser(PTC-Hyp)PLCh fluorimetricdetection(FMOC-Hyp)andinthqua itationfsodes osine.Hyisod smos ewt r inedok owv lum sgaros inflatedlungs mples. Coefficientofvariation(%) PTC-HypFMOC-Hypisodesmosine Within-batch13.96.39 0 n=17176 Between-batch9.34 7 n=72814 PTC-Hyp=phenylthiocarbamyl-Hyp;FMOC-9-fluorenylmeth c lorofor ate-Hyp;numberobservati ns.
-vl
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4.1.2 Desmosine and Isodesmosine Determination by HPLC.
The within-batch and between-batch imprecision of desmosine and isodesmosine
quantitation by HPLC was calculated using paired data obtained from several sample
hydrolysates analysed in duplicate both within a batch and between two batches
(Percy-Robb et al., 1980). Results for isodesmosine are summarised in Table 4.1.
The calibration curves in which known amounts of desmosine or isodesmosine
were plotted versus peak area, were linear with correlation coefficients of 0.999 or
greater over the concentration range 0.0625 nmol-1.0 nmol/10 p.1 injected.
4.2 Regional Variation Within a Lung.
It was also important to assess the regional variation in AWUV, collagen, and
elastin within a lung in order to determine whether samples from a single block of
tissue were representative of the lung as a whole.
Table 4.2 shows mean values obtained for AWUV, Hyp and isodesmosine from
the upper and lower lobes of two post mortem lungs after agarose inflation.
There were no significant differences in AWUV (p = 0.50), Hyp per mm^ (p = 0.95),
or isodesmosine per mm^ (p = 0.40) between the upper and lower lobes of the lung
obtained from a 75 yr old smoker. Similarly, there were no significant differences in
these parameters between the upper and lower lobes of the lung obtained from an 85 yr
old non-smoker (AWUV, p = 0.55; Hyp, p = 0.27; isodesmosine, p = 0.37).
4.3 Analysis of Agarose Inflated Lungs.
HPLC determination of isodesmosine and desmosine on 102 parenchymal
samples from nine agarose inflated lungs demonstrated that these elastin markers were
present in near equimolar amounts over the concentration range measured (Figure 4.1;
r = 0.979, p < 0.001). In view of the highly significant correlation between
isodesmosine and desmosine, data for desmosine measurements were omitted from
some of the comparisons (Tables 4.1, 4.2, 4.6 and 4.7). When the results for Hyp
determination were plotted against those for isodesmosine a significant correlation was
observed (Figure 4.2; r = 0.863, p < 0.001), thus demonstrating the degree to which
collagen and elastin are co-distributed within the alveolar tissue at the 50 mm^ level.
When the amounts of Hyp and isodesmosine in the 102 lung samples were
expressed per mm^ and plotted against their corresponding AWUV values, significant
negative correlations were observed (Figure 4.3) such that as AWUV decreased (i.e. a
decrease in the surface area of alveolar wall per unit volume), there was an increase in
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Figure 4.1 Relationship between the two elastin specific cross-linking amino
acids, desmosine and isodesmosine, over the concentration range
measured. The results were obtained from 102 samples from nine
lungs.
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Figure 4.2 Relationship between collagen (determined as hydroxyproline)
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Figure 4.3 Relationship between (a) the hydroxyproline, (b) the isodesmosine
and (c) the desmosine content per mm^ and the alveolar wall
surface area per unit volume (AWUV) for 102 samples taken from
nine smokers' lungs without macroscopic emphysema.
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the amount of Hyp (r = -0.326, p < 0.001) and isodesmosine (r = -0.265, p < 0.01).
The correlation between desmosine content per mm-' and AWUV was not significant
(r = -0.237; Figure 4.3).
Stronger negative correlations were found when the Hyp and isodesmosine data
were normalised to take into account surface area of alveolar wall, by dividing the
mm-' data by their corresponding AWUV values to give amounts of Hyp and
isodesmosine per mm^ of alveolar wall. The results are summarised in Figure 4.4 and
show highly significant negative correlations between AWUV and Hyp per mm^
(r = -0.530, p < 0.001), and between AWUV and isodesmosine per mm^ (r = -0.458,
p < 0.001). A highly significant negative correlation was also found between
desmosine content per mm^ and AWUV (r = -0.422, p < 0.001; Figure 4.4).
The data show that as the surface area of alveolar wall per unit volume decreases there
is an increase in the amount of collagen and elastin in the alveolar wall that remains.
The relationships between AWUV and Hyp, and between AWUV and
isodesmosine or desmosine, within each of the two post mortem lungs are shown in
Figures 4.5 - 4.8. A significant negative correlation between AWUV and Hyp, and
between AWUV and isodesmosine or desmosine was observed only in the lung of the
75 yr old smoker and only when the biochemical data were expressed per mm^.
4.4 Analysis of Formalin Inflated Lungs.
In order to increase the number of cases to include those with different forms of
emphysema, a store of formalin inflated lungs from the Department of Pathology,
University of Edinburgh, were analysed (section 2.1.2 and section 2.1.4.2).
Tissue samples were analysed biochemically (and for adjacent slice AWUV) from
areas remote from macroscopic emphysematous lesions. Of the 29 smokers' lungs
included in this part of the study, eight had case AWUV values below the lower limit
of "normality" for non-smokers (Gillooly and Lamb, 1993a). Of these lungs, five
had panacinar emphysema, one had centriacinar emphysema and two had a mixture of
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Figure 4.4 Relationship between (a) the hydroxyproline, (b) the isodesmosine and
(c) the desmosine content per mm^ and the alveolar wall surface area
per unit volume (AWUV) for 102 samples taken from nine smokers'
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Figure 4.5 Relationship between (a) the hydroxyproline, (b) the isodesmosine and
(c) the desmosine content per mm^ and the alveolar wall surface area
per unit volume (AWUV) of 24 samples taken from the upper and
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Figure 4.6 Relationship between (a) the hydroxyproline, (b) the isodesmosine and
(c) the desmosine content per mm^ and the alveolar wall surface area
per unit volume (AWUV) of 24 samples taken from the upper and
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Figure 4.7 Relationship between (a) the hydroxyproline, (b) the isodesmosine and
(c) the desmosine content per mm^ and the alveolar wall surface area
per unit volume (AWUV) of 32 samples taken from the upper and
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Figure 4.8 Relationship between (a) the hydroxyproline, (b) the isodesmosine and
(c) the desmosine content per mm^ and the alveolar wall surface area
per unit volume (AWUV) of 32 samples taken from the upper and



















Figure 4.9 Case AWUV plotted against age in a sample of non-smokers and
smokers showing eight subjects with case AWUV values falling below
the lower limit of "normality" for non-smokers.
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In order to determine the effect of formalin fixation on the determination of Hyp,
12 samples from different regions of the same lung were taken and half fixed in 10%
formalin for one week. The mean value for Hyp determined by the FMOC-C1
derivatisation technique for the unfixed samples was 6.6 nmol/mm^
(SD 2.8 nmol/mm^) and the mean value for Hyp for the fixed samples was
8.8 nmol/mm^ (SD 2.6 nmol/mm^). By the Mann-Whitney rank sum test there was
no significant difference between the two groups with respect to Hyp content per
mm3. Furthermore, the storage times of the emphysematous and non-emphysematous
groups were similar and therefore any possible effects of long term storage in formalin
would apply equally to all groups.
Hyp data were again expressed per mm^ and per mm^. In order to obtain an
accurate measurement of surface area with which to normalise the Hyp/mm^ data,
AWUV values were determined on an immediately adjacent slice to the pooled slices
used for Hyp determination (section 2.1.4.2).
4.4.1 Analysis of Non-smokers' Lungs.
Figure 4.10 shows the relationship between age and AWUV in the group of non-
smokers. There was a significant decrease in case AWUV with increasing age
(r = -0.808, p < 0.001) similar to that seen in a study of a larger number of non-
smokers' lungs (Gillooly and Lamb, 1993a).
There was no significant correlation between case AWUV and Hyp content either
per mm^ or per mm^ (Figure 4.11). Similarly, there was no significant correlation
between age and Hyp content per mm^ or per mm^ (Figure 4.12), though the trend in
Figure 4.12 (b) is consistent with the age-related loss in AWUV shown in
Figure 4.10.
4.4.2 Analysis of Smokers' Lungs.
The age ranges of the smoking and the non-smoking groups are summarised in
Table 4.3. The median and mean (±SD) age, case AWUV, Hyp/mm^ and Hyp/mm^
data for the all groups are summarised in Table 4.4. The four youngest non-smokers
have been excluded in order to minimise the effect of age on the morphological and
biochemical data between smokers and non-smokers. Thus, the mean age for the
non-smoking group was 61.2 (SD 12.5), and the mean age for the smoking group was
61.6 (SD 8.5). Comparison by the Mann-Whitney rank sum test showed that there
was no significant difference between non-smokers and smokers with respect to age.
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Figure 4.11 Case AWUV plotted against (a) hydroxyproline content per mm^
and (b) hydroxyproline content per mm2 for single samples from
each of 14 non-smokers' lungs. Hydroxyproline values per mm2
were converted to hydroxyproline per mm2 by dividing the former
figure by the AWUV value determined on the adjacent tissue slice to
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Figure 4.12 Age plotted against (a) hydroxyproline content per mm^ and (b)
hydroxyproline content per mm- for single samples from each of
14 non-smokers' lungs. Hydroxyproline values per mm^ were
converted to hydroxyproline per mm^ by dividing the former
figure by the AWUV value determined on the adjacent tissue
slice to those pooled for hydroxyproline determination.
Table 4.3 . Smoking histories and age ranges of the formalin inflated cases.
Smoking History Age Range n
(years)
Non-smokers 22 - 31 4
49 - 82 10
Smokers (all data) 43 ■- 82 29
CAE 43 •- 72 11
PAE 52--82 9
CAE/PAE 51 - 66 5
No macroscopic emphysema 57 -■ 70 4
CAE = centriacinar emphysema; PAE = panacinar emphysema;
CAE / PAE = mixed centriacinar / panacinar emphysema;
n = number of subjects per group.
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Smokers as a whole had a mean case AWUV of 14.80 (SD 3.28) which was
lower than the mean case AWUV for non-smokers (17.07, SD 1.81).
However, comparison by the Mann-Whitney rank sum test showed that the difference
was barely significant (p = 0.05).
The mean Hyp content for the non-smoking group was 3980 pmol/mm^
(SD 1000 pmol/mm^) and 232 pmol/mm^ (SD 74.2 pmol/mm^). The mean Hyp
content for the smoking group was 6540 pmol/mm^ (SD 3250 pmol/mm^) and
498.1 pmol/mm^ (SD 327.0 pmol/mm^). Comparison by the Mann-Whitney rank
sum test showed Hyp/mm^ was significantly higher in the smoking group than in the
non-smokers (p < 0.05). The significance was greater (p < 0.005) when Hyp/mm^
was normalised to take into account slice surface area and expressed per mm^.
Of the smoking group, lungs with centriacinar emphysema had a mean Hyp
content of 7100 pmol/mm^ (SD 3990 pmol/mm^) and 394.3 pmol/mm^ (SD 149.0
pmol/mm^). Lungs with panacinar emphysema had a mean Hyp content of 7170
pmol/mm^ (SD 3310 pmol/mm^) and 643.4 pmol/mm^ (SD 505.7 pmol/mm^).
Comparison by the Mann-Whitney rank sum test showed that smokers' lungs with
centriacinar emphysema had a significantly higher content of Hyp than non-smokers
lungs (p < 0.05). The level of significance remained the same whether Hyp was
expressed per mm^ or per mm^. Similarly, smokers' lungs with panacinar
emphysema had a significantly higher Hyp content than non-smokers lungs.
When the biochemical data were expressed per mm^, however, the level of
significance increased (p < 0.005 compared to p < 0.05).
Smokers' lungs with no macroscopic emphysema had a mean Hyp content of
5480 pmol/mm^ (SD 1750 pmol/mm^) and 343.5 pmol/mm^ (SD 116.1 pmol/mm^).
Though higher than in non-smokers, the Hyp content of the smokers' lungs, whether
expressed per mm^ or per mm^, was not significantly higher, by the Mann-Whitney
rank sum test, than in non-smokers.
Smokers' lungs with a mixture of centriacinar and panacinar emphysema had a
mean Hyp content of 4990 pmol/mm^ (SD 1970 pmol/mm^) and 588.6 pmol/mm^
(SD 245.3 pmol/mm^). Comparison by the Mann-Whitney rank sum test showed that
there was no statistically significant difference between this group and the non¬
smoking group with respect to Hyp content per mrn^. However, when Hyp was
normalised to take into account slice surface area per unit volume and expressed per
mm^, comparison by the Mann-Whitney rank sum test showed that the smokers'
lungs with a mixture of centriacinar emphysema and panacinar emphysema had
a significantly higher Hyp content per mm^ than the non-smokers (p < 0.005).
There was no statistically significant difference between smoking groups with
respect to Hyp content whether Hyp was expressed per mm^ or per mm^.
In summary, compared to non-smokers, smokers were found to have a
significantly higher collagen content in areas of lung free from macroscopic
emphysema. Smokers' lungs which had lesions of macroscopic centriacinar
emphysema and macroscopic panacinar emphysema present were found to have the
highest collagen content in areas of lung free from macroscopic emphysema, compared
to non-smokers.
4.5 Analysis of Lungs from al-Protease Inhibitor (al-Pi)
Deficient Subjects.
Lungs from three subjects with al-Pi deficiency, and from two smokers and a
non-smoker were analysed both morphometrically (for AWUV) and biochemically (for
Hyp and isodesmosine). One lobe was inflated with 70% (v/v) ethanol to allow the
determination of isodesmosine to be made as well as Hyp (section 2.1.4.3).
Further Hyp measurements were made on the second lobe which was inflated with
10% buffered formalin (section 2.1.4.3).
4.5.1 Analysis of Formalin Inflated Lobes.
Hyp data were expressed per mm^ and per rnrn^, where the latter was derived by
dividing the former figure by the adjacent slice AWUV (section 2.1.4.3).
When samples from the non-smoker and the two smokers were compared, using the
Mann-Whitney rank sum test, to the al-Pi deficient group (Table 4.5), the al-Pi
group had a significantly lower AWUV (p < 0.05) and a significantly higher Hyp
content per mm^ and per mm^ (p < 0.005). The smoking group was not significantly
different from the non-smoker with respect to AWUV, Hyp/mm^ or Hyp/mm^.
4.5.2 Analysis of Ethanol Inflated Lobes.
Due to technical difficulties in inflating lung tissue with ethanol, AWUV
measurements on these lobes were not possible. Isodesmosine content was therefore
expressed per mm^ and per mm^ where the latter was derived by dividing the former
by the mean AWUV which had been determined on the formalin inflated lobes.
Hyp data was expressed per mm^. When the individual cases were again grouped into
a smoking group and an al-Pi deficient group and compared, using the
Mann-Whitney rank sum test, to the non-smoker (Table 4.6), there were no significant
differences between the al-Pi group and the non-smoker with respect to isodesmosine
content either per mm^ or per mm-. The smoking group did, however, have
a significantly higher isodesmosine content per mm^ and per mm- compared to the
non-smoker (p < 0.05 and p < 0.005 respectively) and compared to the al-Pi group
(p < 0.005 and p < 0.05 respectively).
The mean Hyp content per mm^ for all samples from the formalin inflated lobes
was 5922 pmol/mm^ (SD 2624 pmol/mm^; n = 37) and for all samples from the
ethanol inflated lobes the mean Hyp content per mm^ was 6473 pmol/mm^
(SD 2893 pmol/mm^; n = 40). Comparison by the Mann-Whitney rank sum test
showed that these two values did not differ significantly and therefore, despite
problems inflating lobes with ethanol, it was felt that the isodesmosine and Hyp results
from the ethanol inflated lobes accurately reflected changes between the lungs studied.
These changes were reflected in the mean Hyp : isodesmosine ratios of the groups
(Table 4.7). Compared to the non-smoker, the smoking group and the al-Pi group
had a significantly higher Hyp : isodesmosine ratio (p < 0.05 and p < 0.005
respectively). The al-Pi group also had a significantly higher Hyp : isodesmosine
ratio compared to the smoking group (p < 0.005). The increased Hyp : isodesmosine
ratio of the smoking group compared to the non-smoker reflected a proportionally
greater increase in collagen content compared to the increase in elastin content.
The increased Hyp : isodesmosine ratio of the al-Pi group compared to both the non-
smoker and the smoking group reflected a significant increase in collagen content and
no change in elastin content.
Because only one non-smoker was included in this part of the study the results
should at this stage be regarded only as preliminary. In summary, compared to the
non-smoker, the al-Pi deficient lungs as a group were found to have a significantly
higher collagen content per mm^ of inflated lung and per mm^ of alveolar wall and no
loss of elastin. Compared to the non-smoker, the smokers' lungs as a group were
found to have a significantly higher collagen and elastin content per mm^ of inflated
lung and per mm^ of alveolar wall.
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Table 4.7. Descriptive statistics for the Hyp : isodesmosine ratio in ethanol inflated
lobes from the lungs of a single non-smoker, three subjects with al-Pi deficiency and
two smokers. Ratios were calculated from Hyp and isodesmosine values per mm3.
Significance values were calculated from medians using the Mann-Whitney rank sum
test.
na nb Hyp : isodesmosine ratio
Median Mean (SD)
Non-smoker 1 6 189.9 195.8 (21.5)
al-Pi 3 23 331.6 ** 319.4 (50.6)
Smokers 2 11 242.9 * 242.8 (26.7)
*
p < 0.05, ** p < 0.005 compared to the non-smoker; the al-Pi deficient lungs also
had a significantly higher Hyp : isodesmosine ratio compared to the smokers' lungs




5.1 Analysis of Collagen and Elastin in Agarose Inflated
Lung Samples.
Two of the major pitfalls in the analysis of lung connective tissue, the use of
whole lungs (section 1.8) and the use of inappropriate modes of expressing the data
(section 1.8), both of which have led to conflicting results, have been overcome in this
study. First, pleura and major bronchovascular structures were excluded from the
small pieces of tissue used in this study so that the biochemical and morphometric
measurements were more representative of changes in the acinar unit itself.
Second, samples of known volume were used and AWUV was determined on adjacent
slices in order that the biochemical data could be expressed with reference to both a
unit volume of inflated lung parenchyma (per mm^), and to a unit area of alveolar wall
(per mm2), thus accurately taking into account differences in the amount of alveolar
wall per unit volume from sample to sample.
In the analysis of the two post mortem lungs, one from a smoker and the other
from a non-smoker, there were no significant differences between upper and lower
lobes with respect to AWUV, Hyp/mm^ and isodesmosine/mm^ (section 4.2).
Kirk et al. (1986) were also unable to detect a significant difference in collagen content
between upper and lower lobes or vertically throughout the lung.
Therefore, gravitational pull on the human lung would seem to have no significant
effect on the vertical distribution of airspace size and collagen or elastin content.
There may be hidden mechanisms, however, which have evolved to minimise the
possible effects of gravity.
A strong correlation was observed when Hyp/mm^ was plotted against
isodesmosine/mm^, thus demonstrating the close association of collagen and elastin
within the acinar unit. These findings are consistent with those of Mercer and Crapo
(1990), who used morphometric techniques to evaluate the spatial distribution of
collagen and elastin fibres in rat and normal human lung parenchyma. They found
that in normal human lung the amounts of collagen and elastin fibres were greatest in
the walls of the alveolar ducts. Within the alveolar walls, the amounts of collagen and
elastin were greatest within the first 20 |im of wall adjacent to the duct. The ratio of
collagen fibres to elastin fibres remained remarkably constant throughout all the
alveolar tissue. It is possible therefore that the wide range of values for Hyp/mm^ and
for isodesmosine/mm^ observed in the present study may reflect not only the varying
amounts of tissue present per mm^ but also the portion of the acinar unit sampled.
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One of the important and surprising findings of this study was that as AWUV
decreased there was an increase in the amount of hydroxyproline, isodesmosine and
desmosine, per unit volume of alveolar tissue. The resected lung samples showed no
obvious signs of macroscopic emphysema, and the mean AWUV values for the
agarose inflated zones were within the normal range for non-smokers (Gillooly and
Lamb, 1993a). These results therefore, on essentially normal lungs, may simply
reflect the heterogeneity within the acinar unit with respect to collagen, elastin and
airspace size. Within normal lung, distal regions of the acinar unit, which consist
mostly of alveoli, have the highest AWUV values and, according to Mercer and Crapo
(1990), the lowest amount of collagen and elastin, at least compared to alveolar ducts.
More proximal regions of the acinar unit, which consist of terminal bronchioles,
respiratory bronchioles and alveolar ducts, have the lowest AWUV values but may
contain higher amounts of collagen and elastin.
The negative correlation was stronger when the biochemical data were expressed
per unit area of alveolar tissue. This is not surprising, since even if there was no
change in the amount of hydroxyproline, isodesmosine or desmosine per unit volume
between samples as AWUV decreased, there would still be a negative correlation with
AWUV once the biochemical data were expressed per unit area.
In other words, as AWUV decreases, the biochemical data per unit volume is divided
by a progressively smaller AWUV value to give progressively greater biochemical
amounts per unit area. Expressing the biochemical data per unit area, however,
minimises the effects of variable lung inflation and is more appropriate,
in physiological terms, in recognising changes within the walls themselves.
The data for collagen (both per unit volume and per unit area) were more
significantly correlated with AWUV than the corresponding data for elastin.
Again this may be an anatomical feature of normal lungs. Alternatively, the increase
in collagen with decreasing AWUV may reflect a low level of fibrosis, associated with
cigarette smoking, which is not obvious morphologically (see section 5.2).
To summarise, morphological and biochemical techniques have been used to
measure airspace size, collagen and elastin on lung parenchymal tissue devoid of major
bronchovascular structures. The techniques have been successful in detecting changes
in connective tissue in relation to airspace size such that as the amount of alveolar
tissue per unit volume decreases, there is a corresponding increase in the amount of
collagen and elastin in the remaining tissue. The results may simply reflect the
structural heterogeneity of the acinar unit or, in the case of collagen, may reflect a
fibrotic response to injury caused by cigarette smoke.
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5.2 Analysis of Collagen in Formalin Inflated Lung Samples
In order to increase the number of cases to include both non-smokers and
smokers with recognisable forms of emphysema, a store of formalin inflated and fixed
lungs were analysed biochemically to determine the collagen content of 40mm3
parenchymal samples. For reasons described earlier (section 2.1.1.1) it was not
possible to determine the elastin content of these samples. Unlike the agarose inflated
cases, where only mean AWUV for a single inflated block of tissue was available,
mean AWUV values for each of the formalin fixed lungs were determined from
6 random blocks per lobe (section 2.1.4.2).
In the non-smokers, morphometric analysis showed that there was a significant
decrease in case AWUV with increasing age. These results are in agreement with
Gillooly and Lamb (1993a) who established a normal range of AWUV values for
non-smokers between the ages of 21 and 93 years and showed a significant negative
correlation between case AWUV and age, thus demonstrating a normal increase in
airspace size with advancing age in adult lungs. These authors further proposed that
lungs with a case AWUV below the 95% prediction limit of the regression line should
be considered as having microscopic emphysema (Gillooly and Lamb, 1993a). In
another study, on a population of smokers, Gillooly and Lamb (1993b) demonstrated a
similar fall in case AWUV with increasing age. Among the smokers' lungs, however,
only 26% of cases had case AWUV values below the normal, age related, range for
non-smokers and could, therefore, be considered to have microscopic emphysema
(Gillooly and Lamb, 1993b).
In the present study, a subgroup of eight lungs had case AWUV values below the
lower 95% prediction limit for non-smokers. By definition, these lungs had
microscopically assessed emphysema and hence a generalised increase in airspace size.
In five of these lungs there were also areas of macroscopic panacinar emphysema
present, and in two of the lungs there were areas of macroscopic panacinar emphysema
together with emphysematous lesions of the centriacinar type. All but one of the
smokers' lungs with macroscopic centriacinar emphysema, however, had case AWUV
values within the normal limits for age. According to Gillooly and Lamb (1993b), a
reduction in mean AWUV in a lobe or a lung reflects a generalised increase in airspace
size. Microscopically assessed emphysema, therefore, reflects a disease process
which, in macroscopic form, is panacinar emphysema (where the whole of the acinar
unit is affected uniformly) rather than centriacinar emphysema. Focal lesions of the
centriacinar type, where respiratory bronchioles are affected, represent abnormally
large airspaces in the centres of the acinar unit, with normal lung parenchyma
elsewhere. Therefore, centriacinar emphysema does not in general affect overall case
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AWUV (Gillooly and Lamb, 1993a). In a later study, Gillooly and Lamb (1993c)
found that in a population of smokers with centriacinar emphysema, 85% had normal
case AWUV values.
The subgroups analysed were (a) non-smokers, (b) smokers without
macroscopic emphysema, (c) smokers with panacinar emphysema, (d) smokers with
centriacinar emphysema and (e) smokers with both centriacinar and panacinar
emphysema. If mean data for each group is considered then the effect of
heterogeneity in lung structure and collagen content (section 5.1) is minimised.
Any differences in mean Hyp content between the groups, therefore, is likely to be due
to a disease process. As the interest of the present study was changes in early
emphysema, samples for Hyp determination were taken from areas free from any
macroscopic emphysematous lesions, on the assumption that macroscopically
unaffected areas were representative of the early stages of the disease process.
The four youngest of the non-smoking group were excluded from any statistical
analyses in order that smoking and non-smoking groups were age matched.
Thus, there were no significant differences between non-smokers and smokers as
a whole, or between non-smokers and each of the smoking subgroups, with respect
to age.
Samples from the smoking group had a significantly higher mean Hyp content
than samples from the non-smoking group. The level of significance was greater
when Hyp was expressed per unit area of alveolar wall rather than per unit volume of
inflated lung. When the smoking group was sub-divided into types of emphysema,
those with centriacinar emphysema and those with panacinar emphysema had
significantly higher Hyp contents than non-smokers, whether Hyp was expressed per
unit volume of inflated lung or per unit area of alveolar wall. Smokers with a mixture
of centriacinar and panacinar emphysema had a significantly higher Hyp content than
non-smokers, but only if Hyp was expressed per unit area of alveolar wall. Of the
smoking group, those with panacinar emphysema had the highest Hyp content per
mm2- Although the group of smokers with no macroscopic emphysema had a higher
Hyp content, both per mm^ and per mm^, than the non-smokers, this was not
statistically significant. There was also no statistically significant difference between
the smoking groups with respect to Hyp content.
A likely explanation for the increased collagen content in the lungs of smokers,
particularly in the light of recent observations, is that this increase results from a
fibrotic response to an inflammatory process caused by injury due to cigarette smoke.
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Pulmonary fibrosis is used as a general term to describe disorders characterised
histologically as having diffuse thickening of the alveolar walls. Fibrous tissue,
thought to consist mostly of collagen, is localised predominantly in the interstitium
(Laurent, 1986). Studies of pulmonary fibrosis in humans
(Zapol et al., 1979; Collins et al., 1984) and in experimentally induced fibrosis in
animals (Starcher et al., 1978; McCullough et al., 1978; Laurent et al., 1981b) have
shown increases in total lung collagen. Kirk et al. (1986) also showed increases in
both total lung collagen and in collagen concentration (milligrams collagen per gram
dry weight) in a large sample of patients with pulmonary fibrosis.
Indirect evidence supports an increased rate of collagen synthesis in human
pulmonary fibrosis. Increased levels of collagen III propeptides have been reported in
serum (Kirk et al., 1984b) and lavage fluid (Low et al., 1983), and increased serum
levels of glucosyl transferase have also been demonstrated in patients with fibrosing
lung disease (Anttinen et al., 1985). In addition, Laurent and McAnulty (1983)
demonstrated a decreased degradation of newly synthesised collagen in the lungs of
rabbits with bleomycin induced fibrosis.
In relation to human pulmonary emphysema, evidence is emerging that fibrosis is
present in alveolar tissue. Dissecting light and scanning electron microscopic
observations of emphysema in humans (Nagai and Thurlbeck, 1991) demonstrated the
presence of fibrotic tissue in thickened alveolar walls from
14 patients with centriacinar emphysema. Fibrous tissue was not apparent in
panacinar emphysematous lesions which were present in 2 of the 14 patients.
These observations call into question two aspects of emphysema. The first concerns
the definition of emphysema (Snider et al., 1985) which states that no obvious fibrosis
accompanies destruction of alveolar walls. It is possibile that standard histological
techniques are relatively insensitive for detecting increases in connective tissue
proteins, unlike the biochemical analysis reported here. The second question concerns
the pathogenesis of emphysema (see below).
Evidence over the last 20 years or so tends to support the protease-antiprotease
hypothesis of emphysema (Janoff, 1985). If there is increased collagen, however, in
some forms of emphysema at least, then perhaps a more conventional concept of
inflammation may be envisaged, namely inflammatory injury followed by fibrotic
healing. According to Cardoso et al. (1993), an increase in collagen in lung
parenchymal tissue would tend to support an inflammatory repair hypothesis of
emphysema whereas a decrease in elastin would tend to support the protease-
antiprotease hypothesis. Cardoso et al. (1993) measured collagen and elastin
biochemically in 147 small samples from 25 human lungs. Collagen was also
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measured histochemically on an adjacent slice which was also used to determine the
presence, type and severity of emphysema. Expressing the biochemical data per
milligram dry weight, Cardoso et al. (1993) found that collagen was increased only in
irregular airspace enlargement while histochemically collagen was increased in
centriacinar emphysema, distal acinar emphysema and irregular airspace enlargement.
Elastin (determined biochemically using desmosine and expressed as micrograms per
milligram dry weight) was decreased in all grades of panacinar emphysema, in severe
centriacinar emphysema, in severe distal acinar emphysema, and in irregular airspace
enlargement. These authors concluded that, except in panacinar emphysema, collagen
deposition and loss of elastin go together in response to injury. Furthermore, their
data supported a protease-antiprotease hypothesis in panacinar emphysema, and an
inflammation-repair hypothesis in centriacinar emphysema, distal acinar emphysema
and in irregular air-space enlargement. These data support the idea that two different
mechanisms lead to separate morphologic patterns, as suggested by Gough (1952).
Contrary to the results of Cardoso et al. (1993), the present study demonstrates
biochemically an increase in collagen in all the types of emphysema studied
(centriacinar, panacinar and mixed centriacinar/panacinar), and in smokers' lungs with
no macroscopic emphysema, although the latter was not significantly different from
non-smokers. These differences between the present results and those of
Cardoso et al. (1993) may be due, in part, to the two fundamentally different ways in
which the studies were carried out. The first difference relates to the mode of
expression of the biochemical results. Cardoso et al. (1993) expressed their results
per milligram dry weight of parenchymal tissue unlike the volume or area related
measurements reported here. Despite Cardoso et al. (1993) taking the precaution of
excluding samples contaminated by proteins contained in oedema, blood and
inflammatory cells, it is felt that expressing the biochemical data per unit volume and
per unit area of alveolar tissue gives a more informative measure of collagen within the
alveolar walls compared to dry weight. The second difference relates to the
population studied and the site of sampling. All samples analysed by
Cardoso et al. (1993) were from smokers' lungs removed for cancer and comparisons
were made between lesions and apparently normal areas of the same lungs.
A generalised increase in collagen content would therefore have masked any increases
in the collagen content of the emphysematous lungs compared to unaffected control
lungs. Biochemically, increases in collagen were only observed in cases with
irregular air-space enlargement, a condition that is often associated with obvious
fibrosis (Snider et al., 1985). In the present study, samples from emphysematous
lungs were taken from areas free from macroscopic emphysema and the results
compared with those from non-smokers' lungs. Interestingly, smokers with no
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macroscopic emphysema had a higher collagen content than non-smokers.
The increased collagen content in all types of emphysema studied here would tend to
support the hypothesis of a repair process following inflammation.
The possibility that additional pathological processes lead to human emphysema,
other than a protease-antiprotease imbalance, was first suggested by
Snider et al. (1988) who used a hamster model of air-space enlargement with fibrosis
induced by cadmium chloride. Previously, respiratory air-space enlargement with
fibrosis had been demonstrated in humans after massive accidental exposure to
cadmium (Lane and Campbell, 1954; Bulmer et al., 1938). Experimental air-space
enlargement with fibrosis has also been produced in guinea pigs by intratracheally
instilled cadmium chloride (Thurlbeck and Foley, 1963) which has been shown to
produce a lesion in rats resembling human centriacinar emphysema
(Snider et al., 1973). Snider et al. (1988) demonstrated that hamster lung elastin
which had been radiolabelled with [^H] valine in the neonatal period was not lost
when, at a later date, air-space enlargement with fibrosis was induced by
intratracheally instilled cadmium chloride. Total lung collagen and elastin were shown
to be increased. Snider et al. (1988) concluded that enzymatically induced elastic fibre
damage may not, therefore, be the cause of this form of air-space enlargement and that
it is possible that the emphysema of cigarette smokers, which is predominantly of the
centriacinar type, may be a form of fibrosis with air-space enlargement.
Hoidal et al. (1985) showed that depleting hamsters of neutrophils with antineutrophil
anti-serum did not inhibit air-space enlargement produced by combined cadmium
chloride/(3-aminopropionitrile treatment and, therefore, this type of air-space
enlargement does not depend on neutrophil elastase. It has been shown that one
cigarette contains, on average, 1 pg of cadmium, and of this, approximately 70%
passes into smoke (Schroeder et al., 1961; Nandi et al., 1969). Cigarette smoke is an
important source of cadmium accumulation in human organs. Compared to
non-smokers, smokers accumulate more cadmium in direct relation to the number of
pack-years smoked (Lewis et al., 1972). For example, Hirst et al. (1973)
demonstrated a 4-fold increase in the cadmium content of emphysematous lungs
compared to controls.
Controversy surrounds the observation made by Damiano et al. (1986) that
elastase can be immunolocalised to elastic fibres in the lungs of smokers.
The observation was later confirmed by Ge et al. (1990), in support of the protease-
antiprotease hypothesis of emphysema in smokers. In contrast, Fox et al. (1988)
were unable to show specific binding of anti-elastase antibodies to elastic fibres in
emphysematous lungs, when care was taken to block non-specific binding by using
non-immune serum that was homologous to the second antiserum. When ovalbumin
was used as a blocking agent, non-specific binding to elastin of the immunogold
conjugated second antibody was observed (Fox et al., 1988). Damiano et al. (1986)
and Ge et al. (1990) both used bovine serum albumin as the blocking agent and,
therefore, their results may be due to non-specific binding.
It remains the case that most research effort has been, and continues to be, based
on the hypothesis that a protease-antiprotease imbalance is responsible for emphysema
in smokers. The evidence for this hypothesis appears to be so compelling that many
investigators have explored ways to prevent emphysema by manipulating the protease-
antiprotease balance (Snider et al., 1990). The main approach that has been considered
is that of supplementing the antiprotease system of the lungs, and to this end a
synthetic antiprotease is already in the early phase of clinical trials
(Snider, 1992).
The present study and those of Nagai and Thurlbeck (1991) and
Cardoso et al. (1993) support the idea that following inflammatory injury there is some
attempt at repair. An inflammatory-repair hypothesis does not necessarily contradict
the protease-antiprotease hypothesis and it seems likely that the morphological and
biochemical features of emphysema in smokers can be explained by a combination of
both hypotheses. Thus, destruction of extracellular matrix components, in particular
elastic fibres, by excess protease activity leads to loss of alveolar architecture and an
increase in air-space size. Fibrotic healing, characterised by an increase in alveolar
collagen content and possible repair of elastic fibres, cannot however restore normal
alveolar architecture and may even exacerbate alveolar loss by distortion of normal
areas rendering them more prone to attack by elastases.
All samples in the present study were taken from areas that were free from
macroscopic emphysema, regardless of whether emphysematous lesions were present
elsewhere in the lungs. Therefore, the increases in collagen in these areas of smokers'
lungs compared to non-smokers seems to suggest that an
inflammatory-fibrotic repair process occurs in the early stages of emphysema before
proteolysis of elastic fibres.
In summary, the present study has demonstrated that parenchymal samples taken
from areas of smokers' lungs without macroscopic emphysema have a significantly
higher collagen content than samples from non-smokers' lungs. Samples taken from
smokers' lungs which also have areas of macroscopic emphysema had the highest
collagen content. The higher collagen content may represent fibrotic tissue in
thickened alveolar walls as a result of inflammatory injury caused by cigarette smoke
followed by fibrotic healing. The fact that an increase in collagen content was
demonstrated in areas without macroscopic emphysema suggests that a possible
inflammatory repair process precedes elastic fibre destruction and/or damage ultimately
leading to macroscopic emphysema.
5.3 Analysis of al-Protease Inhibitor (al-Pi) Deficient Lungs
Lungs from three subjects with al-Pi deficiency, and lungs from two smokers
and one non-smoker, were analysed biochemically and morphometrically for the
determination of Hyp, isodesmosine, desmosine and AWUV. For the determination
of Hyp, isodesmosine and desmosine, lungs were inflated with 70% (v/v) ethanol.
Due to technical difficulties in inflating lung tissue with ethanol, especially lung tissue
from al-Pi deficient subjects, AWUV measurements were not possible on these lobes.
Therefore AWUV and further Hyp determinations were made on second lobes inflated
in the standard manner with formalin (section 2.1.4.2).
Despite concerns about possible variable inflation of the ethanol inflated lobes
(M.R. Lang, personal communication), there was no statistically significant difference
between Hyp content per mm^ of ethanol inflated lobes compared to corrresponding
formalin inflated lobes. It was felt, therefore, that the isodesmosine results from the
ethanol inflated lobes accurately reflected the isodesmosine contents of the
corresponding formalin-treated lobes.
The al-Pi group as a whole had a significantly lower AWUV and a significantly
higher Hyp content (per mm^ and per mm^) than both the non-smoker and the
smokers as a group. Compared to the non-smoker, however, the al-Pi group did not
have a significantly different isodesmosine content (per mm^ and per mm^).
Compared to the non-smoker and the al-Pi group, the smokers as a group had a
significantly higher isodesmosine content (per mm^ and per mm^).
It should be noted that because the genotypes and smoking histories of the al-Pi
deficient subjects have not yet been established, it cannot be stated whether
emphysema was solely a result of al-Pi deficiency and/or a result of smoking.
The extent and severity of emphysema compared to the smokers (section 4.4) would
tend to suggest that al-Pi deficiency would at least exacerbate emphysema caused by
cigarette smoking. The increase in collagen content compared to the non-smoker is
consistent with the presence of an inflammatory-repair process (section 5.2). As only
one non-smoker was included in this part of the study, the results must be regarded as
preliminary. This is the first study to demonstrate, however, no change in the elastin
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content of emphysematous lungs with al-Pi deficiency, compared to non-smoking,
unaffected controls.
Chrzanowski et al. (1980) and Tarjan et al. (1989) found that the elastin content
of lung parenchymal tissue from subjects with panacinar emphysema, including
subjects with al-Pi deficiency, was decreased from normal when expressed as a
proportion of crude connective tissue. In view of the present findings it seems likely
that the simple explanation for these authors' findings is that the decrease in the
proportion of elastin in the crude connective tissue samples was due to an increase in
the collagen content of the samples rather than a decrease in the elastin content.
These authors did not measure the collagen content of their samples. Of course it
cannot be stated that destruction of lung elastin does not take place.
A possible explanation for the present findings is that the processes leading to the
presumed destruction of lung elastin are being counterbalanced by synthesis of elastin
in a manner that does not restore alveolar architecture. Alternatively, there is a
rearrangement of existing elastin as alveolar walls undergo possible structural
remodelling caused by damage to, rather than destruction of, elastic fibres
(Fukuda et al., 1989).
One question which still remains to be answered is: Why do only 15% of long
term smokers develop chronic obstructive pulmonary disease (COPD) including
emphysema (Snider et al., 1990)? Also, of the total population with severe al-Pi
deficiency, only a few per cent present medically for COPD (Eriksson, 1965;
Mittman et al., 1974). Although PiMZ heterozygotes have intermediate serum levels
of al-Pi, current evidence indicates that this is not associated with an increased risk of
developing COPD (Bruce et al., 1984). It may be that healthy PiMZ heterozygotes do
not expose themselves to lung injury by smoking and therefore, intermediate levels of
al-Pi are sufficient to protect the lung against proteolytic attack.
The susceptibility of certain smokers to emphysema may have a genetic basis.
Two independent studies have recently shown that certain restriction fragment length
polymorphisms in the al-Pi gene occur more commonly in patients with COPD even
though they express the common MM phenotype and have normal serum levels of
al-Pi (Poller et al., 1990; Kalsheker et al., 1990). The 15% of smokers who have
COPD may therefore represent a group with a genetic predisposition to COPD which is
triggered by long term smoking.
The collagen content of lung parenchymal tissue from subjects with al-Pi
deficiency was found to be significantly increased compared to that of the non-smoker.
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This increase may, like the increase seen in the smokers of section 4.4, reflect the
presence of fibrotic tissue as a result of a repair process following inflammation.
One important difference between these smokers and the al-Pi deficient subjects,
however, was that the samples from the smokers' lungs were taken from areas free
from macroscopic emphysema, unlike the al-Pi deficient lungs where all areas were
affected. Therefore results on the smokers' lungs may be more indicative of the early
disease processes, while results from the al-Pi deficient lungs may be more indicative
of end stage disease.
In summary, preliminary data suggest that elastin may not necessarily be lost
from the lung parenchyma of subjects with emphysema associated with al-Pi
deficiency. One possible explanation for this finding may be that loss of elastin is
counterbalanced by resynthesis without restoration of normal alveolar architecture.
A second possible explanation is that there is a rearrangement of existing elastin as
alveolar walls undergo structural remodelling caused by damage to, rather than
destruction of, elastic fibres.
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Quantitative Studies of Human Lung Airspace Wall
in Relation to Collagen and Elastin Content
MALCOLM R. LANG1, GERALD W. FIAUX2, DAVID J. S. HULMES2,
DAVID LAMB1 and ANDREW MILLER2
1 Department of Pathology, Medical School, University of Edinburgh, Teviot Place and
2 Department ofBiochemistry, Hugh Robson Building, University of Edinburgh, George Square,
Edinburgh, Scotland.
Abstract
Biochemical determinations of the collagen and elastin content in 50 mm3 samples of human
lung are presented in relation to morphometric measurements of lung structure, as the amount of
alveolar wall surface area per unit volume (AWUV), on adjacent slices. There were no differences
in AWUV values, collagen content (determined as hydroxyproline) or elastin content (deter¬
mined as isodesmosine) between upper and lower lobes within a single lung. In a study of
102 samples from 9 smokers lungs with no evidence of macro- or microscopic emphysema (as
estimated by AWUV measurement), there was a negative correlation between AWUV and the
amounts of collagen or elastin per unit volume of inflated lung. The correlation was stronger
when collagen and elastin content were expressed per unit area of alveolar wall. The negative
correlation is interpreted as representing either the anatomical variation within the complex
hierarchy of normal lung structure or possibly low levels of fibrosis in response to cigarette
smoking.
Key words: collagen, elastin, lung, morphometry.
ritroduction
iollagens and elastin are the major extracellular matrix
IM) proteins of lung (Zapol et ah, 1.979; Kirk et al.,
16; John and Thomas, 1972; Pierce et al., 1961; Pierce
i Ebert, 1965). These proteins play vital physiological
■s in lung mechanics, enabling the tissue to stretch during
ation, preventing over-inflation, and facilitating subse-
nt recoil (Snider and Karlinsky, 1977). Various studies
e been directed towards identifying changes in the
)unts of collagen and elastin, during ageing and pulmo-
Y disease. Few studies, however, have substantiated any
nge from normality at a biochemical level, with the
■ssment of lung structure being rather subjective and
quantitative (Saetta et al., 1985; Saito et al., 1989;
;ai et al., 1989). The purpose of the present study is to
te morphometric techniques for quantifying alveolar
cture at the microscopic level to corresponding
Jhemical measurements of collagen and elastin content.
Many changes have been observed, both morphologi¬
cally and functionally, in the ageing human lung. One
major change is the progressive loss in the proportion of
tissue occupied by the alveolar walls. It has been estimated
morphometrically by Thurlbeck (1967b) that between the
ages of 20 and 80 one third of total airspace wall surface
area is lost. Gillooly and Lamb (1993a) also found that
airspace wall per unit volume decreased by one third
between the ages of 20 and 90. This loss of alveolar walls,
with increase in airspace size, results in a reduction of
surface area available for gas exchange. A loss of the lung's
elastic recoil (at 60% total lung capacity) is also age de¬
pendent (Turner et al., 1968; Zapletal et al., 1971). It is
likely that the loss of both airspace wall and elasticity must
in some way reflect alterations in the structure and
composition of the ECM.
The diseased state pulmonary emphysema, defined in
pathological terms as
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"a condition of the lung characterised by abnormal
enlargement of the airspaces distal to the terminal
respiratory bronchiole accompanied by destruction of
the walls, without obvious fibrosis" (Snider etal., 1985),
is usually induced by cigarette smoking. It has been shown
that this disease process further accelerates the loss of air¬
space wall with age (Gillooly and Lamb, 1993 b). Biochemi¬
cal comparisons, however, of collagen and elastin content
between non-emphysematous and emphysematous lungs
have usually failed to identify any changes in these ECM
components, in spite of abnormalities in microscopic struc¬
tural appearance. An early study on whole lung
homogenates (Pierce et al., 1961) found no changes in total
collagen and elastin levels in emphysematous and non-
emphysematous lungs. More recently Cardoso et al. (1993)
assessed lungs microscopically for emphysema, and made
quantitative biochemical measurements of collagen and
elastin within lesions from 4 types of emphysematous
lungs. They reported an increase in collagen with irregular
emphysema (IE) and a reduction in elastin with both IE and
centriacinar emphysema (CAE), per dry weight of tissue.
These authors also observed that although fibrosis was
obvious microscopically it was not detected biochemically
in lesions other than IE.
Any attempt to account for both age and disease related
changes in relation to biochemical alterations in ECM com¬
ponents must take account of the complex hierarchy of lung
structure (Weibel, 1959). Histological assessment of
emphysematous lung has usually only been qualitative,
even though quantitative morphometric techniques have
been available for some time. Collagens and elastin are
distributed non-uniformly throughout the bronchial tree
(Laurent, 1986; Starcher, 1986) therefore, in order to iden¬
tify any morphological and biochemical changes within the
airspace walls, it is important to select only parenchymal
tissue that is free of pleura and major bronchovascu
structures. Problems associated with inappropriate san
ling of the lungmay account for some of the conflicting d
in the literature on the amounts of ECM components
ageing and disease. Figure 1 shows the microanatomy of
lung acinar unit, depicting the successive change in str
ture from proximal to distal regions of the unit.
The choice of denominator is of crucial importance in
quantitation of lung ECM components. In emphysema,
example, changes in collagens and elastin are difficult
interpret when expressed per weight of lung tissue. A m
useful denominator would be either inflated lung volume
some quantitative measure of the amount of airspace w
We have recently developed a fast interval processing te
nique for the quantitation of airspace wall surface a
(Gillooly et al., 1991). Here we describe procedures for
biochemical analysis of collagens and elastin and tf
expression in relation to a quantitative measure of airsp




Lungs or lobes were obtained from 9 patients who f
undergone surgery for the removal of small periphe
tumours. All patients were smokers within the .
range 55 — 85 and showed no evidence of macrosco
emphysema. An additional two lungs were obtained
autopsy from a 75-year old smoker and an 85-year old m
smoker.
Fig. 1. Digital binary image from a
tological section (H fie E stain) of hut
lung parenchyma showing the succes
change in structure from proximal to d
end of the acinar unit. The frame (da;
box) represents a typical 1 mm2 fieli
tissue. Mag. x40.
KEY
T: terminal bronchiole, R: respira
bronchiole, D: alveolar duct, A: alveol
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Lungpreparation and sampling
In order to express the biochemical data in terms of lung
ucture it was necessary to develop a technique whereby
:asurements of total collagen and elastin could be carried
t on known volumes of fresh, inflated lung tissue. The
ndard procedure of inflation (Wentworth, 1950) by
rabronchial perfusion with buffered neutral formalin
MF), was unsuitable in this study in view of the reaction
formaldehyde with the amino groups of lysine (Kadler
d Chapman, 1988) and hence possible interference with
termination of the elastin specific cross-links desmosine
d isodesmosine. A technique was required for the prepa-
:ion of fresh lobes or portions of lobes in a condition
table for both morphometric and biochemical analysis,
e method developed is described in detail below.
Following resection, lung tissue was immediately placed
on ice and on arrival at the laboratory was transferred to a
high risk fume cabinet. A random zone of the lung (approx¬
imately 100 X 50 X 50 mm) was then transpleurally
inflated away from the tumour with an injection of 2%
agarose solution (approximately 150—200 ml depending
upon specimen size) previously heated to 30 °C. The zone
was considered inflated when the pleural surface became
firm and smooth in appearance. The tissue was maintained
on ice for a further lOmin until the agarose had solidified
within the airspaces, effectively maintaining inflation. The
inflated zone was then dissected free from the surrounding
lung, trimmed of pleura, and stored at 4 °C for a further
20 min. After placing the zone on a purpose built template,
slices approximately 15 X 15 X 2 mm were taken with a
Transpleural injection
of agarose solution at
30 deg. centigrade
MORPHOMETRY


















H&E stain acid hydrolysis
AWUV estimations on FIP
Biochemical estimations
of ECM's
2. Schematic representation of the
hod of sample preparation of fresh lung
le for morphometric measurement of
UV and biochemical estimations of
igen (hydroxyproline) and elastin
lesmosine).
V
Microscopic inspection : sections with
significant bronchovascular structures
are excluded from the sample.
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surgical skin graft knife blade (Downs Surgical, Mitcham,
England). The position of each slice within the zone was
recorded and alternate slices were stored in either 10%
BNF (for histology and subsequent morphometry), or 70%
ethanol (for collagen and elastin determinations). In order
to study lung composition within smaller defined regions,
the tissue prepared for biochemical measurements was fur¬
ther subdivided into approximately 50 mm3 samples (5x5
X 2 mm) with a surgical blade. The exact dimensions of
these subdivisions were determined with callipers and their
position within the larger slice recorded. At this stage the
morphology of a histological section from the adjacent slice
was examined microscopically and those regions contain¬
ing obvious, large amounts of bronchovascular structures
were excluded. From 9 lungs, 102 samples were prepared
by the above method. Figure 2 shows a schematic re¬
presentation of the sample preparation procedure.
Sampling ofpost mortem lungs
Whole lungs were obtained at autopsy in order to study
any anatomical variations in AWUV, collagen or elastin.
Three zones (upper, middle and lower) within each of the
upper and lower lobes were inflated with 2% agarose solu¬
tion. The zones were placed on ice and processed to 2mm
thick slices as described previously. Alternate slices (15 X
15x2 mm) were taken for either morphometry or
biochemical estimations. Slices for collagen and elastin
determinations were further subdivided into 50 mm3 sam¬
ples. Upper and lower lobes of each lung were compared by
one-way analysis of variance (ANOVA). The mean AWUV
of individual subdivisions (5x5 mm) within a slice (15 X
15 mm) comprised at least 20 AWUV estimations (see
below).
Preparation oftissue for morphometry
Formalin fixed slices of agarose inflated lung were dehy¬
drated through a graded ethanol series and embedded in
paraffin. From each slice histological sections were cut at
4 pm on a rotary microtome. The sections were de-waxed in
xylene and stained by the haematoxylin and eosin method
(Culling, 1963). AWUV values were determined for each
1 mm X 1 mm field in an 11 X 11 mm region within each
section. Tissue shrinkage occurs during processing into
paraffin wax. Therefore, it was necessary to calculate a
shrinkage factor for each section and adjust the mor¬
phometry data accordingly. Tissue slice dimensions were
measured before and after processing, and used to calculate
the area shrinkage factor and, its square root, the linear
shrinkage factor. AWUV values were multiplied by the
reciprocal of this linear factor (Gillooly et al., 1991).
AWUVmeasurement by Fast Interval Processor (FIP)
AWUV values were measured by the Fast Interval Proct
sor (FIP; Tucker and Shippey, 1981), a prototype version
a commercially available fully automated rapid scanni:
device, the Cytoscan (Image Recognition Systems, Wt
rington, Cheshire, England). The system was specifical
modified to enable lung alveoli to be quantified on histolo
ical sections. It consists of a MIPROC microprocess
(Plessey) linked to a Nikon inverted microscope with
motorised stage and a Fairchild CCD linear image sense
Photosensitive units within the sensor recognise optic
density pattern in the specimen creating a digitised ima
consisting of picture elements or 'pixels'. A user-defin
threshold limit determines what is recognised as bac
ground or tissue. A size filter then reduces 'noise'
eliminating particles (such as debris and lung inflammato
cells) less than 6 pm in diameter thus ensuring that or
intercepts with tissue are counted by the electronic test lit
The FIP uses the method of mean linear intercept (Li
Aherne and Dunnill, 1982), whereby intercepts of tiss
with a test line are counted, and the average distar
between intercepts is determined. Tissue surface area p
unit volume is then derived from Lm. A more detail
description of the FIP is given by Gillooly et al. (199
Perimeter values for each 1 mm2 field were stored on t
FIP, transferred to a mainframe computer (Unix™) a
AWUV values were calculated for each 1 mm2 field (such
the 1 mm2 region of alveolar tissue outlined in Fig. 1). 1
AWUV values for each section were displayed and me
AWUV values were calculated for each 5x5 mm subdi
sion, for comparison with biochemical data from cor
sponding sub-divisions of adjacent lung slices. Values
Lm and AWUV were derived as follows:
Lm = Total test-line length / Total number of intercep
Surface area (SA mm2) = 2 V / Lm, where V = volu
(mm3).
Airspace Wall surface area per Unit Volume (AWUV)
2/Lm (mm'/mnr).
Determinations oftotal collagens
Total collagen was measured using 4-hydroxyprol
(hyp) as a relatively specific marker. Hyp values w
obtained either by complete amino acid analysis or
selective determination of secondary amino acids.
Amino acid analysis was performed on a model 42'
amino acid analyser (Applied Biosystems, Warringtc
Briefly, the samples were de-fatted and homogenised-
acetone. A known amount of nor-leucine (BDH Ltd., Poi
England) was added as an internal standard and the s;
pies were hydrolysed in 6N HC1 (110°C for 24 h) in
vapour phase. The samples were reconstituted in 20'
0.025% K3EDTA, passed through a 0.22 pm filter (Geln
Sciences Ltd., Northampton, England), diluted a 100-1
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stilled water and 5 pi was applied to the analyser. The
10 acids were labelled automatically with phenyliso-
:yanate (PITC) and the resulting phenylthiocarbamyl-
10 acid derivatives (PTC-AA) were separated on a
nm (I.D.) X 22 cm cartridge-style reverse-phase col-
packed with C18 bonded phase silica. The peaks were
Ived by gradient elution (I. Davidson, personal com-
ication) as follows: 0—4min, 2% buffer B (70% v/v
initrile in 32 mM sodium acetate, pH6.1); 4—lOmin,
. bufferB; 10—20min, 35% bufferB; 20—25 min,
i bufferB; 25—30 min; 100% bufferB. BufferA con-
d of 3% (v/v) acetonitrile in 50mM sodium acetate,
i.22. The eluate was monitored at 254 nm. The amount
ach amino acid was determined from peak areas in
ion to known standards and corrected for recovery of
lor-leucine internal standard.
^proximately 50% of the hyp data were obtained on
imino acid analyser. The remainder were obtained by
tive determination of secondary amino acids using 9-
•oenylmethylchloroformate (FMOC-C1) derivatisation
rlink et ah, 1989). In this procedure a known amount
,4-dehydroproline (DHP; Sigma Chemical Co. Ltd.,
e, England) was added to the samples as internal stan-
. Samples were hydrolysed in liquid phase 6N hydro-
tic acid for 24 h at 110°C, dried in a Speed Vac Con-
rator (Savant Instruments Inc., Farmingdale, NY, USA)
reconstituted in 200 pi 0.025% K3EDTA. The deriva-
ion procedure and chromatography conditions were a
ification of the method of Teerlink et al. (19 8 9). HPLC
ysis was performed on a 4.6 mm ID X 25 cm Dynamax-
k column (Rainin Instrument Co. Inc., Woburn, MA,
) packed with 5 pm CI8 bonded spherical silica using a
on model 306 solvent delivery system and a model 231
sampler (Gilson Medical Electronics S.A., Villiers-le-
France). The peaks were resolved isocratically at a flow
of l.Oml/min, using 30% (v/v) acetonitrile in 50 mM
c acid (adjusted to pH4.3 with 1 M NaOH). Fluores-
s of the eluate was monitored with an LC 240 fluores-
s detector (Perkin-Elmer Ltd., Maidstone, Kent, Eng-
) using an excitation wavelength of 260 nm and an
sion wavelength of 330 nm. Results were calculated
calibration curves, constructed with known amounts
'p versus the ratio of the peak areas of hyp and a fixed
ant of 3,4-DHP.
ztermination ofelastin
ismosine and isodesmosine, determined as elastin
fic marker cross-links, were also determined by HPLC.
lies were hydrolysed as above (liquid phase hydrolysis)
treated by the cellulose "mini-column" method of
aer (1982) to remove interfering substances,
losine and isodesmosine were analysed by HPLC using
idification of the method of Yamaguchi et al. (1987)
the same column and solvent delivery system as for
hyp determination following FMOC derivatisation. The
peaks were resolved isocratically, at a flow rate of 0.8 ml/
min, using 18% (v/v) acetonitrile / 82% (v/v) 0.1 M sodium
phosphate containing 20 mM SDS, final pH 4.5. The eluate
was monitored at 270 nm with a model 759A u.v. absorb-
ance detector (Applied Biosystems Inc., Foster City, CA,
USA). Results were calculated from calibration curves, con¬
structed with known amounts of pure desmosine and
isodesmosine (Elastin Products, Owensville, MO, USA)
versus peak area.
Presentation and expression ofdata
Biochemical measurements of alveolar collagen and elas¬
tin were expressed per mm3 of agarose inflated tissue. Pro¬
tein amounts per unit area of airspace wall (amino acids/
mm2) were obtained by dividing the amino acids/mm3 val¬
ues by corresponding AWUV values (mm2/mm3).




The inter-observer reproducibility ofAWUV determined
by FIP was assessed by repeating the scans on a series of 100
random sections from 11 lungs with two different
operators. The intra-observer reproducibility was esti¬
mated by scanning the same section 20 times by the same
operator.
The FIP AWUV data from the two observers were com¬
pared and found to be highly linearly related (r = 0.986, p
<0.001) and were within 1% of each other. When the data
Table I. Intra- and inter-assay variation in collagen and elastin
determinations on independent hydrolysates of alveolar tissue.
PTC-hypa FMOC-hypb isodesmosine
(a)Intra-assay
CVC 13.85 6.3 9.0
nd 17 11 76
(b) Inter assay
CV 9.3 4.3 9.7
n 7 28 14
Amounts of hydroxyproline (hyp) and isodesmosine were deter¬
mined on approximately 5x5x2 mm sub-divided slices of agar-
ose-inflated lung. The PTC-hyp and FMOC determinations were
made on independent samples. Intra-assay and inter-assay vari¬
ations were assessed partly by the method of Percy-Robb et al.
(1980).
a PTC-hyp = phenylthiocarbamyl-hyp
b FMOC-hyp = 9-fluoroenylmethylchloroformate-hyp
c CV = coefficient of variation
d
n = number of assays
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Fig. 3. Relationship between the two e
tin markers, desmosine and isodesmo


























1 Fig. 4. Correlation between alveolar c
50
gen (hydroxyproline) and elastin (isc
mosine) content for 102 samples 1
9 lungs.
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e II. Anatomical variation in AWUV, alveolar collagen (hydroxyproline) and elastin (isodesmosine) content within individual lungs
i a 75 year old smoker and an 85 year old non-smoker.
75-year old smoker 85-year old non -smoker
: AWUV hyp ide AWUV hyp ide
mm2/mm3 (pmol/mm3) (pmol/mm3) (mm2/mm3) (pmol/mm3) (pmol/mm3)
18.61 (1.85) 7080 (2500) 27.7(4.8) 14.74 (1.04) 6440 (640) 25.9 (6.7)
17.86 (2.64) 7150 (3450) 30.2(10.7) 15.23 (1.58) 5876 (1270) 28.0 (4.2)
reviations:
= upper lobe, LL = lower lobe
JV = amount of alveolar wall per unit area
= hydroxyproline
= isodesmosine
represents means with standard deviation
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. AWUV as a function of hydroxyproline and isodesmosine, in cumulative data from the 9 resected cases, 102 samples, (a) hydroxy-
le per mm3 (b) hydroxyproline per mm2 (c) isodesmosine per mm3 and (d) isodesmosine per mm2.
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were compared by Mann-Whitney U Test there was no
significant difference between the two observers (p = 0.68).
Variation in AWUV data from the sections scanned
20 times by the same observer was 0.72%.
Since some of the earlier hydroxyproline data (approxi¬
mately 50% of the total) were obtained on the amino acid
analyser (rather than selective determination of secondary
amino acids), results obtained by each method on identical
samples were compared. When hydroxyproline data from
10 samples were compared in this way, Mann-Whitney U
Test showed that the results obtained by either method did
not differ significantly (p = 0.97) and therefore hydroxy-
proline results from both methods were combined. Table I
shows the intra-assay and inter-assay variations in the PTC-
hyp, FMOC-hyp and isodesmosine determinations.
Regional variation within a lung
Table II shows the AWUV values, collagen and elastin
content for upper and lower lobes of two post mortem
lungs. There were no significant anatomical differences in
AWUV (p = 0.50), collagen per mm3 (p = 0.95), or elastin
per mm' (p = 0.40) between the upper or lower lobes of the
75-year old smoker, or within the lung of the 85-year old
non-smoker (p = 0.55, p = 0.27 and p = 0.37, respec¬
tively).
Analysis ofseveral cases
The collagen and elastin contents for 102 samples from 9
resected lungs are shown below. Data for the two elastin
markers, desmosine and isodesmosine, are closely corre¬
lated (Fig. 3; r = 0.979, p <0.001) and in an approximate
1:1 ratio. In the results below, total elastin is represented by
isodesmosine (ide). The relationship between total colla-
gens and elastin is shown in Fig. 4. The data show a strong
relationship between estimations of the two proteins and
demonstrates their degree of co-distribution within alveo¬
lar tissue at the level of the 50 mm3 sampling size.
Cumulative data for AWUV in relation to both collagen
and elastin content are shown in Fig. 5. The data for colla¬
gen and elastin are expressed in two ways. First, as shown in
Fig. 5 (a), total hyp within each 50 mm3 sample is expressed
per unit volume (mm3) of lung tissue. Second, as shown in
Fig. 5 (b), hyp amounts per unit volume have been divided
by AWUV to give hyp per unit area of alveolar wall (mm2).
When hyp data were expressed per unit volume, r =
— 0.326 (p < 0.001) and when expressed per unit area, r =
— 0.530 (p <0.001). Fig.5 (c) and (d) show corresponding
data for elastin, with r = —0.265 (p <0.01) per unit
volume and r = — 0.459 (p <0.001) per unit area. The data
show that when collagen and elastin are expressed either
per unit volume or per unit area of airspace wall, there is a
negative correlation between changes in AWUV and the
amounts of these ECM proteins, i.e. as AWUV drops over
the measured range there is a corresponding increas
alveolar collagen and elastin content. The significanc
the negative correlation is greater when protein amo
are expressed per unit area of airspace wall.
Discussion
We have determined the biochemical amounts of c<
gen and elastin in human lung in relation to the arnoui
alveolar wall per unit volume (AWUV). The work is pa
a larger study of the changes in extracellular matrix (EC
in relation to morphological changes in human lung
space wall, particularly in emphysema. As the amour
alveolar wall falls in emphysema (Thurlbeck, 1967 a, 1
Gillooly and Lamb, 1993 a), and as the lung loses elasti
it would be reasonable to expect a similar fall in E
content. The pathogenic mechanisms proposed for
emphysematous process suggest that the elasticity of
lung is lost as a consequence of the release of neutro
and/or macrophage proteolytic enzymes into the extr;
lularmatrix (Wright, 1961; Flayes et ah, 1975; Kuhn ei
1976; Soskel and Sandberg, 1987), though there is 1
quantitative biochemical data about changes in ECM
teins to substantiate this theory. In order to investigate s
changes, it was first necessary to establish the rela
between ECM content and AWUV in lungs without em|
sema. The tissue was prepared by agarose inflatioi
enable both collagen and elastin to be expressed per
volume or per unit surface area of inflated lung ur
previous biochemical determinations where data were
malised to tissue dry weight (Cardoso et ah, 1993) or w
lungs (Pierce et al., 1961). In addition, care was take
ensure that the samples used in the analysis were devoi
the major bronchovascular support structures of the 1
which are rich in ECM.
There were no significant variations in AWUV or
amounts of collagen and elastin per unit volume of 1
when data averaged from several slices in both upper
lower lobes were compared (Table II). We conclude f
these findings that in man gravitational stress on the
has little influence on the distribution of alveolar coll;
and elastin. These observations are consistent with tho
Kirk et al. (1986), who also showed no difference in c
gen either between lobes or vertically throughout the 1
Within slices however, significant variations in A\
were detected at the level of the 5x5x2 mm sub-
sions, though average AWUV values for whole slices (
15 X 2 mm) were relatively constant (Lang and L;
unpublished observations). In view of this local variatii
AWUV, collagen and elastin data for the 5x5 mm sub
sions were related to AWUV data for corresponding
5 mm fields in the adjacent slice.
Analysis of samples from 9 resected lungs show
negative correlation between sample AWUV and
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ounts of collagen (measured as hydroxyproline) or elas-
(measured as isodesmosine), whether expressed per unit
ume or per unit surface area of alveolar tissue. Collagen
[ elastin were found to co-distribute, though the negative
relation with AWUV was more significant for the colla-
data. Samples with low AWUV contained more colla-
and elastin (per unit volume of lung or per unit area of
;olar wall) than samples with high AWUV.
Ve propose two possible interpretations of these find-
5. First, within normal lung, areas of high AWUV occur
listal regions of the acinar unit and these may be less rich
1CM proteins (per unit volume) than the more proximal
ions (containing vascular material and supporting struc-
;s such as respiratory bronchioles) with low AWUV.
: resected lung samples showed no obvious signs of
croscopic emphysema, and the AWUV values for the
rose inflated zones were within the normal range for
i-smokers (Gillooly and Lamb, 1993 a). Therefore our
ervations may simply reflect the complex hierarchical
icture of the acinar unit. Second, the biochemical data
y be detecting a low level of fibrosis in the low AWUV
tples that may not be obvious morphologically, as inch¬
ed by the increased amount of ECM per unit volume of
ated lung.
"he negative correlation with AWUV is more significant
en protein amounts were expressed per unit area of
eolar wall. It should be noted that even if there is no
relation between AWUV and ECM per unit volume,
n a negative correlation with AWUV may appear when
M per unit volume is divided by AWUV to give ECM per
t area of alveolar wall. Samples with constant amounts
1CM per unit volume will have greater amounts of ECM
unit area as the AWUV value decreases. However,
iressing ECM amounts per unit area of alveolar wall has
advantage of minimising the effects of variable lung
ation, and is more physiologically appropriate in recog-
ng changes within the walls themselves. We feel that the
dication of these techniques will facilitate the under-
iding of changes in lung structure in relation to collagen
I elastin in patients with early to late stage emphysema.
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Collagen content of alveolar wall tissue in
emphysematous and non-emphysematous lungs






























Background - Emphysema is currently
defined as "a condition of the lung char¬
acterised by abnormal, permanent
enlargement of the airspaces distal to
the terminal bronchiole, accompanied by
destruction of their walls, and without
obvious fibrosis." The functional and
morphological changes that occur in
emphysema have largely been attributed
to changes in alveolar elastin rather than
in collagen. A study was performed to
determine whether the amount of colla¬
gen in the alveolar wall changes with age
in the lungs of non-smokers and of
smokers with different types of macro-
scopically defined emphysema in re¬
lation to a microscopic measurement of
lung structure.
Methods - Total alveolar wall collagen
was measured (as hydroxyproline) in
known volumes of distended lung tissue
(by reverse phase high pressure liquid
chromatography) in the lungs of non-
smokers (n = 23) and in regions sampled
away from emphysematous lesions in the
lungs of 36 smokers (four with no emphy¬
sema, 13 with centriacinar emphysema
(CAE), nine with panacinar emphysema
(PAE), and 10 with a mixture (MIX) of
both PAE and CAE). Mean lung airspace
wall surface area per unit volume
(AWUV) was calculated from at least six
random blocks per lung and on histologi¬
cal sections immediately adjacent to
those prepared for collagen measure¬
ment with a rapid scanning device (fast
interval processor).
Results - In non-smokers there was no
significant correlation between the
amount of collagen in the alveolar wall
tissue and either mean lung AWUV or
increasing patient age when amounts of
collagen were expressed either per unit
volume of distended lung (40 mm3
sample) or per unit surface area of air¬
space wall tissue. Smokers without
emphysema had similar amounts of col¬
lagen to non-smokers. Lungs with PAE
and MIX, but not CAE alone, contained
significantly more collagen than normal
when expressed per unit volume of air¬
space wall tissue whereas all groups,
including CAE, contained significantly
raised amounts of collagen when
expressed per unit surface area.
Conclusions - There is no significant age
related change in the collagen content of
the lungs of non-smokers which suggests
that, as AWUV is lost with age, the main
collagenous framework is maintained.
However, in smokers with emphysema
there is a loss of airspace wall tissue in
regions remote from the macroscopic
lesions that is accompanied by a net in¬
crease in collagen mass. The greater ac¬
cumulation of collagen in MIX lungs than
in CAE lungs suggests a greater degree of
structural damage, indicative of an
alternative pathogenetic mechanism
operating between the different types of
emphysema. Our results suggest an act¬
ive alveolar wall fibrosis in emphysema
as a consequence of cigarette smoking. It
is suggested that the definition of emphy¬
sema may require further revision to
include such change.
(Thorax 1994;49:319-326)
The presence of collagen in the extracellular
matrix is fundamental to the normal structural
integrity, compartmentation, and functional
capacity of the lung. Collagens are found in
abundance in airways, vessels, pleura, base¬
ment membranes, and alveolar wall tissue.
Both collagen and elastin are found in intimate
association within the alveolar wall matrix, and
form an intricate network of supporting fibres
running through the interstitium.1 Collagen
types I and III, in a ratio of approximately 2:1,
are the main fibrous components of the inter¬
stitium, representing more than 90% of all
parenchymal collagens.23 Any alterations in
alveolar wall structure are therefore likely to be
a consequence of changes in the collagenous
composition of the tissue. It has been sug¬
gested that the collagens of parenchymal tissue
have an important role in lung compliance.45
Pulmonary emphysema has been defined in
pathological terms as "a condition of the lung
characterised by abnormal, permanent en¬
largement of the airspaces distal to the termi¬
nal bronchiole, accompanied by destruction of
their walls, and without obvious fibrosis."6
The increase in airspace size with concomitant
loss of alveolar wall tissue that occurs in
emphysema can be quantified indirectly by
measuring airspace wall surface area per unit
volume of lung tissue (AWUV). A range of
normal AWUV values in relation to age was
recently established in a study of the lungs of
non-smokers.7 Current concepts of the patho¬
genesis of emphysema implicate neutrophil
derived proteinases, particularly human neu¬
trophil elastase, as mediators of alveolar wall
matrix destruction.8 Proteinases induce lung
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injury by their proteolytic action on a range of
connective tissue proteins including collagens.
It is thought that an imbalance between the
proteinases released by inflammatory cells and
their inhibitors, specifically a-1-proteinase
inhibitor, may account for the morphological
changes that occur in emphysema.910
Collagens and elastin are important proteins
in emphysema, but attempts to quantify bio¬
chemical changes in the amounts of these lung
matrix proteins have been confusing, with
many studies presenting conflicting data. Most
of this work has focused on elastin in emphy¬
sema.11-13 Studies of collagen in emphysema
have been few. The characteristic thinning of
alveolar wall tissue with increased lung com¬
pliance and loss of recoil has been regarded
solely as a consequence of alterations in elastin
metabolism. Increased alveolar wall collagen
(per dry weight, corrected for lung volume14)
has been more closely associated with inflam¬
matory diseases such as interstitial pulmonary
fibrosis (cryptogenic fibrosing alveolitis).
Studies of collagen in emphysema have
related biochemical estimations to wet or dry
weight of tissue. Recently Cardoso and col¬
leagues15 showed that, in samples from the
lesions of lungs with irregular emphysema,
amounts of collagen were raised beyond nor¬
mal when expressed as pg hydroxyproline/mg
freeze dried tissue. We feel, however, that to
recognise any change from normality within
parenchymal tissue biochemical estimations
should be related to a measurement of lung
structure such as AWUV. Furthermore, in
view of the observations that the airspace walls
are the sites of tissue loss in emphysema,
biochemical measurements of collagen should
be confined only to this alveolated portion of
the lung.
We have recently quantified the collagen
and elastin content of parenchymal tissue in
lungs from smokers with no evidence of mac¬
roscopic or microscopic emphysema in multi¬
ple 5x5x2 mm (50 mm3) samples taken from
nine different lungs1617 and found that, as the
AWUV for the 50 mm3 samples decreased, the
concentrations of both collagen and elastin
increased. The relative increase in collagen
and elastin was apparent when expressed both
per unit volume of lung sample or per unit
surface area of alveolar wall. These results
suggest either low levels of fibrosis occurring
within the tissue, perhaps in response to cigar¬
ette smoking, or alternatively anatomical dif¬
ferences in extracellular matrix content
according to the portion of the acinar unit
contained within the sample. This work also
indicated that the approach of combining mor-
phometric measurements of lung structure
with quantitative biochemistry is a sensitive
way of detecting differences in the extracellu¬
lar matrix content of the alveolar wall.
In this study we have investigated the effect
of both age and microscopic emphysema on
the collagen content of alveolar walls in regions
of tissue from emphysematous lungs sampled
from non-involved areas without any obvious
macroscopic lesion. Sampling from these re¬
gions may indicate the possible changes in the
amounts of alveolar wall collagen occurrin
early stage emphysema.
Methods
SELECTION AND CLASSIFICATION OF LUNG
SAMPLES
Samples comprised either whole lungs or lc
from 59 individuals. Lungs were obtai
either at necropsy or from patients undergo
surgery for the removal of peripheral 1
tumours.
Macroscopic emphysema was considc
present if airspace size was greater than 11
in diameter on inspection of the mid sagi
slice from the lung or lobe.18 Lungs u
assessed by an experienced pathologist (E
Macroscopic emphysema was classi
according to its distribution within the aci
as (1) centriacinar emphysema (CAE) -
space enlargement around the respirat
bronchioles with parenchymal tissue s
rounding CAE lesions appearing normal to
naked eye; (2) panacinar emphysema (PAI
airspace enlargement affecting the whole
nar unit; and (3) mixed emphysema (MI>
both CAE and PAE lesions present in the si
specimens.19
Microscopic emphysema was considerec
be present if the mean AWUV of the specir
was lower than the range of age related AW
values recently described in non-smokers,
the emphysematous lungs both morphome
and biochemical analyses were carried out
regions both remote from any lesion and
void of macroscopic emphysema.
Lungs were included in the control gr<
only if clinical records stated that the subji
were "life long non-smokers." Twenty tl
lungs were from life long non-smokers anc
were from smokers with either no emphyse
CAE, PAE, or MIX. The non-smokers
eluded lungs from patients aged 22-82 ye
while the age ranges of the smoking gro
were significantly smaller (table 1). To pret
the introduction of bias in the collagen ci
parisons the non-smokers were age mate
with the different smoking groups. The n
smoker group contained a number of necrc
lungs from young individuals (age range
32; n = 8). These lungs were excluded f
any comparisons with the smoking groi
Further details of the ages of the non-smo1
and each of the different smoking groups
shown in table 1.
Table I Smoking histories and age ranges of the
non-smoking and smoking groups investigated







No emphysema 57-70 4
CAE = centriacinar emphysema; PAE= panacinar emphy
MIX = lungs having a mixture of both panacinar and c
acinar emphysema.
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lung inflation
Lobes were floated in a plastic specimen box
containing buffered formalin (10%) and in¬
flated by intrabronchial perfusion with buf¬
fered formalin at a pressure of 25 cm H,0 from
an elevated reservoir until the pleural surface
became firm and smooth.20
morphometry: estimation of mean lung
awuv
Following complete fixation for at least 24
hours the lungs were placed on a purpose built
template and 1 cm thick parasagittal slices
were taken from each lobe. From the mid
sagittal slice at least six random blocks,
20 x 20 x 5 mm, were taken per lobe.21 The
blocks were processed and embedded in glycol
methacrylate resin and 3 pm sections were cut
from each block and stained by the haematoxy-
lin and eosin method. For each block AWUV
was estimated using an automated image scan¬
ning system, the fast interval processor
(FIP).161721 Mean AWUV from either six or 12
blocks (depending upon number of lobes avail¬
able per lung) was calculated for each speci¬
men. AWUV was also estimated in blocks
adjacent to the samples prepared for total
collagen estimations as described below.
preparation of tissue for total collagen
estimation
The following technique was devised to enable
quantitative biochemistry of collagen amounts
to be related to morphometric measurements
of lung structure on adjacent tissue sections.
The technique was a modification of the
method of Lang et al17 devised to quantify
collagen and elastin amounts in localised zones
of lung tissue inflated with agarose. From the
mid sagittal slice of each lobe prepared for
mean AWUV estimation (described above) an
additional 20 x 20 x 5 mm block was taken at
random from the non-smoking and smoking
lung groups and stored in 10% formalin. In
emphysematous lungs (CAE, PAE, and MIX)
all samples were taken from macroscopically
non-involved areas away from any lesion.
These blocks were removed from the formalin
fixative, placed on an absorbent tissue, and
gentle pressure applied until the formalin was
expelled from the block. The tissue was then
placed into a medium sized peel away mould
(Cat. No. 18646B, Park Scientific, UK) and
fully immersed in approximately 5 ml of opti¬
mal cutting temperature cryoembedding com¬
pound (OCT Tissue-Tek; Bayer Diagnostics,
UK). The block was left in OCT for 15
minutes until the airspaces were fully pene¬
trated. OCT maintains tissue inflation and
block rigidity during subsequent histological
processing. The blocks were frozen by placing
the tissue on a cryostat chuck and immersing
the chuck in liquid nitrogen. Each block was
left for 10 minutes to equilibrate in the cryostat
chamber. In order to measure collagen
amounts within known volumes of distended
lung tissue, four serial 25 pm sections (total
volume 40 mm') were taken from each block
and placed directly into glass hydrolysis tubes.
A further 3 pm section was prepared from each
block for AWUV measurement. Details of the
procedure are shown in diagrammatic form in
fig 1.
measurement of alveolar wall collagen
content
Total collagen was measured (as hydroxypro-
line) in each 40 mm7 sample by selective deter¬
mination of secondary amino acids, using
9-fluoroenylmethylchloroformate (FMOC-C1)
derivatisation.22 Samples were hydrolysed in
liquid phase 6N hydrochloric acid for 24 hours
at 110°C, dried in a Speed Vac Concentrator
(Savant Instruments, Farmingdale, New
York, USA) and reconstituted in 200 pi
0-025% K,EDTA. High pressure liquid chro¬
matography (HPLC) analysis was performed
on a 4-6 mm internal diameter x 25 cm Dyna-
max-300A column (Rainin Instrument Co,
Woburn, Massachusetts, USA) packed with
5 pm C18 bonded spherical silica using a Gil-
son model 306 solvent delivery system and a
model 231 auto sampler (Gilson Medical Elec¬
tronics SA, Villiers-le-Bel, France). Details of
the hydroxyproline quantitation have been de¬
scribed fully by Lang et al}1
calculation of the amounts of alveolar
wall collagen
In the frozen sectioned material collagen was
quantified in a known volume of airspace wall
tissue (40 mm'), and AWUV (mm2/mm3) was
measured on the adjacent section of tissue.
Collagen content is expressed either as
hydroxyproline per unit volume (nmol/mm')
or hydroxyproline per unit surface area of
airspace wall (nmol/mm2), the latter obtained
by dividing the amount per unit volume by the
AWUV value for the adjacent slice. In the
non-smokers hydroxyproline amounts per unit
area of alveolar wall were plotted against mean
case AWUV, the latter being determined from
the glycol methacrylate embedded blocks.
hydroxyproline and formalin fixation
By normalising our collagen amounts to local
lung structure we were able to eliminate any
possible variations in shrinkage with length of
storage in fixative.
We are unaware of any effect of formalin
fixation on the determination of hydroxypro¬
line. Control experiments on lung samples
from different regions of the same lung, with
or without formalin fixation, showed no signi¬
ficant difference in collagen amounts per unit
volume (data not shown). Furthermore, the
storage times of the various experimental
groups were similar, hence any long term
effects of formalin fixation would apply equally
to all groups.
statistical analysis
In the non-smoking group the effects of ageing
and mean lung AWUV on the hydroxyproline
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Figure 1 Schematic representation of the method of sample preparation of alveolar wall tissue for morphometric
measurement of AWUV and biochemical estimations of collagen.
content of the alveolar wall tissue were com¬
pared by multivariate regression analysis.23
Hydroxyproiine data of the lungs of smokers
were compared with those of non-smokers
using the non-parametric rank Mann-Whitney
U test for the difference between the group
medians. Median and mean (SE) values are
shown for the amounts of hydroxyproiine,
patient age, and lung AWUV. Differences
were considered significant if p<0-05.
Results
MEAN LUNG AWUV VALUES
Non-smokers
In the non-smokers the mean lung AWUV
dropped significantly with age from 22 34 to
14-02 mnr/mm3 (age range 22-82 years;
r= — 0-801, p<0-001). A similar age dif¬
ference has previously been shown in a larger
sample of lungs from non-smokers.7
Smokers
The lungs of smokers assessed to be free of any
macroscopic emphysema had mean AWUV
values within the normal age related limits in
non-smokers (table 2). The median AWUV
values of each group of macroscopic
emphysematous lungs (CAE, PAE, and M
were significantly lower than the median
the non-smoking group (table 2). When ii
vidual lungs within each group were c
sidered in relation to the lower limit of norn
ity of the non-smoking population we fo1
that, of the 13 CAE lungs measured two
mean AWUV values below normal, whiL
the nine PAE lungs five had lower AW
values than normal, and in the MIX group
of the 10 lungs were abnormal. In a lai
sample of emphysematous lungs24 mean 1
AWUV values in 15% of CAE lungs v
below the lower limit of normality, wherea
PAE and MIX lungs 63% and 58% resp
ively were below the normal limit (Gilli
and Lamb, unpublished observations).
ALVEOLAR WALL COLLAGEN CONTENT
Non-smokers
In the lungs of non-smokers collagen cont
expressed as hydroxyproiine per unit vol1
(fig 2A) or per unit surface area (fig 2B
alveolar wall tissue showed no significant
relation with case AWUV. The ranges of 1
roxyproline content in the alveolar wall ti
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Table 2 Median, mean (SE) lung AWUV and hydroxyproline content of alveolar wall tissue (expressed per unit
volume and per unit surface area) of the smoking and non-smoking groups










Non-smokers 63-0, 64-3 (3-30) 17-06, 17-23 (0-50) 4-62, 4-56 (1-44) 0-254, 0-272 (0-026)
Smokers
CAE 62-0, 59-3 (2-71) 15-91, 16-01 (0-69)* 5-80, 7-18 (1-10) 0-371, 0-438 (0-058)*
PAE 62-0, 62-2 (3-16) 10-45, 12-23 (1-25)** 7-68, 8-11 (3-01)** 0-461, 0-643 (0-169)**
MIX 63-0, 62-4 (1 69) 11-45, 12-58 (1-10)** 6-63, 6-71 (3-79)* 0-676, 0-716 (0 068)**
No emphysema 66-0, 64-8 (3-01) 17-01, 17-30 (0-97) 5-82, 5-48 (1-75) 0-319, 0-343 (0-058)
CAE = macroscopically assessed centriacinar emphysema; PAE =macroscopically assessed panacinar emphysema; MIX = mixture
of both panacinar and centriacinar emphysema.
*
p < 0 05, ** p < 0 005 smoking group v non-smoking group.
of the lungs of non-smokers (n = 23 samples,
age range 22-80 years) were 2-46-8-03 nmol/
mm' (per unit volume) and 0-116-0-515 nmol/
mnr (per unit surface area). Furthermore,
when patient age was considered we found no
significant relation with alveolar wall collagen
content, either per unit volume (fig 2C) or per
unit surface area (fig 2D). When age, mean
lung AWUV, and hydroxyproline content of
the alveolar wall were compared by multivar¬
iate regression analysis hydroxyproline was
not significantly related to either age or mean
lung AWUV.
Smokers
Table 2 shows data obtained from the lungs of
smokers for patient age, mean lung AWUV,
and collagen content expressed per unit
volume and per unit surface area of alveolar
wall tissue. Patient ages in each of the smoking
groups were not statistically different from the
older subpopulation of non-smokers (table 1).
In the PAE and MIX groups there were signi¬
ficantly increased amounts of collagen com¬
pared with the non-smokers when expressed
both per unit volume or per unit surface area
of airspace wall tissue. Collagen amounts were
also significantly raised in CAE lungs when
expressed per unit surface area of alveolar wall
tissue. However, when collagen was expressed
per unit volume CAE lungs showed no signi¬
ficant change from the lungs of non-smokers.
Table 2 shows the significance values of the
differences in alveolar wall collagen content
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Figure 2 (A) Mean lung AWUV in 23 life long non-smokers plotted against alveolar wall collagen content (as
hydroxyproline) per unit volume. (B) Mean lung AWUV in 23 life long non-smokers plotted against alveolar wall
collagen content per unit surface area of alveolar wall. (C) Alveolar wall collagen (hydroxyproline) content per
unit volume plotted against patient age in non-smokers. (D) Collagen in the lungs of non-smokers expressed per unit
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Figure 3 (A) Median alveolar wall collagen content
(as hydroxyproline per unit volume alveolar wall tissue)
in the lungs of smokers (with and without macroscopic
emphysema) compared with life long non-smokers.
CAE = centriacinar emphysema; PAE = panacinar
emphysema; MIX= both CAE and PAE. Data analyses
were made on similar age groups. In the CAE, PAE,
and MIX lungs samples were taken from regions
showing no macroscopic emphysema. For each group
median collagen content is represented by a horizontal
bar. Significant differences from the non-smoking group
are indicated: * p <005, ** p <0-005. (B) As (A)
with collagen expressed per unit surface area of alveolar
wall tissue. Significant differences from the non-smoking
group are indicated: * p< 0-05, ** p< 0-005.
age matched non-smoking group. Figures 3A
and B show the collagen contents of the lungs
of individual non-smokers and smokers. There
was an increased scatter in the data for CAE,
PAE, and MIX lungs compared with both the
non-smokers and the smokers without emphy¬
sema.
Discussion
In this study we have quantified airspace
structure morphometrically in emphysema
and related our measurements to biochemical
estimations of collagen content. Emphysema
was classified into subtypes depending upon
the distribution of abnormal airspace within
the acinar unit. Analyses of collagen content in
emphysematous lungs were performed in areas
with minimal macroscopic abnormality. As¬
sessment of microscopic emphysema24 may
identify mild microscopic PAE not visible
macroscopically. However, for the purposes of
this paper we have confined our classification
to macroscopically assessed emphysema.
We have used a morphometric measurement
- the amount of airspace wall surface area per
unit volume (AWUV) - to assess lung struc-
Lang, Fiaux, Gillooly, Stewart, Hulmes, L
ture. The use of AWUV enables the detect
of early stage microscopic enlargement of ;
spaces. Amounts of collagen in the alvet
wall tissue can then be expressed either
unit volume or per unit surface area. To
knowledge this is the first investigation re
ing biochemical analyses of amounts of co
gen in airspace tissue to detailed mease
ments of local and mean lung architecture
both non-emphysematous and emphyser
tous lungs.
COLLAGEN IN NORMAL, NON-SMOKERS' LUNG
As the normal lung ages, airspace size
creases with an associated loss of AWU
Biochemical estimations must therefore t
into account this change with age. In ordei
identify alterations in connective tissue p
teins in emphysema statistical comparisi
must be made between samples of compara
ages.
In view of the loss in alveolar wall tis
density with age, we may speculate that th
could also be age related changes in the cont
of extracellular matrix. Our observatio
however, showed no significant correlat
between the collagen content of the alvec
wall and either increasing age or change
mean lung AWUV when collagen \
expressed per unit volume of alveolar v
tissue. When collagen amounts were expres:
per unit surface area of alveolar wall tis:
correlations with both change in age and mi
lung AWUV were apparent, but these w
not statistically significant. It should be no
that we have calculated mean lung AWI
from at least six random blocks per lung, wl
hydroxyproline per unit surface area is derb
from AWUV measured on slices adjacent
those prepared for collagen determinatio
The data indicate that, although there i
significant loss of alveolar wall tissue as
human lung ages, there may be an act
process maintaining a constancy in amount
structural collagen that enable the lung
function.
COLLAGEN IN SMOKERS' LUNGS
To identify changes from normal in emphj
matous lung collagen we have expres
amounts both volumetrically and per unit 5
face area. These data may not be dire
comparable to work published elsewhere,
example, amounts of collagen have often b
reported per dry weight.141' As our intentio
to relate alveolar wall collagen to change:
regional lung structure we feel that a rr
meaningful normalisation of the collagen t
is either to volume or alveolar wall sur
area. When expressed per unit surface are
alveolar wall the effects of any local differei
in lung inflation are automatically eliminai
The lungs of smokers without macrosci
emphysema had mean AWUV values wi'
the normal range for age.7 Although the ah
lar wall collagen content of these lungs ten
to be higher than in the lungs of non-smok
the difference was insignificant, perl
'agen and emphysema 325
emphysema
Figure 4 Digital binary image demonstrating the enlargement of airspace size and concomitant loss of alveolar wall,
both with age (22 and 82 year old non-smokers) and in a lung from a 70 year old smoker with panacinar
emphysema (PAE). In the PAE lung airspace enlargement due to microscopic emphysema can be seen.
Magnification x 40.
because of the small sample size (n = 4; table
2). A previous study of smokers' lungs free of
any macroscopic or microscopic emphysema
clearly demonstrated increased amounts of
alveolar wall collagen and elastin (either per
unit volume or per unit surface area) in
samples with low AWUV compared with the
more alveolated specimens which contained
relatively less collagen and elastin.1617 These
earlier analyses were made in 5x5x2 mm
samples and may have identified variations in
AWUV within the acinar unit.
In emphysematous lungs we may expect an
increase in airspace size with concomitant loss
of alveolar wall surface area, as stated in the
definition of emphysema.6 For example, fig 4
demonstrates the extent of microscopic air¬
space enlargement in two lungs from an 82
year old non-smoker and a 70 year old smoker
with PAE compared with a 22 year old life long
non-smoker. From such morphological
changes we might expect a loss, or at least no
change, in amounts of collagen per unit
volume of lung. Surprisingly, however, when
the lungs of smokers with emphysema were
compared as a group to the lungs of non-
smokers of similar ages, the emphysematous
group contained significantly more collagen
per unit volume (median hydroxyproline con¬
tent 4-49 nmol/mm1 in non-smokers v
6-62 nmol/mm3 in emphysematous lungs).
Similarly, when the amounts of collagen in
each emphysematous group were considered
individually in comparison with the lungs of
life long non-smokers (age ranges 49-82
years), collagen amounts per unit volume were
also elevated beyond normal in each group
except CAE. When expressed per unit surface
area of alveolar wall the amount of collagen
increased in all emphysematous groups includ¬
ing CAE. In lungs with CAE the median
alveolar wall collagen per unit surface area was
increased some 1-6 times, whereas both PAE
and MIX lungs had an increase in collagen
content per unit surface area of 2-4^2-5 times
respectively.
A recent study15 found that collagen (as a
proportion of birefringence per volume of
sample) appeared to be increased within
lesions from CAE, distal acinar, and irregular
airspace enlargement. However, a biochemical
increase in collagen (as hydroxyproline pg/mg
of tissue) was only detected in lesions from
lungs with irregular airspace enlargement. Our
results on non-macroscopically involved re¬
gions of alveolar wall tissue indicate that colla¬
gen per unit volume remains unchanged in
CAE, but in PAE the amounts are significantly
raised despite reduced amounts of alveolar
wall per unit surface area. Furthermore, mor¬
phometry measurements of airspace wall have
shown that around 85% of CAE lungs have
mean lung AWUV values within normal limits
for age.24 This observation may highlight the
larger proportion of normal, uninvolved re¬
gions surrounding the emphysematous lesions
in CAE which may contain less fibrotic air¬
space wall than PAE lungs in which airspace
enlargement has affected the whole acinar unit.
This finding lends further support to the
hypothesis that there may be alternative path¬
ogenetic mechanisms contributing to the mor¬
phometry and biochemical differences in
lungs with purely CAE or PAE.
EMPHYSEMA AND COLLAGEN METABOLISM
There have been few previous studies of the
changes in the amount of collagen in patients
with emphysema. Emphysema is usually
regarded as a condition of the lung in which
elastin amounts are altered, although data on
this are conflicting with reports of either no
change,12 or decreased amounts1315 of elastin.
Changes in collagen have been more closely
associated with inflammatory diseases such as
idiopathic pulmonary fibrosis (cryptogenic
fibrosing alveolitis) in which increases in the
total collagen have suggested a progressive
deposition of collagen throughout the dis¬
ease.14
Normal lung collagen homeostasis requires
that collagen synthesis be counterbalanced by
mechanisms in which collagen is degraded.25 26
A tight balance between synthesis and degra¬
dation of connective tissue proteins therefore
enables tissue which is rich in collagens, such
as alveolar wall, to function normally. Our data
indicate that in emphysema (CAE, PAE, and
MIX lungs) there is likely to be an imbalance
between the two processes which leads to an
increase or accumulation of collagen mass
within the tissue of the alveolar walls. Turn¬
over studies are required to determine
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whether the observed increase in collagen in
emphysema is due to increased synthesis, de¬
creased degradation, or both.
The definition of emphysema states an in¬
crease in airspace size but "without obvious
fibrosis." In this paper the amounts of collagen
represent an increase beyond normal in macro-
scopically "normal" alveolar wall regions of
emphysematous lungs. Despite the definition
of emphysema6 there appears to be a clear
association between emphysema and an in¬
crease in the collagen content (fibrosis) of the
alveolar wall tissue detectable at the level of
quantitative biochemistry.
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